logotest1logotest1logotest1logotest1
  • WHICH BLENDS ARE BEST FOR ME?
  • 88/8: EXTREME WEIGHTLOSS PROTOCOL (MESSAGE FOR PASSWORD)
  • TESTIMONIALS
  • SHOP
  • CART
  • SAMPLES
  • COMBOS
  • HOME
  • MAILING LIST
  • CONTACT SHIPPING
  • CONTACT GAVIN
  • SCIENCE
  • ABOUT
  • INGREDIENTS
  • TEXT SIGN UP
  • TELEGRAM PORTAL (MESSAGE ORDER NUMBER)
  • INTERSTELLAR BLOGS
  • ULTIMATE DRY FASTING RESOURCE
  • MY ACCOUNT
  • RESET PASSWORD
0
    ✕
              No results See all results
              INTERSTELLAR MATCHA
              February 6, 2017
              anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity
              SAMPLES 200:1
              May 19, 2017
              THUNDER (Male Sexual Health)

              THUNDER (Male Sexual Health)

              Rated 5.00 out of 5 based on 16 customer ratings
              (16 customer reviews)

              $275.00

               

              Clear
              SKU: N/A Category: Featured Tag: Featured
              Share
              0
              • Description
              • Additional information
              • Reviews 16
              THUNDER
              200:1 STRENGTH VERY POTENT

              Proprietary herbal blend for men.

              Apigenin

              Arugula (Eruca sativa)
              Beet (Beta vulgaris subsp.)
              Butea superba
              Cacao
              Carnosine
              Passion flower
              Citrus sinensis

              Damiana (Turnera diffusa)

              Epimedium sagittatum

              Panax ginseng

              Grapefruit (Citrus paradisi)

              Gynostemma pentaphyllum

              IcarIin

              Kaempferia parviflor

              Maca (Lepidium meyenii)

              Moringa oleifera
              Pomegranate (Punica granatum)
              Quercetin
              Resveratrol
              Rubus coreanus

              Ruta chalepensis

              Rutin

              Scutellaria baicalensis

              Sophora flavescens

              Tongcat Ali

               

              Warnings:

              As with any supplement, consult your medical practitioner prior to using this product if you are pregnant, may become pregnant, breastfeeding, taking medication, other dietary supplements or have a medical condition. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

              *Daily Value has not been established

              Probiotic Microbes Sustain Youthful Serum Testosterone Levels and Testicular Size in Aging Mice

              … -07 USE OF STROMAL VASCULAR FRACTION OF ADIPOSE TISSUE IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION: EVALUATION OF CLINICAL …

              … -07-008 Exploring the number of low intensity shock wave treatment (LiSWT) sessions needed in patients with VASCULOGENIC ERECTILE DYSFUNCTION (ED): 6 vs …

              … -08 LONGITUDINAL RISK OF DEVELOPING CARDIO VASCULAR DISEASES AMONG PATIENTS WITH ERECTILE DYSFUNCTION-WHICH PATIENTS DESERVE …

              … -label, Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra (R)(Sildenafil Citrate) in Males with ERECTILE DYSFUNCTION and Arterial HYPERTENSION  …

              … -S&T-15 THE RELATIONSHIP BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG THE VASCULOGENIC ERECTILE DYSFUNCTION …

              … -term conventional treatment for overlap syndrome (obstructive sleep apnea and chronic obstructive PULMONARY disease) on concurrent erectile dysfunction

              … ‐rated patient preference and patient‐and partner‐rated preference for tadalafil or sildenafil citrate: results from the Canadian ‘Treatment of Erectile Dysfunction’ …

              … , and ERECTILE DYSFUNCTION in congestive HEART failure: a double-blind, placebo-controlled, randomized study followed by a prospective treatment for erectile dysfunction

              … , Multicenter, Flexible Dose Study to Evaluate the Efficacy and Safety of Viagra®(Sildenafil Citrate) in Korean Men with ERECTILE DYSFUNCTION and Arterial HYPERTENSION  …

              … : EXPLORATION OF THE ASSOCIATION BETWEEN DIETARY INTAKE AND ENDOTHELIAL FUNCTION AMONG VASCULOGENIC ERECTILE DYSFUNCTION …

              … : metode za očuvanje protoka Kroz unutrašnju ilijačnu arteriju.[Endo VASCULAR treatment of aortoiliac aneurysms (EVAR) and erectile dysfunction: methods to preserve …

              … : POOLED ANALYSIS OF SATISFACTION WITH VARDENAFIL TREATMENT IN MEN WITH ERECTILE DYSFUNCTION AND THEIR PARTNERS

              … . FTY720 supplementation partially improves ERECTILE DYSFUNCTION in rats with streptozotocin-induced type 1 diabetes through inhibition of endothelial dysfunction and …

              … . J Sex Med 2007; 4: 226–30. This article was inadvertently listed as a Case Report. It should have been listed as Original Research—Erectile Dysfunction.

              … ‘SEXUAL DYSFUNCTIONS: Women’s Sexual Function Improves When Partners Are Administered Vardenafil for Erectile Dysfunction: A Prospective, Randomized …

              … /hydrogen sulfide pathway induces cGMP-dependent relaxation of corpus cavernosum and penile arteries from patients with ERECTILE DYSFUNCTION and improves arterial …

              … ®) on hemodynamic parameters during exercise testing and occurrence of ventricular arrhythmias in patients with ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              … 6.5. Prevalenta disfunctiei erectile la pacientii de sex masculin cu accident VASCULAR cerebral, factori de risc si co-morbiditati asociate/Prevalence of erectile dysfunction …

              … and 6-month durability of endo VASCULAR pelvic arterial re VASCULAR ization in alleviating lower urinary tract symptoms and ERECTILE DYSFUNCTION in patients with …

              … and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 476 Patients with Erectile Dysfunction: Implications for Endo VASCULAR  …

              … AND INCREASED AORTIC STIFFNESS AND PENILE VASCULAR DISEASE SEVERITY IN ERECTILE DYSFUNCTION PATIENTS WITH METABOLIC …

              … AND INFLAMMATION IN CORPUS CAVERNOSUM ARE INCREASED COMPARED TO ARM BLOOD LEVEL: IMPACT ON ERECTILE DYSFUNCTION

              … and Partial Bladder Outlet Obstructed Rabbit Corpus Cavernosal Contractility: Modulation of Nitric Oxide-mediated Relaxation and Relevance to Erectile Dysfunction

              … and stem cell therapy in the treatment of ERECTILE DYSFUNCTION and PULMONARY HYPERTENSION ; potential treatments for the common problem of endothelial dysfunction

              … AND WAVE REFLECTIONS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

              … ARTERIAL STIFFENING AND WAVE REFLECTIONS IN DIABETES: THE EFFECTS OF AUTONOMIC NEUROPATHY AND ERECTILE DYSFUNCTION

              … ARTERY CALCIFICATIONS IN HEMODIALYSIS PATIENTS AND ITS CORRELATION WITH THE PREVALENCE OF ERECTILE DYSFUNCTION

              … artery peak systolic velocity among normal adults in Abuja, Nigeria: A Baseline parameter for sonographic diagnosis of VASCULOGENIC erectile dysfunction

              … Assessment of Prevalence and Distribution of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in Patients with Erectile Dysfunction

              … assessment of sexual functions in women with male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve female partner’s …

              … Association Between Aortic Stiffness, Wave Reflections, and Duration of VASCULOGENIC Erectile Dysfunction: Linking ERECTILE DYSFUNCTION With Generalized VASCULAR  …

              … Association of the T-786C, G894T and 4a/4b Polymorphisms of the Endothelial Nitric Oxide Synthase Gene with VASCULOGENIC ERECTILE DYSFUNCTION in Iranian Subjects

              … between arterial stiffness, left ventricular geometry and the severity of erectile dysfunction: A ventriculoarterial interaction in ERECTILE DYSFUNCTION patients

              … between the venous shunts of penile corpus spongiosum and cavernous compartments during erection used in the pharmacotherapy of erectile dysfunction.

              … C-reactive protein are complementary determinants of global arterial function and early structural changes in HYPERTENSIVE males with erectile dysfunction

              … cavernosal ARTERY intima-media thickness in patients with erectile dysfunction. A new parameter in the diagnosis of VASCULAR erectile dysfunction. Our experience on 59 …

              … CELLS AND REDUCES ENDOTHELIAL INFLAMMATORY MARKERS IN PATIENTS WITH ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK

              … characterization of population with ERECTILE DYSFUNCTION and analysis of its CARDIO VASCULAR risk factors and degree of ERECTILE DYSFUNCTION in a quaternary center

              … COURSE OF TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR FRACTION IN TYPE 2 DM RATS (ZFDM) WITH ERECTILE DYSFUNCTION

              … crossover, placebo‐controlled comparative clinical trial of arginine aspartate plus adenosine monophosphate for the intermittent treatment of male erectile dysfunction

              … Dimethylamini-Hydrolase Causes Elevation of Asymmetric Dimethyl Arginine in Atherosclerotic Rat Model of VASCULOGENIC Erectile Dysfunction

              … displayer) for audiovisual sexual stimulation after oral phosphodiesterase type 5 (PDE 5) inhibitor medication for the diagnosis of VASCULOGENIC erectile dysfunction

              … DOPPLER ULTRASOUND AS A DIAGNOSTIC TOOL FOR PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR VASCULOGENIC ERECTILE DYSFUNCTION

              … duplex ultrasonography in men with Peyronie’s disease: Is it veno‐occlusive dysfunction or poor cavernosal arterial inflow that contributes to erectile dysfunction?

              … DYSFUNCTION DETECTED BY PERIPHERAL ARTERIAL TONOMETRY IS MORE PREVALENT IN MEN WITH ERECTILE DYSFUNCTION

              … editor re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A systematic review of the association between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease …

              … embolization of an arteriovenous fistula from the arteria bulbi penis to the corpus spongiosum penis in the treatment of erectile dysfunction: normal function regained …

              … entitled “Low-intensity shockwave therapy improves hemodynamic parameters in patients with VASCULOGENIC erectile dysfunction: a triplex ultrasonography …

              … Erectile dysfunction shock wave therapy (EDSWT) improves hemodynamic parameters in patients with VASCULOGENIC ERECTILE DYSFUNCTION (ED): A triplex …

              … EVALUATION OF ARTERIAL STIFFNESS AND CARDIAC FUNCTION IN PATIENTS WITH VASCULAR ERECTILE DYSFUNCTION, ACUTE EFFECTS OF …

              … EXPRESSING VASCULAR ENDOTHELIAL GROWTH FACTOR FOR POTENTIAL USE IN THE TREATMENT OF NEURO VASCULAR ERECTILE DYSFUNCTION

              … expression of VASCULAR endothelial growth factor and its receptors at the insulin-resistant stage of a type II diabetic rat model: a possible cause for erectile dysfunction …

              … FOR IDENTIFYING WALL MOTION ABNORMALITIES DURING STRESS TEST IN ERECTILE DYSFUNCTION HYPERTENSIVE MEN: COMPARISON OF …

              … from a database of 48 million men in the United States: Relationship of CARDIO VASCULAR disease, diabetes mellitus and depression with age and erectile dysfunction

              … FUNCTION OF CAVERNOUS ARTERIES CORRELATES WITH ITS CLINCAL EFFICACY IN PATIENTS WITH ARTERIOGENIC ERECTILE DYSFUNCTION

              … growth factor and adeno-associated virus mediated brain derived neurotrophic factor on neurogenic and VASCULOGENIC ERECTILE DYSFUNCTION induced by hyperlipidemia

              … heart failureRapid realist reviews for interventions to improve access to primary health care for vulnerable populationsAre ERECTILE DYSFUNCTION medications a gateway …

              … HelpED study: agreement and impact of the erection hardness score on sexual function and psychosocial outcomes in men with ERECTILE DYSFUNCTION and their partners

              … HISTOMORPHOLOGICAL STRUCTURE AND FUNCTION WITH STEM CELLS IN A RAT MODEL OF NEURO VASCULAR ERECTILE DYSFUNCTION

              … HUMAN PLACENTAL STEM CELLS PROMOTE ERECTILE FUNCTION RECOVERY IN A RODENT NEURO VASCULAR ERECTILE DYSFUNCTION …

              … IMPROVES AORTIC ELASTIC PROPERTIES AND WAVE REFLECTIONS IN PATIENTS WITH ERECTILE DYSFUNCTION OF VASCULAR ORIGIN

              … in Cavernosal ARTERY Parameters According to Different Anatomic Sampling Locations During the Diagnosis of VASCULAR ERECTILE DYSFUNCTION Using Duplex Ultrasound

              … INTIMA MEDIA THICKNESS ARE ASSOCIATED WITH PENILE DOPPLER FINDINGS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

              … is associated with diminished levels of VASCULAR endothelial growth factor (VEGF) and its receptors in the penis: implications in the pathogenesis of erectile dysfunction …

              … LOW INTENSITY SHOCK WAVE THERAPY TO THE PENIS FOR VASCULOGENIC ERECTILE DYSFUNCTION-A RANDOMIZED SHAMCONTROLLED …

              … MELANOMA WITH PHOSPHODIESTERASE TYPE 5 INHIBITOR USE AMONGST PATIENTS WITH ERECTILE DYSFUNCTION, PULMONARY HYPERTENSION AND …

              … MOTION ABNORMALITIES DURING STRESS ECHOCARDIOGRAPHY TESTING IN HYPERTENSIVE MEN WITH VASCULAR ERECTILE DYSFUNCTION

              … neuro VASCULAR bundle changes after nerve-sparing radical retropubic prostatectomy (RRP): a potential diagnostic tool for optimal management of erectile dysfunction …

              … Nogo-B receptor inhibits penile corpus cavernosum VASCULAR smooth muscle cell apoptosis of rats with diabetic ERECTILE DYSFUNCTION by down-regulating ICAM-1

              … Nymphaea lotus Linn.(Nymphaeaceae) on N (ω)-nitro-L-arginine methyl ester-induced tissular oxidative damages and ERECTILE DYSFUNCTION in HYPERTENSIVE male …

              … of brachial ARTERY flow-mediated dilatation and carotid ARTERY intima-media thickness measurements may be a method to determine VASCULOGENIC erectile dysfunction

              … of Chicken Leg Bone Hydrolysates under Different Drying Conditions and Its Effectiveness on Improving ERECTILE DYSFUNCTION of Spontaneously HYPERTENSIVE  …

              … OF LOW-INTENSITY EXTRACORPOREAL SHOCKWAVE IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION: A MULTI-CENTER …

              … of monocyte count with carotid intima-media thickness, aortic stiffness and penile Doppler findings, in patients with VASCULOGENIC erectile dysfunction

              … of neuro VASCULAR bundles on pelvic CT and evaluation of radiation dose to structures putatively involved in ERECTILE DYSFUNCTION after prostate brachytherapy

              … of Obstructive Pelvic Arterial Lesions by Computed Tomographic Angiography in 261 Patients with Erectile Dysfunction: Endo VASCULAR Therapeutic Implications

              … of penile BLOOD flow including peak systolic velocity, end diastolic velocity and rigidity index: five patients of ERECTILE DYSFUNCTION experience in Shin Kong …

              … of the predictive value of testosterone levels and carotid femoral pulse wave velocity for major adverse CARDIO VASCULAR events in patients with erectile dysfunction

              … OF THE THERAPEUTIC TARGETING POTENTIAL OF MICRORNA-93 IN THE TREATMENT OF VASCULOGENIC ERECTILE DYSFUNCTION

              … of VASCULAR Endothelial Growth Factor Receptors (VEGFR-1 and VEGFR-2) in Corpora Cavernosa (CC) Tissue in Diabetic Patients with ERECTILE DYSFUNCTION  …

              … ON PENILE MICRO VASCULAR ENDOTHELIAL REACTIVITY AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS WITH ERECTILE DYSFUNCTION

              … on the CARDIO VASCULAR system based on examination of serum oxidative status and paraoxonase activity in men with erectile dysfunction: a preliminary study

              … on: adipokines, hormonal parameters, and CARDIO VASCULAR risk factors: similarities and differences between patients with ERECTILE DYSFUNCTION of arteriogenic and …

              … on: Amino-Terminal Pro-C-Type Natriuretic Peptide is Associated with the Presence, Severity, and Duration of VASCULOGENIC Erectile Dysfunction

              … PEAK SYSTOLIC VELOCITY IS RELATED TO MAJOR ADVERSE CARDIO VASCULAR EVENTS IN HYPERTENSIVE PATIENTS WITH ERECTILE DYSFUNCTION

              … Penile Arterial Flow as an Adjunct to Increased Aortic Stiffness for Detecting Myocardial Ischemia During Stress Echocardiography in Erectile Dysfunction …

              … penile Doppler ultrasound findings and penile arterial insufficiency under percutaneous transluminal angioplasty for patients with erectile dysfunction

              … Plasma Asymmetrical Dimethylarginine (ADMA) as an Independent Predictor for the Presence of CARDIO VASCULAR Disease in Men with Erectile Dysfunction

              … Product Sciences: Articles; Ginsenoside Re Enriched Fraction (GS-F3K1) from Ginseng Berries Ameliorates Ethanol-Induced ERECTILE DYSFUNCTION via Nitric Oxide …

              … RELAXATION INDUCED BY INSULIN IN HUMAN CORPUS CAVERNOSUM AND PENILE ARTERIES IS IMPAIRED IN ERECTILE DYSFUNCTION.

              … relaxation of pudendal ARTERY and corpus cavernosum with increased VASCULAR sensitivity in spontaneously HYPERTENSIVE rats: Is it a new target for erectile dysfunction?

              … RETINAL ARTERIOLAR DIAMETER AND INCREASED RETINAL VENULAR DIAMETER IS ASSOCIATED WITH ERECTILE DYSFUNCTION

              … RISK FACTORS FOR CARDIO VASCULAR DISEASE ON THE CARDIOLOGISTIS’INTEREST IN ERECTILE DYSFUNCTION IN PATIENTS WITH …

              … Severe and Long-standing “Penile Angina” Are Additively Associated with Poor Exercise Performance in ERECTILE DYSFUNCTION Patients with HYPERTENSION

              … sexual satisfaction before and after penile prosthesis implantation in radical prostatectomy patients: a comparison with patients with VASCULOGENIC erectile dysfunction

              … SIAMS-ED Trial: A National, Independent, Multicentre Study on Cardiometabolic and Hormonal Impairment of Men with ERECTILE DYSFUNCTION Treated with Vardenafil

              … stimulation improves relaxant capacity of PDE5 inhibitors in human penile arteries and recovers the reduced efficacy of PDE5 inhibition in diabetic erectile dysfunction

              … strategy of mesenchymal stem cell injection with VASCULAR endothelial growth factor gene therapy for the treatment of diabetes‐associated erectile dysfunction

              … tea influence expression of VASCULAR endothelial growth factor and its receptor in aged rat erectile tissue? Possible implications for VASCULOGENIC erectile dysfunction …

              … the Efficacy of Type 5 Phosphodiesterase Inhibitors to Relax Human Corpus Cavernosum and Penile Arteries from Diabetic Patients with Erectile Dysfunction

              … the erection hardness score to facilitate patient/partner-healthcare provider communication concerning ERECTILE DYSFUNCTION significance and management

              … to congratulate you and express my appreciation of the articles’ Understanding prostate cancer’,’Benign prostatic hyperplasia’and’Erectile dysfunction’in the journal of …

              … TREATMENT EFFECT OF AUTOLOGOUS ADIPOSE STROMAL VASCULAR FRACTION IN TYPE 2 DM RATS (ZFDM) WITH ERECTILE DYSFUNCTION

              … type 5 with tadalafil is associated to an improved activity of circulating angiogenic cells in men with CARDIO VASCULAR risk factors and erectile dysfunction

              … value of nitric oxide, lipoprotein (a), and malondialdehyde levels in the peripheral venous and cavernous BLOOD of diabetics with erectile dysfunction

              … VARDENAFIL (LEVITRA®) ON ENDOTHELIAL FUNCTION OF CAVERNOUS AND BRACHIAL ARTERIES IN PATIENTS WITH ERECTILE DYSFUNCTION

              …  VASCULAR endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy and reverse venogenic erectile dysfunction …

              …  VASCULAR ENDOTHELIAL GROWTH FACTOR AND IMPROVED THE ERECTILE FUNCTION IN RATS WITH DIABETIC ERECTILE DYSFUNCTION

              [PP. 23.20] PREVALENCE AND SEVERITY OF ERECTILE DYSFUNCTION IN PATIENTS WITH RESISTANT HYPERTENSION

              [PP. 26.07] IMPACT OF VALSARTAN AND COMBINATION OF VALSARTAN AND HYDROCHLOROTHIAZIDE ON ERECTILE DYSFUNCTION IN PATIENTS WITH …

              015 Sepiapterin Supplementation Fails to Ameliorate Diesel Exhaust Particle Exposure-Related Erectile and Coronary ARTERY Dysfunction in Young Lewis Rats

              021 Topically Applied Sildenafil-nanoparticles Improve Erectile Function in an Aging-rat Model of Erectile Dysfunction

              022 Cardiology Referrals, CARDIAC Risk Stratification and CARDIAC Catheterizations Procedures Generated From A High Volume Erectile Dysfunction …

              034 Penile BLOOD flow assessment using Doppler ultrasonography (PDUS) in ERECTILE DYSFUNCTION patients: A 10-Year Experiences at an International …

              034 Topical application of Sildenafil-nanoparticles (proximal and distal) improve erectile function in an aging-rat model of erectile dysfunction

              0389: Preference for ERECTILE DYSFUNCTION treatments in patients with chronic HEART failure

              045 Androgen Pattern and Endothelial Dysfunction in Patients With VASCULOGENIC Erectile Dysfunction

              0510: ERECTILE DYSFUNCTION (ED) and Chronic HEART Failure (CHF): correlation between severity of ED and the 6 minutes walk test

              076 Sexual dynamics as a critical part in the individualised management of men with ERECTILE DYSFUNCTION in UK

              104 Pluripotent Fetal Stem Cells for Treatment of the VASCULAR Factor of Erectile Dysfunction

              1066-196 ERECTILE DYSFUNCTION of VASCULAR origin is associated with generalized endothelial dysfunction

              1070: Up-Regulation of Nadph Oxidase Contributes to the ERECTILE DYSFUNCTION in Angiotensin II-Induced HYPERTENSIVE Rats

              1096-74 CARDIO VASCULAR risk factors as correlates of erectile dysfunction: Results of a survey in 71,503 men in Brazil

              1107 Assessment of aortic elastic properties in patients with ERECTILE DYSFUNCTION by conventional and colour tissue Doppler echocardiography

              1116 Use of stromal VASCULAR fraction of adipose tissue in patients with VASCULOGENIC erectile dysfunction: Evaluation of clinical effectiveness and safety …

              112 Efficacy and Safety of Fixed Dose Combination of Amlodipine and Tadalafil in Both ERECTILE DYSFUNCTION and HYPERTENSION Patients Being Treated …

              1141-196 Effect of atorvastatin and sildenafil on endothelial function in patients with ERECTILE DYSFUNCTION and increased CARDIO VASCULAR risk

              115 Elevated plasma transforming growth factor-β1 level in patients with VASCULOGENIC erectile dysfunction

              1158 Arterial function and structure parameters are significantly impaired in pre-diabetic men with arterial HYPERTENSION and erectile dysfunction

              117 Erectile dysfunction: Looking for a BLOOD test to identify endothelial disease in patients consulting for impotence

              1198 ERECTILE DYSFUNCTION IS AN INDEPENDENT RISK FACTOR FOR THE PRESENCE OF HIGH RISK CORONARY ARTERY CALCIFICATION

              120 CARDIO VASCULAR parameters changes in patients with ERECTILE DYSFUNCTION using 5-PDE inhibitors: A first study with sildenafil 50mg and vardenafil 10mg

              1252: Association Between ERECTILE DYSFUNCTION and Coronary ARTERY Disease. Role of Coronary Clinical Presentation and Extent of Vessel Involvement …

              1282: VASCULAR Damage as Risk Factor for Lower Urinary Tract Symptoms and Erectile Dysfunction

              1324 IS THERE A CONCORDANCE BETWEEN CAROTID AND CAVERNOUS ARTERY INTIMA-MEDIA THICKNESS IN PATIENTS WITH ERECTILE DYSFUNCTION …

              1326: ERECTILE DYSFUNCTION as a Predictor of Coronary HEART Disease in Aging Men: Prospective Results from the Massachusetts Male Aging Study

              1333: Association of ERECTILE DYSFUNCTION and Subsequent CARDIO VASCULAR Disease

              1338: The Impact of VASCULAR Risk Factors on Penile Hemodynamics in Men with Erectile Dysfunction

              1340: ERECTILE DYSFUNCTION Predicts Extension of Coronary ARTERY Disease by Angiography in Acute Coronary Syndromes. The Dead Goose Study

              1351: Erectile dysfunction, HEART failure and pharmacology: Keeping the patient safe by providing effective treatment

              136 Human Cord BLOOD Endothelial Colony Forming Cells Induce Significant Recovery of Severe ERECTILE DYSFUNCTION in Obese Type II Diabetic Rats

              137 Superparamagnetic Iron Oxide Nanoparticle Targeting of Adipose Tissue-Derived Stem Cells in Diabetes-Associated Erectile Dysfunction

              1533 COMPARISON OF RATES AND RISK FACTORS FOR DEVELOPMENT OF ERECTILE DYSFUNCTION AFTER RADICAL OR PARTIAL NEPHRECTOMY

              1620: The Comparison of HYPERTENSION Prevalence Rates Between Men with and without Erectile Dysfunction: Evidence From A Large National Managed …

              1638: ERECTILE DYSFUNCTION and Oxidative Stress-Media Ted Cavernosal Cell Death in Spontaneously HYPERTENSIVE Rats

              17: Female Partners of Men with ERECTILE DYSFUNCTION Treated with Sildenafil Citrate Report Greater Satisfaction and Enjoyment from Sexual Intercourse: A Multicenter …

              176 RELATIONSHIP BETWEEN CORONARY ARTERY DISEASE, VASCULOGENIC ERECTILE DYSFUNCTION AND ENDOGENOUS SERUM …

              1804 PENILE RE VASCULAR IZATION IN VASCULOGENIC ERECTILE DYSFUNCTION: LONG-TERM FOLLOWUP

              18F-FLOURIDE UPTAKE IN PENILE ARTERIES: DOES IT REPRESENT ATHEROSCLEROTIC BASIS OF ERECTILE DYSFUNCTION IN PATIENTS WITH …

              18F-fluoride positron emission tomographic imaging of penile arteries and erectile dysfunction

              18F-fluoride uptake in Penile Arteries and Erectile Dysfunction

              207 15 ERECTILE DYSFUNCTION AN AGE-INDEPENDENT PREDICTOR FOR CARDIO VASCULAR EVENTS?

              208 Low-Intensity Shock Wave Therapy for Treatment of VASCULOGENIC Erectile Dysfunction: Phase 1 Results of the Dornier Aries in the First United States …

              208 Relationship between ERECTILE DYSFUNCTION and coronary anatomy in patients with ischemic HEART disease debut

              209 SEVERE ERECTILE DYSFUNCTION AS AN INDEPENDENT RISK FACTOR FOR CORONARY ARTERY DISEASE

              213 Nrf2 activation improves both hyperpolarization-and NO-mediated responses in penile vasculature from patients with erectile dysfunction

              2132 IMPACT OF RENAL TRANSPLANT ON VASCULOGENIC AND NEUROGENIC DETERMINANTS OF ERECTILE DYSFUNCTION IN PATIENTS WITH …

              221 Comparing ERECTILE DYSFUNCTION with Traditional VASCULAR Risk Factors in the Prediction of Coronary ARTERY Disease in Patients Presenting with Chest Pain

              225 VARDENAFIL VERSUS SILDENAFIL IN MEN WITH ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK FACTORS: A SUBGROUP ANALYSIS

              249 Micro VASCULAR changes in erectile dysfunction

              267 Pericyte Number and Micro VASCULAR Density Change in Corpus Cavernosum of ERECTILE DYSFUNCTION Rat Models

              285 VASCULAR damage as risk factor for lower urinary tract symptoms and erectile dysfunction

              287 Erectile Dysfunction, Penile Atherosclerosis and Coronary ARTERY Disease in HEART Transplant Recipients

              294 ERECTILE DYSFUNCTION associates own” arterial phenotype”defined by greater atherosclerotic burden, arterial stiffness and thickness and VASCULAR reactivity …

              353 THE PATHOGENETIC BASIS FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH CARDIO- VASCULAR RISK FACTORS

              355 CARDIORESPIRATORY FITNESS IN MEN WITH ERECTILE DYSFUNCTION

              380 Penile Doppler, Vendys® and SphygmoCor® in the Diagnosis of VASCULAR Erectile Dysfunction: Evaluation and Development of a Diagnostic …

              385 Losartan Preserves Erectile Function by Suppression of Cavernosal Fibrosis and Corporal Veno-Occlusive Dysfunction in Diabetic Rats

              417 Spontaneously Diabetic Torii Fatty Rats do not Show ERECTILE DYSFUNCTION Under High-Blood Glucose Levels in a Preliminary Study: The Importance of Model …

              454 Inverse correlation between testosterone and CARDIAC function in HEART failure patients with erectile dysfunction. Is there a resistance to testosterone?

              462 ERECTILE DYSFUNCTION AS A SUBROGATE MARKER OF CORONARY ARTERY DISEASE

              5 ERECTILE DYSFUNCTION IN ThE CArDIoloGy PrACtiCe

              52 Do the HEART transplant patients ask about their ERECTILE DYSFUNCTION to the nurse?

              530 Early start of oral sildenafil 100mg for ERECTILE DYSFUNCTION after robotic assisted laparoscopic radical prostatectomy: Preliminary results from …

              54 DOES ERECTILE DYSFUNCTION IMPROVE CARDIO VASCULAR DISEASE RISK PREDICTION?

              543Vardenafil improves treatment satisfaction and sexual pleasure in men with ERECTILE DYSFUNCTION and their partners

              580 Family history regarding CARDIO VASCULAR disease and diabetes and ERECTILE DYSFUNCTION in patients with coronary ARTERY disease

              5930Correlation of brachial flow-mediated vasodilatation and ERECTILE DYSFUNCTION severity and association with coronary ARTERY disease among CAD patients …

              670 Percutaneous angioplasty of internal pudendal arteries in the treatment of ERECTILE DYSFUNCTION not responsive to pharmacological therapy. Our initial …

              676 Penile re VASCULAR ization surgery in patients with diabetic erectile dysfunction: long term results

              689: Correlation between Penile Doppler Findings and C-Reactive Protein Levels in Patients with ERECTILE DYSFUNCTION of VASCULAR Origin

              694Is ERECTILE DYSFUNCTION an indicator for increased risk of coronary HEART disease or stroke?

              695Association between ERECTILE DYSFUNCTION and coronary ARTERY disease. Role of coronary clinical presentation and extent of vessel involvement. The …

              697: Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for Erectile Dysfunction: A Review of> 44,800 Patients in Clinical and …

              699 High BLOOD pressure accelerates penile arterial insufficiency in young ERECTILE DYSFUNCTION patients. A window of opportunity for preventing VASCULAR  …

              706 Influence of socioeconomic factors on the presence and intensity of ERECTILE DYSFUNCTION in men with coronary ARTERY disease

              707 Influence of testosterone deficiency on the BLOOD -pressure increase, in aortic stiffness, of the ERECTILE DYSFUNCTION patients

              733 ERECTILE DYSFUNCTION in spontaneously HYPERTENSIVE rats is accompanied by corporal endothelial dysfunction and remodelling: Cause or consequence …

              750 CORRECTION OF DIABETIC ERECTILE DYSFUNCTION WITH ADIPOSE DERIVED STEM CELLS MODIFIED WITH THE VASCULAR ENDOTHELIAL …

              864: ERECTILE DYSFUNCTION and Coronary HEART Disease

              909 SOCIODEMOGRAPHIC AND PSYCHOLOGICAL CORRELATES ASSOCIATED WITH ERECTILE DYSFUNCTION AMONG HYPERTENSIVE PATIENTS

              919 ERECTILE DYSFUNCTION DOES NOT INDEPENDENTLY PREDICTOR CARDIO VASCULAR DEATH: DATA FROM THE VITAMINS AND LIFESTYLE …

              921 INCIDENT HYPERTENSION AND RISK OF SUBSEQUENT ERECTILE DYSFUNCTION IN MEN WITH TYPE 1 DIABETES

              952 CORRELATION OF THE ERECTILE DYSFUNCTION WITH LESIONS OF CEREBRO VASCULAR ACCIDENTS

              953 PENILE DOPPLER FINDINGS OF ARTERIAL FLOW IN RELATION TO VASCULAR RISK FACTORS IN PATIENTS WITH ERECTILE DYSFUNCTION

              A case of ERECTILE DYSFUNCTION and risk factors for coronary ARTERY disease

              A combined-constructionist therapeutic approach to couples experiencing erectile dysfunction: Part II

              A comparative, crossover study of the efficacy and safety of sildenafil and apomorphine in men with evidence of arteriogenic erectile dysfunction

              A Computational Model for the Exploration of VASCULOGENIC Erectile Dysfunction

              A cross-sectional study of HYPERTENSIVE outpatients to determine the necessity of asking about ERECTILE DYSFUNCTION symptoms

              A Letter to the Editor Regarding the Original Article by Mulhall et al: Utility of Tacrolimus (FK506) trough level for the Prevention of Erectile Dysfunction

              A multidisciplinary approach to assess ERECTILE DYSFUNCTION in high-risk CARDIO VASCULAR patients

              A Natural Approach to ERECTILE DYSFUNCTION that Improves VASCULAR Health

              A new parameter in the diagnosis of VASCULAR ERECTILE DYSFUNCTION with penile Doppler ultrasound: cavernous ARTERY ondulation index

              A novel experimental model of ERECTILE DYSFUNCTION in rats with HEART failure using volume overload

              A Population Survey to Study the Association Between Microalbuminuria and ERECTILE DYSFUNCTION Among Patients With CARDIO VASCULAR Risk Factors: Interaction with …

              A population-based study on the association between rheumatoid arthritis and erectile dysfunction

              A population-based, longitudinal study of ERECTILE DYSFUNCTION and future coronary ARTERY disease

              A prospective randomised crossover trial on the effect of vardenafil 10mg on BLOOD pressure in patients with ERECTILE DYSFUNCTION who receive concomitant …

              A review of hypogonadism and ERECTILE DYSFUNCTION among HIV-infected men during the pre-and post-HAART eras: diagnosis, pathogenesis, and management

              A Review on ERECTILE DYSFUNCTION Among HYPERTENSIVE Patients on Pharmacotherapy

              A simple noninvasive test to detect VASCULAR disease in patients with erectile dysfunction: a novel method

              A spontaneous, double-blind, double-dummy cross-over study on the effects of daily vardenafil on arterial stiffness in patients with VASCULOGENIC erectile dysfunction

              A state of art review on vardenafil in men with ERECTILE DYSFUNCTION and associated underlying diseases

              A state-of-art review of low intensity extracorporeal shock wave therapy and lithotripter machines for the treatment of erectile dysfunction

              A study of the VASCULOGENIC and endocrinal factors in cases of metabolic syndrome suffering from erectile dysfunction

              A systematic approach to ERECTILE DYSFUNCTION in the CARDIO VASCULAR patient: a Consensus Statement–update 2002.

              A systematic review of the association between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              A systematic review of the long-term efficacy of low-intensity shockwave therapy for VASCULOGENIC erectile dysfunction

              A young man with position-dependent erectile dysfunction: diagnostic work-up and interventional therapy of an arteriovenous malformation

              AB006. ERECTILE DYSFUNCTION (ED) as a marker for CARDIO VASCULAR diseases (CVD)

              AB008. The link between ERECTILE DYSFUNCTION (ED) and CARDIO VASCULAR disease (CVD): what a urologist needs to know

              AB039. Metabolic syndrome/cardio VASCULAR disease and ERECTILE DYSFUNCTION (ED)

              AB130. The relationship between dietary intake and endothelial function among VASCULOGENIC ERECTILE DYSFUNCTION population

              AB145. Comparison of the prevalence of CARDIO VASCULAR risk factors between young male and the elderly with erectile dysfunction

              AB174. ERECTILE DYSFUNCTION and usage of PDE5-inhibitors in male partner of infertile couple

              AB231. The relationship between CARDIO VASCULAR disease and ERECTILE DYSFUNCTION among aged men in Southern China

              AB67. Molecular mechanisms of Chinese herbal formula Shuganyiyang (SGYY) capsule of treating arteriogenic ERECTILE DYSFUNCTION (ED) in a rat model

              Abnormal insulin signaling: early detection of silent coronary ARTERY disease-erectile dysfunction?

              Accounts of the impact of ERECTILE DYSFUNCTION on heterosexual couples from men seeking erectogenic treatment and their partners

              Activation of the ET‐1/ETA pathway contributes to ERECTILE DYSFUNCTION associated with mineralocorticoid HYPERTENSION

              Acute effect of sildenafil on inflammatory markers/mediators in patients with VASCULOGENIC erectile dysfunction

              Adipokines, hormonal parameters, and CARDIO VASCULAR risk factors: similarities and differences between patients with ERECTILE DYSFUNCTION of arteriogenic and …

              Adjustments for smoking, diabetes, HYPERTENSION and coronary HEART disease do not fully explain the age-related increase in prevalence of erectile dysfunction

              Aetiology and management of male ERECTILE DYSFUNCTION and female sexual dysfunction in patients with CARDIO VASCULAR disease

              Age-matched cavernous peak systolic velocity: a highly sensitive parameter in the diagnosis of arteriogenic erectile dysfunction

              Alfuzosin attenuates ERECTILE DYSFUNCTION in rats with partial bladder outlet obstruction

              All men with VASCULOGENIC ERECTILE DYSFUNCTION require a CARDIO VASCULAR workup

              Alteration of Redox Homeostasis and Protein Expression of Constitutive Nitric Oxide Synthases Contributes to ERECTILE DYSFUNCTION of HEART Failure Rats

              Alterations in Endothelial Nitric Oxide Synthase and RhoA/ROCK are Associated with ERECTILE DYSFUNCTION in Angiotensin II-induced HYPERTENSIVE Rats

              Alterations in microRNA expression in a murine model of diet‐induced VASCULOGENIC erectile dysfunction

              Amino-terminal pro-C-type natriuretic peptide is associated with the presence, severity, and duration of VASCULOGENIC erectile dysfunction

              Amiodarone, ERECTILE DYSFUNCTION drugs, and non-arteritic ischemic optic neuropathy

              An analysis of treatment preferences and sexual quality of life outcomes in female partners of Chinese men with erectile dysfunction

              An investigation into the link between vitamin D status, ERECTILE DYSFUNCTION and CARDIO VASCULAR risk factors in ageing men in New Zealand: a thesis presented in partial …

              An investigation of sexual dysfunction in female partners of men with erectile dysfunction: how interviews expand on questionnaire responses

              Analysis of related factors for ERECTILE DYSFUNCTION in middle-aged and elderly patients with HYPERTENSION [J]

              Androgen deficiency, ERECTILE DYSFUNCTION and chronic micro VASCULAR complications in male diabetic patients

              Androgens, ERECTILE DYSFUNCTION and CARDIO VASCULAR risk in type 2 diabetes

              VASCULAR -re VASCULAR ization-pudendal-artery-atherosclerotic-disease”>Angiography and endo VASCULAR re VASCULAR ization of pudendal ARTERY atherosclerotic disease in patients with medically refractory erectile dysfunction

              Angiopoietin-1-induced VASCULAR remodeling and angiogenesis: Could it be an effective treatment for atherosclerotic ERECTILE DYSFUNCTION and obesity?

              Angiotensin II increases corpus cavernosal contractility and oxidative stress in partial bladder outlet obstructed rabbits: relevance to erectile dysfunction

              Angiotensin Receptor Blockers for ERECTILE DYSFUNCTION in HYPERTENSIVE Men: A Brief Meta-Analysis of Randomized Control Trials

              Animal models of ERECTILE DYSFUNCTION (ED): potential utility of non-human primates as a model of atherosclerosis-induced VASCULAR ED

              Antihypertensive Drug Therapy and Erectile Dysfunction

              Antihypertensive drugs and ERECTILE DYSFUNCTION as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers

              Antihypertensive therapy causes erectile dysfunction

              Antihypertensive treatment and ERECTILE DYSFUNCTION in a cohort of type II diabetes patients

              Antiplatelet (aspirin) therapy as a new option in the treatment of VASCULOGENIC erectile dysfunction: a prospective randomized double-blind placebo-controlled study

              Aortic stiffness and carotid intima media thickness are associated with penile Doppler findings in patients with VASCULOGENIC erectile dysfunction

              Aortic/penile index is a marker of occult coronary ARTERY disease in middle-aged HYPERTENSIVE patients with erectile dysfunction

              apomorphine (3 mg) with oral sildenafil (50 mg) for male erectile dysfunction. Journal of Urology 172: 2347-2349, No. 6, Part 1, Dec 2004 800995972

              Application and value of color Doppler ultrasonograghy in the diagnosis of VASCULOGENIC erectile dysfunction

              Application of colour doppler ultrasonography after intracavernous injection in the diagnosis of VASCULOGENIC erectile dysfunction

              Application of colour Doppler ultrasonography in the diagnosis of VASCULOGENIC erectile dysfunction

              Approach to ERECTILE DYSFUNCTION in Patients with HYPERTENSION and Coronary ARTERY

              Approach to ERECTILE DYSFUNCTION in patients with HYPERTENSION and coronary ARTERY disease

              Are ERECTILE DYSFUNCTION medications causally related to nonarteritic anterior ischemic optic neuropathy?

              Are men with ERECTILE DYSFUNCTION more likely to have HYPERTENSION than men without erectile dysfunction? A naturalistic national cohort study

              Are VASCULAR disorders a common cause of ERECTILE DYSFUNCTION in non hypogonadal, non neuropsychiatric patients?

              ARTERIAL ELASTIC PROPERTIES IN PATIENTS WITH ERECTILE DYSFUNCTION

              Arterial elasticity and ERECTILE DYSFUNCTION in HYPERTENSIVE men

              Arterial ERECTILE DYSFUNCTION and peripheral arterial disease: reliability of a new phenotype of endothelial progenitor cells and endothelial microparticles

              Arterial ERECTILE DYSFUNCTION is an early sign of VASCULAR damage: the importance for the prevention of CARDIO VASCULAR health

              Arterial erectile dysfunction: different severities of endothelial apoptosis between diabetic patients “responders” and “non responders” to sildenafil

              Arterial erectile dysfunction: reliability of new markers of endothelial dysfunction

              Arterial erectile dysfunction: reliability of penile Doppler evaluation integrated with serum concentrations of late endothelial progenitor cells and endothelial …

              Arterial function and intima-media thickness in HYPERTENSIVE patients with erectile dysfunction

              Arterial HYPERTENSION and erectile dysfunction: an under-recognized duo

              Arterial stiffness evaluation for the early detection of endothelial dysfunction in men with ERECTILE DYSFUNCTION (ED3): result from a retrospective study using …

              Arterial surgery for erectile dysfunction

              Arteriogenic ERECTILE DYSFUNCTION alters protein expression within the cavernosal tissue in an animal model

              Arteriosclerosis is associated with ERECTILE DYSFUNCTION in type 2 diabetic rats

              Arteriosclerosis of penile arteries: histological findings and their significance in the treatment of erectile dysfunction

              Assays for erectile and bladder dysfunction and VASCULAR health

              Assessing erectile neurogenic dysfunction from HEART rate variability through a Generalized Linear Mixed Model framework

              Assessing satisfaction in men and their female partners after treatment with phosphodiesterase type 5 inhibitors for erectile dysfunction

              Assessment of aortic elastic properties in patients with ERECTILE DYSFUNCTION by conventional and colour tissue Doppler echocardiography

              Assessment of CARDIO VASCULAR risk in patients with erectile dysfunction

              Assessment of EndoPAT Scores in men with VASCULOGENIC and non‐vasculogenic erectile dysfunction

              Assessment of Health States and Erectile Dysfunction-Associated Quality of Life Among Adult Males and Females With Male Partners in Germany, the …

              Assessment of Mean Platelet Volume in men with VASCULOGENIC and nonvasculogenic erectile dysfunction

              Assessment of Psychological Factors, Erectile Dysfunction, and Quality of Life before and after Re VASCULAR ization Procedures

              Assessment of the relationship between asymmetric dimethylarginine and severity of ERECTILE DYSFUNCTION and coronary ARTERY disease

              Association Between Arterial Wave Reflections and Penile Doppler Findings in HYPERTENSIVE Men with VASCULOGENIC Erectile Dysfunction

              Association between cardiometabolic index and erectile dysfunction: a new index for predicting CARDIO VASCULAR disease

              Association between CARDIO VASCULAR health and endothelial function with future erectile dysfunction: the Multi-Ethnic Study of Atherosclerosis

              Association between carotid and femoral atherosclerotic burden and VASCULOGENIC erectile dysfunction

              Association between chronic obstructive PULMONARY disease and risk of erectile dysfunction: a systematic review and meta-analysis

              Association between chronic periodontitis and VASCULOGENIC erectile dysfunction

              Association between Coronary ARTERY Disease and ERECTILE DYSFUNCTION in Patients of a University Hospital

              Association Between Coronary ARTERY Lesion Severity and ERECTILE DYSFUNCTION in Stable Coronary HEART Disease Patients

              Association between coronary HEART disease and ERECTILE DYSFUNCTION in Chinese Han population

              Association between endogenous serum testosterone concentrations and arterial stiffness in ERECTILE DYSFUNCTION patients

              Association between ERECTILE DYSFUNCTION and asymptomatic CARDIO VASCULAR damage in middle-aged men

              Association between ERECTILE DYSFUNCTION and CARDIO VASCULAR risk in individuals with type-2 diabetes without overt CARDIO VASCULAR disease

              Association between ERECTILE DYSFUNCTION and coronary ARTERY disease: matching the right target with the right test in the right patient

              Association between ERECTILE DYSFUNCTION and coronary ARTERY disease. Role of coronary clinical presentation and extent of coronary vessels involvement: the COBRA …

              ASSOCIATION BETWEEN ERECTILE DYSFUNCTION AND DEATH OR CARDIO VASCULAR OUTCOMES AFTER MYOCARDIAL INFARCTION

              Association between ERECTILE DYSFUNCTION and echocardiographic variables of ventricular hypertrophy and diastolic function in HYPERTENSIVE patients with type 2 …

              Association between ERECTILE DYSFUNCTION and Quality of Life in Patients with Coronary ARTERY Disease

              Association Between ERECTILE DYSFUNCTION and Severity of Coronary ARTERY Disease: Observations from a Coronary Angiographic Study in Asian Indians

              ASSOCIATION BETWEEN ERECTILE DYSFUNCTION SEVERITY AND MAJOR ADVERSE CARDIO VASCULAR EVENTS IN MEN WITH METABOLIC …

              Association between ERECTILE DYSFUNCTION severity and major adverse CARDIO VASCULAR events in men with metabolic syndrome

              Association between erectile dysfunction, testosterone levels and prediction of 10-year CARDIO VASCULAR mortality

              Association between periodontal flap surgery for periodontitis and VASCULOGENIC ERECTILE DYSFUNCTION in Koreans

              Association between physical exercise and quality of erection in men with ischaemic HEART disease and ERECTILE DYSFUNCTION subjected to physical training

              Association between treatment for ERECTILE DYSFUNCTION and death or CARDIO VASCULAR outcomes after myocardial infarction

              Association between VASCULAR lesion and penile erection hardness in Japanese patients with erectile dysfunction

              VASCULAR -lesions-hardness-penis/129/01222926″>ASSOCIATION BETWEEN VASCULAR LESIONS AND THE HARDNESS OF THE PENIS IN ERECTILE DYSFUNCTION

              ASSOCIATION OF A TRIAD MORBID: DEPRESSION, ERECTILE DYSFUNCTION AND ISCHEMIC HEART DISEASE

              Association of coronary ARTERY disease, erectile dysfunction, and endothelial nitric oxide synthase polymorphisms

              ASSOCIATION OF ERECTILE DYSFUNCTION AND ITS TREATMENT WITH POOR MEDICATION ADHERENCE TO CARDIOPROTECTIVE MEDICATIONS OF …

              Association of ERECTILE DYSFUNCTION with CARDIO VASCULAR risk factors and increasing existing VASCULAR disease in male Chinese type 2 diabetic patients

              Association of peripheral micro VASCULAR dysfunction and erectile dysfunction

              Association of the T‐786C, G894T and 4a/4b polymorphisms of the endothelial nitric oxide synthase gene with VASCULOGENIC ERECTILE DYSFUNCTION in Iranian subjects

              Associations of carotid ARTERY plaque with lower urinary tract symptoms and erectile dysfunction

              Asymmetric dimethyl arginine levels correlate with CARDIO VASCULAR risk factors in patients with erectile dysfunction

              Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and L‐arginine in patients with arteriogenic and non‐arteriogenic erectile dysfunction

              Asymmetrical dimethylarginine (ADMA) is associated with CARDIO VASCULAR risk factors in men with erectile dysfunction

              Asymmetrical dimethylarginine and severity of ERECTILE DYSFUNCTION and their impact on CARDIO VASCULAR events in patients with acute coronary syndrome

              Attitudes and experiences: qualitative perspectives on ERECTILE DYSFUNCTION from the female partner

              Autologous adipose tissue derived stromal VASCULAR fraction for treatment of VASCULOGENIC erectile dysfunction: Results of clinical trial phase I/II

              Autologous Stromal VASCULAR Fraction Containing Stem Cells Combined with Low Intensity Shock Wave for the Treatment of Human Erectile Dysfunction

              BALNEOTHERAPY AND NEURO VASCULAR TRAINING IN CORRECTION OF ERECTILE DYSFUNCTION IN PATIENTS WITH CHRONIC PROSTATITIS FAVN …

              Basic science evidence for the link between ERECTILE DYSFUNCTION and cardiometabolic dysfunction

              Bibliometric analysis on relations between CARDIO VASCULAR disease and erectile dysfunction

              Bicycle Riding, Arterial Compression and Erectile Dysfunction

              Bilateral simultaneous nonarteritic anterior ischemic optic neuropathy after ingestion of sildenafil for erectile dysfunction

              Biomarkers, erectile dysfunction, and CARDIO VASCULAR risk prediction: the latest of an evolving concept

              Bisoprolol Therapy and The Risk of ERECTILE DYSFUNCTION in Stable Coronary ARTERY Disease Patients

              Blood examination for erectile dysfunction

              Blood gas changes in the corpora cavernosa: metabolic and histomorphometric implications in the patient with erectile dysfunction

              Blood platelet activity in men with VASCULOGENIC erectile dysfunction

              BLOOD PRESSURE AND HEART RATE VARIABILITY IN ERECTILE DYSFUNCTION

              Blood pressure-lowering medication and erectile dysfunction: are the drugs to blame?

              Blood pressure, antihypertensive medication use, and risk of ERECTILE DYSFUNCTION in men with type I diabetes

              Brachial ARTERY flow mediated assessment: A tool to predict the response to chronic PDE5 inhibition with tadalafil in patients with erectile dysfunction

              Brachial flow-mediated dilation correlates with vardenafil response in HYPERTENSIVE men with VASCULOGENIC erectile dysfunction

              Buttock claudication and ERECTILE DYSFUNCTION after internal iliac ARTERY embolization in patients prior to endo VASCULAR aortic aneurysm repair

              Calcification of the internal pudendal ARTERY and development of ERECTILE DYSFUNCTION in adenine‐induced chronic kidney disease: A sentinel of systemic VASCULAR  …

              Can Eosinophil Count, Platelet Count, and Mean Platelet Volume Be a Positive Predictive Factor in Penile Arteriogenic ERECTILE DYSFUNCTION Etiopathogenesis?

              Can ERECTILE DYSFUNCTION in Young Patients Serve as a Surrogate Marker for Coronary ARTERY Disease?

              Can ERECTILE DYSFUNCTION Predict Major CARDIO VASCULAR Events?

              Can ERECTILE DYSFUNCTION severity predicts coronary ARTERY disease?

              Can serum asymmetric dimethylarginine become a marker of VASCULOGENIC erectile dysfunction?

              Can the International Index of Erectile Function (IIEF-5) be used as a diagnostic tool to the severity of VASCULOGENIC erectile dysfunction?

              Can the mean platelet volume be a risk factor for VASCULOGENIC erectile dysfunction?

              Captopril treatment reverses ERECTILE DYSFUNCTION in male stroke prone spontaneously HYPERTENSIVE rats

              Cardiac allograft vasculopathy and ERECTILE DYSFUNCTION in male patients undergone to HEART transplantation: role of endothelial progenitor cells

              Cardiometabolic risk factors in patients with erectile dysfunction

              Cardiorenal Determinants of ERECTILE DYSFUNCTION in Primary Prevention: A Cross-Sectional Study

              Cardio VASCULAR and metabolic syndrome risk among men with and without erectile dysfunction: case-control study

              Cardio VASCULAR aspects of erectile dysfunction

              Cardio VASCULAR aspects of ERECTILE DYSFUNCTION as outlined by Avicenna.

              Cardio VASCULAR autonomic neuropathy, ERECTILE DYSFUNCTION and lower urinary tract symptoms in men with type 1 diabetes: findings from the DCCT/EDIC

              Cardio VASCULAR disease and erectile dysfunction

              Cardio VASCULAR disease prevention in men with VASCULAR erectile dysfunction: the view of the preventive cardiologist

              Cardio VASCULAR Disease Risk Assessment and Treatment of ERECTILE DYSFUNCTION in Men with Diabetes Mellitus

              Cardio VASCULAR disease risk, VASCULAR health and ERECTILE DYSFUNCTION among middle-aged, clinically depressed men

              VASCULAR _disease,_metabolic_syndrome_and.9.aspx”>Cardio VASCULAR disease, metabolic syndrome and erectile dysfunction

              Cardio VASCULAR disease: The effect of ERECTILE DYSFUNCTION on adherence to CARDIO VASCULAR disease medication

              Cardio VASCULAR diseases and erectile dysfunction

              Cardio VASCULAR diseases and erectile dysfunction: the two faces of the coin of androgen deficiency

              Cardio VASCULAR drug use and the incidence of erectile dysfunction

              Cardio VASCULAR drugs and erectile dysfunction

              Cardio VASCULAR drugs and erectile dysfunction–a symmetry analysis

              Cardio VASCULAR Effects of Nonphosphodiesterase-5 Inhibitor ERECTILE DYSFUNCTION Therapies

              Cardio VASCULAR effects of sildenafil in HYPERTENSIVE men with ERECTILE DYSFUNCTION and different alleles of the type 5 cGMP-specific phosphodiesterase (PDE5)

              VASCULAR _effects_of_sildenafil_in_hypertensive_men_with_erectile_dysfunction_and_different_alleles_of_the_type_5_cGMP-specific_phosphodiesterase_PDE5/links/00b4953441ca004133000000.pdf”>Cardio VASCULAR effects of sildenafil in HYPERTENSIVE men with ERECTILE DYSFUNCTION and different alleles of type 5 cGMP-specific phosphodiesterase (PDE5)

              Cardio VASCULAR effects of the 3 phosphodiesterase-5 inhibitors approved for the treatment of erectile dysfunction

              Cardio VASCULAR health, erectile dysfunction, and testosterone replacement: controversies and correlations

              Cardio VASCULAR implications of erectile dysfunction

              Cardio VASCULAR Implications of Treatment for ERECTILE DYSFUNCTION (Special Lecture 3)(Special Program)

              Cardio VASCULAR Issues in the Treatment of Erectile Dysfunction

              Cardio VASCULAR mortality in men with erectile dysfunction: increased risk but not inevitable

              Cardio VASCULAR parameter changes in patients with ERECTILE DYSFUNCTION using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 20 mg

              Cardio VASCULAR parameter changes in patients with ERECTILE DYSFUNCTION using PDE‐5 inhibitors: A study with sildenafil and vardenafil

              Cardio VASCULAR parameters changes in patients with ERECTILE DYSFUNCTION using 5-PDE inhibitors: a first study with Sildenafil 50 mg and Vardenafil 10 mg.

              Cardio VASCULAR risk among men seeking help for erectile dysfunction

              Cardio VASCULAR risk among men with and without erectile dysfunction: case-control study

              Cardio VASCULAR risk and erectile dysfunction

              Cardio VASCULAR risk assessment using high-sensitivity C-reactive protein in patients with erectile dysfunction

              Cardio VASCULAR risk factors associated with ERECTILE DYSFUNCTION in the region of Dakar, Senegal

              Cardio VASCULAR risk factors in men with ischemic HEART disease and erectile dysfunction

              VASCULAR _Risk_Factors_in_Patients_with_Erectile_Dysfunction/links/56df355408ae979addef557a.pdf”>Cardio VASCULAR Risk Factors in Patients with Erectile Dysfunction

              Cardio VASCULAR risk stratification and CARDIO VASCULAR risk factors associated with erectile dysfunction: assessing CARDIO VASCULAR risk in men with erectile dysfunction

              Cardio VASCULAR safety in ERECTILE DYSFUNCTION treatment

              Cardio VASCULAR safety of phosphodiesterase inhibitors for treating ERECTILE DYSFUNCTION in elderly men

              Cardio VASCULAR safety of sildenafil in the treatment of erectile dysfunction

              Cardio VASCULAR -protective effect of tadalafil in the treatment of erectile dysfunction

              Cardiowave analysis in patients with ERECTILE DYSFUNCTION (ED)

              Carotid ARTERY intima-media thickness and ERECTILE DYSFUNCTION in patients with metabolic syndrome

              Carotid ARTERY intima-media thickness can predict the response of patients with ERECTILE DYSFUNCTION to phosphodiesterase 5 inhibitors

              Carvacrol Improves ERECTILE DYSFUNCTION in Spontaneously HYPERTENSIVE Rats

              CASE REPORT: Association Between ERECTILE DYSFUNCTION and Coronary ARTERY Disease: A Case Report Study

              Cavernous ARTERY intima-media thickness: a new parameter in the diagnosis of VASCULAR erectile dysfunction

              Central Haemodynamics and prediction of CARDIO VASCULAR events in patients with erectile dysfunction

              Central hemodynamics and prediction of CARDIO VASCULAR events in patients with erectile dysfunction

              Central pressures and wave reflections are independently associated with major adverse CARDIO VASCULAR events in men with erectile dysfunction

              Changes in ERECTILE DYSFUNCTION and arterial stiffness following CARDIAC rehabilitation-a clinical research study

              Changes in ERECTILE DYSFUNCTION over time in relation to Framingham CARDIO VASCULAR risk in the Boston Area Community Health (BACH) Survey

              Characteristics of coronary arteriography among males with coronary ARTERY disease and erectile dysfunction

              Characterization of ERECTILE DYSFUNCTION and overactive bladder in HEART failure rats: model of volume overload (837.6)

              Chemistries of love: Impotence, ERECTILE DYSFUNCTION and Viagra in Läkartidningen

              Chronic administration of an oral Rho kinase inhibitor prevents the development of VASCULOGENIC ERECTILE DYSFUNCTION in a rat model

              Chronic inhibition of nitric‐oxide synthase induces HYPERTENSION and ERECTILE DYSFUNCTION in the rat that is not reversed by sildenafil

              Chronic intermittent hypoxia exposure reduces NOS isoforms in internal pudendal ARTERY : linking sleep apnea and erectile dysfunction

              Chronic obstructive PULMONARY disease (COPD) and ERECTILE DYSFUNCTION (ED): Results of the BRED observational study

              Chronic obstructive PULMONARY disease and erectile dysfunction

              Chronic obstructive PULMONARY disease and erectile dysfunction: a missed relationship

              Chronic vardenafil treatment improves erectile function via structural maintenance of penile corpora cavernosa in rats with acute arteriogenic erectile dysfunction

              Cigarette smoking and ERECTILE DYSFUNCTION among Chinese men without clinical VASCULAR disease

              Cigarette smoking, HYPERTENSION and diabetes mellitus as risk factors for ERECTILE DYSFUNCTION in upper Egypt

              Circulating endothelial progenitor cells and endothelial microparticles in patients with arterial ERECTILE DYSFUNCTION and metabolic syndrome

              Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with ERECTILE DYSFUNCTION in patients without known coronary ARTERY  …

              Clarifying the relative impacts of VASCULAR and nerve injury that culminate in ERECTILE DYSFUNCTION in a pilot study using a rat model of prostate irradiation and a …

              Clinical and imaging outcomes up to 1 year following balloon angioplasty for isolated penile ARTERY stenoses in patients with erectile dysfunction: the PERFECT-2 study

              Clinical and metabolic evaluation of subjects with erectile dysfunction: a review with a proposal flowchart

              Clinical cardiology: physician update: ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              Clinical Research of Bushenyixin Tablet for ERECTILE DYSFUNCTION with HYPERTENSION [J]

              Clinical significance of ERECTILE DYSFUNCTION developing after acute coronary event: exception to the rule or confirmation of the ARTERY size hypothesis?

              Clinical, paraclinical and epidemiological profile of ERECTILE DYSFUNCTION in consultation at the urology department of the Point G University Hospital

              Colour duplex Doppler ultrasonography evaluation of non‐vasculogenic male erectile dysfunction: An Indian perspective

              Combination of Gene Therapy with Antioxidant Therapy in a Rat Model of VASCULOGENIC Erectile Dysfunction.

              Combination of stromal VASCULAR fraction and Ad-COMP-Ang1 gene therapy improves long-term therapeutic efficacy for diabetes-induced erectile dysfunction

              Combination treatment with low intensity extracorporeal shock waves and PDE5 inhibitors for VASCULOGENIC erectile dysfunction: a comparative study

              Combined Therapy of the ERECTILE DYSFUNCTION in Patients with Arterial HYPERTENSION

              Commentary to low-energy shock wave therapy ameliorates ERECTILE DYSFUNCTION in a pelvic neuro VASCULAR injuries rat model, published in J Sex Med 2016; 13: 22-32 …

              Commentary: Angioplasty of Internal Pudendal and Penile Arteries for Arteriogenic Erectile Dysfunction: Reassuring, but the Jury Is Still Out

              Commentary: Endo VASCULAR Treatment of ERECTILE DYSFUNCTION due to Penile ARTERY Stenosis: Balloon Angioplasty of Small-Caliber Vessels Offers Valid …

              Common grounds for ERECTILE DYSFUNCTION and coronary ARTERY disease

              Common pitfalls in some of the experimental studies in erectile function and dysfunction: a consensus article

              Communication about ERECTILE DYSFUNCTION among men with ED, partners of men with ED, and physicians: The Strike Up a Conversation Study (Part I)

              Communication about ERECTILE DYSFUNCTION among men with ED, partners of men with ED, and physicians: the Strike Up a Conversation study (Part II)

              Comparative analysis of penile implants in patients with VASCULOGENIC ERECTILE DYSFUNCTION versus postradical prostatectomy erectile dysfunction

              Comparative efficacy of tadalafil once daily in men with ERECTILE DYSFUNCTION who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or …

              Comparison of findings on stress myocardial perfusion imaging in men with versus without ERECTILE DYSFUNCTION and without prior HEART disease

              Comparison of metabolic syndrome subjects with and without erectile dysfunction–levels of circulating oxidised LDL and arterial elasticity

              Comparison of Sexual Dysfunction Before and After Coronary ARTERY Bypass Grafting Using the International Index of ERECTILE DYSFUNCTION Questionnaire

              Comparison of the prevalence of CARDIO VASCULAR risk factors between young male and the elderly with erectile dysfunction

              Complete BLOOD count and penile colour doppler ultrasonography findings in erectile dysfunction: Is there a relationship?

              Complex Treatment of ERECTILE DYSFUNCTION with VASCULAR Factor Deficit by Use of Pluripotent Fetal Stem Cells

              VASCULAR -intervention-for-erectile-dysfunction”>Complexities of VASCULAR intervention for erectile dysfunction

              Consensus meeting on erectile dysfunction: ERECTILE DYSFUNCTION and CARDIO VASCULAR disease.

              Conventional and unconventional CARDIO VASCULAR risk factors in men with erectile dysfunction

              Coronary ARTERY calcifications in hemodialysis patients and their correlation with the prevalence of erectile dysfunction

              Coronary ARTERY disease topography in relation to rheology of the peripheral small arteries in middle aged ERECTILE DYSFUNCTION men

              Coronary ARTERY flow reserve in diabetics with ERECTILE DYSFUNCTION using sildenafil

              Coronary ARTERY risk factors in patients with erectile dysfunction

              Coronary HEART Disease and Erectile Dysfunction

              Coronary phenotypes in patients with ERECTILE DYSFUNCTION and silent ischemic HEART disease: a pilot study

              Corpus cavernosum electromyography in patients with VASCULOGENIC erectile dysfunction

              Correction of diabetic ERECTILE DYSFUNCTION with adipose derived stem cells modified with the VASCULAR endothelial growth factor gene in a rodent diabetic model

              Correlates of ERECTILE DYSFUNCTION in moderate‐to‐severe chronic obstructive PULMONARY disease patients

              Correlation and risk factors between VASCULAR endothelial dysfunction and erectile dysfunction

              Correlation and risk factors between VASCULAR endothelial dysfunction and ERECTILE DYSFUNCTION [J]

              Correlation Between ERECTILE DYSFUNCTION and Dose to Penile Bulb and Neuro VASCULAR Bundles Following Prostate Brachytherapy

              Correlation between HYPERTENSION and erectile dysfunction

              Correlation between internal pudendal ARTERY stenosis and ERECTILE DYSFUNCTION in patients with suspected coronary ARTERY disease

              Correlation between peak systolic velocity and diameter of cavernosal arteries in flaccid versus dynamic state for the evaluation of erectile dysfunction

              Correlation between penile cavernosal ARTERY BLOOD flow and retinal VASCULAR findings in arteriogenic erectile dysfunction

              Correlation between penile duplex findings and stress electrocardiography in men with erectile dysfunction

              CORRELATION OF ERECTILE DYSFUNCTION WITH METABOLIC RISK FACTORS OF INCREASED CARDIO VASCULAR RISK IN NEVER TREATED …

              CORRELATION OF PSYCHOLOGICAL FACTORS WITH PERIODONTAL AND ERECTILE DYSFUNCTION DISEASES IN CORONARY HEART DISEASE (CHD) …

              Correlation of the ERECTILE DYSFUNCTION with lesions of cerebro VASCULAR accidents

              Correlations between lower urinary tract symptoms, erectile dysfunction, and CARDIO VASCULAR diseases: are there differences between male populations from primary …

              Could ERECTILE DYSFUNCTION in type 2 diabetes change the presumption of normative total BLOOD serum testosterone?

              COUPLES’SEXUAL DYSFUNCTIONS: ERECTILE DYSFUNCTION (ED) is a Shared Sexual Concern of Couples II: Association of Female Partner Characteristics with Male …

              CRT-93 Prevalence Of Internal Pudendal ARTERY Disease In Diabetic Patients With ERECTILE DYSFUNCTION And Angiographically Documented Multi-vessel Coronary …

              Current Opinion in VASCULOGENIC Erectile Dysfunction

              VASCULAR Surgery.pdf”>Current role of VASCULAR surgery (arterial and venous) in erectile dysfunction

              Current state of endo VASCULAR treatment for VASCULOGENIC erectile dysfunction

              Cutaneous microcirculatory function predicts the responsiveness to tadalafil in patients with ERECTILE DYSFUNCTION and coronary ARTERY disease

              Decrease of the insulin‐like growth factor‐1 bioavailability in spontaneously HYPERTENSIVE rats with erectile dysfunction

              Depression, Erectile Dysfunction, and Coronary HEART Disease: An Interlinked Syndrome in Men

              Depression: links with ischemic HEART disease and erectile dysfunction.

              Depressive symptoms and ERECTILE DYSFUNCTION in men with coronary ARTERY disease

              Detection of ERECTILE DYSFUNCTION and peculiarities of its treatment in men with high CARDIO VASCULAR risk

              Deterioration of chronotropic responses and HEART rate recovery indices in men with erectile dysfunction

              Deterioration of HEART rate recovery index in patients with erectile dysfunction

              Determinants of Early Response to Low-Intensity Extracorporeal Shockwaves for the Treatment of VASCULOGENIC Erectile Dysfunction: An Open-Label, Prospective …

              DETERMINANTS OF INCREASED CARDIO VASCULAR RISK IN MEN< 60; 50 YEARS OF AGE WITH ERECTILE DYSFUNCTION

              Determination of changes in BLOOD pressure during administration of sildenafil (Viagra®) in patients with spinal cord injury and erectile dysfunction

              Determining the Prognostic Implications of ERECTILE DYSFUNCTION for Future CARDIO VASCULAR Disease with Noninvasive Testing

              Diabetes exacerbates the functional deficiency of NO/cGMP pathway associated with ERECTILE DYSFUNCTION in human corpus cavernosum and penile arteries

              Diabetes, CARDIO VASCULAR diseases and risk of erectile dysfunction: a brief narrative review of the literature

              Diabetes, coronary ARTERY disease and ERECTILE DYSFUNCTION doppler study

              Diagnosing Erectile Dysfunction: flow‐chart

              Diagnosis and treatment of ERECTILE DYSFUNCTION for reduction of CARDIO VASCULAR risk

              Diagnosis and treatment of trauma-associated arteriogenic erectile dysfunction

              Diagnosis and treatment of VASCULAR ERECTILE DYSFUNCTION with the vibration-vacuum penis stimulator” Sanos”

              Diagnosis of arteriogenic ERECTILE DYSFUNCTION at the level of primary health care

              Diagnostic and therapeutic implications of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

              Diagnostic value of four-dimensional CT angiography in arterial ERECTILE DYSFUNCTION using 320-detector row dynamic volume CT

              DIAGNOSTICS OF PENILE MICROCIRCULATION DISORDERS IN PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

              Did men with ERECTILE DYSFUNCTION discuss their condition with partner and physicians? A survey of men attending a free call information service

              Dietary antioxidants improve arteriogenic erectile dysfunction

              Disfunção erétil como preditor de doença arterial coronariana ERECTILE DYSFUNCTION as a predictor of coronary ARTERY disease

              Do ERECTILE DYSFUNCTION and CARDIO VASCULAR disease have the same mechanism?

              Document Guidelines for the assessment of the vasculogenig erectile dysfunction

              Does any association exist between chronic obstructive PULMONARY disease and erectile dysfunction? The DECODED study

              Does CARDIO VASCULAR risk reduction alleviate ERECTILE DYSFUNCTION in men with type II diabetes mellitus?

              Does ERECTILE DYSFUNCTION contribute to CARDIO VASCULAR disease risk prediction beyond the Framingham risk score?

              VASCULAR _risk/links/5dc93a4092851c818043d4c6/Does-erectile-dysfunction-improve-the-assessment-of-cardio VASCULAR -risk.pdf”>Does ERECTILE DYSFUNCTION improve the assessment of CARDIO VASCULAR risk?

              Does ERECTILE DYSFUNCTION independently predict CARDIO VASCULAR events? It’s time to act on the evidence

              Does radical nephrectomy increase the risk of ERECTILE DYSFUNCTION compared with partial nephrectomy? A cohort analysis

              Doppler evaluation of erectile dysfunction–Part 1

              Doppler evaluation of erectile dysfunction–part 2

              Doppler Imaging of Arteriogenic and Venogenic causes of Erectile Dysfunction: A Pictorial Review

              Drug interactions with phosphodiesterase-5 inhibitors used for the treatment of ERECTILE DYSFUNCTION or PULMONARY HYPERTENSION

              Dual implantation of artificial urinary sphincter and inflatable penile prostheses for concurrent male urinary incontinence and erectile dysfunction

              Duplex ultrasonography and internal pudendal arteriogram in the diagnosis of trauma-associated arteriogenic ERECTILE DYSFUNCTION (a report of 7 cases)

              Dynamic observation of penile hemodynamic change in patients with VASCULOGENIC ERECTILE DYSFUNCTION after prostaglandin E1 treatment

              Dynamic penile peak systolic velocity predicts major adverse CARDIO VASCULAR events in HYPERTENSIVE patients with erectile dysfunction

              Dysregulation of Dimethylarginine Dimethylaminohydrolase Causes Elevation of Asymmetric Dimethylarginine in a Rat Model of VASCULOGENIC Erectile Dysfunction

              Early conceptual and linguistic development of a patient and partner treatment satisfaction scale (TSS) for erectile dysfunction

              Early endothelial dysfunction as a marker of VASCULOGENIC ERECTILE DYSFUNCTION in young habitual cannabis users

              Early onset ERECTILE DYSFUNCTION is usually not associated with abnormal cavernosal arterial Inflow

              Early onset of fibrosis within the arterial media in a rat model of type 2 diabetes mellitus with erectile dysfunction

              Early recoil after balloon angioplasty of erection-related arteries in patients with arteriogenic erectile dysfunction

              ED 04. Losartan improves ERECTILE DYSFUNCTION in diabetic patients: A clinical trial

              ED 11. Incompetent cavernous endothelial cell-cell junction is responsible for why ERECTILE DYSFUNCTION is highly prevalent and precedes other systemic VASCULAR  …

              ED 26. Multiple arterial occlusion with clinical manifestations of erectile dysfunction

              ED PHARMACOTHERAPY: Comparing Vardenafil and Sildenafil in the Treatment of Men with ERECTILE DYSFUNCTION and Risk Factors for CARDIO VASCULAR Disease: A …

              ED PHARMACOTHERAPY: Sildenafil Citrate 100 mg Starting Dose in Men with ERECTILE DYSFUNCTION in an International, Double‐Blind, Placebo‐Controlled Study …

              ED PHARMACOTHERAPY: The Efficacy and Safety of Udenafil [Zydena] for the Treatment of ERECTILE DYSFUNCTION in HYPERTENSIVE Men Taking Concomitant …

              Editorial Comment on “Low Energy Shock Wave Therapy Ameliorates ERECTILE DYSFUNCTION in a Pelvic Neuro VASCULAR Injuries Rat Model”

              Editorial Comment on “ VASCULAR and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study”

              Editorial on ERECTILE DYSFUNCTION as sentinel for CARDIO VASCULAR disease

              Effect of aerial part and root extracts from Ferula orientalis L. growing in Turkey on ERECTILE DYSFUNCTION in streptozotocin-ınduced diabetic rats

              Effect of Aerial Parts and Root Extracts from Four Ferulago Species on ERECTILE DYSFUNCTION in Streptozotocin-Induced Diabetic Rats

              Effect of Aerobic Exercise on C-reactive protein (Crp) and Index of Erectile Function in Subjects with HYPERTENSION and Erectile Dysfunction, Kano, Nigeria

              Effect of correcting serum cholesterol levels on erectile function in patients with VASCULOGENIC erectile dysfunction

              Effect of depression on ERECTILE DYSFUNCTION in stable coronary HEART disease patients

              Effect of endurance CARDIO VASCULAR training intensity on ERECTILE DYSFUNCTION severity in men with ischemic HEART disease

              Effect of ERECTILE DYSFUNCTION medications on coexisting sexual dysfunctions in couples: Partners’ Preference Study

              Effect of Extracts of the Aerial Parts and Roots from Four Ferulago Species on ERECTILE DYSFUNCTION in Rats with Streptozotocin-Induced Diabetes.

              EFFECT OF HYPOGONADISM ON THE MANAGEMENT PLAN OF SEVERE VASCULOGENIC ERECTILE DYSFUNCTION (ED)

              Effect of Losartan on C-Reactive Protein and Sexual Function in Patients with HYPERTENSION and Diabetes Merging Insulin Resistance and Erectile Dysfunction

              Effect of Nitric Oxide Levels in Hypertensi Patient with Erectile Dysfunction

              Effect of short‐and long‐term sildenafil treatment on ERECTILE DYSFUNCTION in rats with partial bladder outlet obstruction

              Effect of Shugan Yiyang capsules on sexual function and sex gland weight in rats with arteriogenic erectile dysfunction

              Effect of Shuganyiyang Capsule on the expression of endothelin and connexin43 of rat model with arteriogenic ERECTILE DYSFUNCTION [J]

              Effect of sildenafil in cavernous arteries of patients with erectile dysfunction

              Effect of sildenafil on arterial stiffness, as assessed by pulse wave velocity, in patients with erectile dysfunction

              Effect of sildenafil on CARDIO VASCULAR patients with erectile dysfunction: A review of recent researches

              Effect of systemic arterial pressure on ERECTILE DYSFUNCTION in the initial stages of chronic arterial insufficiency

              Effect of treating ERECTILE DYSFUNCTION on management of systolic HYPERTENSION

              Effect of vardenafil on BLOOD pressure profile of patients with ERECTILE DYSFUNCTION concomitantly treated with doxazosin gastrointestinal therapeutic system for benign …

              VASCULAR -research/jvree/2008/07/001/effect-weight-reduction- VASCULAR -function-erectile/250/00001682″>EFFECT OF WEIGHT REDUCTION ON VASCULAR FUNCTION, ERECTILE DYSFUNCTION AND PROINFLAMMATORY CYTOKINES IN PATIENTS WITH …

              Effect of Zhenyangjian on the penile hemodynamics of the patients with arterial erectile dysfunction

              Effective ERECTILE DYSFUNCTION (ED) treatment enables men to enjoy better sex: The importance of erection hardness, psychological well-being, and partner satisfaction

              Effectiveness and safety of combined treatment of the ERECTILE DYSFUNCTION in patients with arterial HYPERTENSION

              Effectiveness and safety of the treatment with sildenafil (Viagra) in patients with ERECTILE DYSFUNCTION and arterial HYPERTENSION

              Effects of autologous adipose-derived stromal VASCULAR fraction on ERECTILE DYSFUNCTION of HYPERTENSIVE rats

              Effects of chronic vardenafil treatment persist after end of treatment in rats with acute arteriogenic erectile dysfunction

              Effects of daily vs. on-demand Vardenafil on arterial stiffness in patients with erectile dysfunction

              Effects of hydrogen sulphide donor, sodium hydrosulphide treatment on the ERECTILE DYSFUNCTION in L‐NAME‐induced HYPERTENSIVE rats

              Effects of icariin on the erectile function and expression of nitrogen oxide synthase isoforms in corpus cavernosum of arterigenic ERECTILE DYSFUNCTION rat model

              Effects of Microdesmis keayana alkaloids on VASCULAR parameters of erectile dysfunction

              Effects of moxonidine and metoprolol in penile circulation in HYPERTENSIVE men with erectile dysfunction: results of a pilot study

              Effects of nonlinear aerobic training on ERECTILE DYSFUNCTION and CARDIO VASCULAR function following radical prostatectomy for clinically localized prostate cancer

              EFFECTS OF PRIMARY HYPERTENSION ON ERECTILE DYSFUNCTION

              Effects of quercetin on intracavernous pressure and expression of nitrogen synthase isoforms in arterial ERECTILE DYSFUNCTION rat model

              Effects of tadalafil on platelets and endothelium in patients with ERECTILE DYSFUNCTION and CARDIO VASCULAR risk factors: a pilot study

              Efficacy and limits of sildenafil citrate in patients with arterial erectile dysfunction: role of peripheral arterial disease and CARDIO VASCULAR comorbidities

              Efficacy and safety of combination of tadalafil and aspirin versus tadalafil or aspirin alone in patients with VASCULAR erectile dysfunction: a comparative randomized …

              Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and CARDIO VASCULAR  …

              Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION and chronic HEART failure

              Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION and congestive HEART failure: a randomized placebo-controlled trial

              Efficacy and safety of sildenafil citrate in men with ERECTILE DYSFUNCTION and stable coronary ARTERY disease

              Efficacy and Safety of Sildenafil Citrate in Patients with ERECTILE DYSFUNCTION and Diabetes Mellitus Taking Multiple Antihypertensive Agents

              Efficacy and safety of sildenafil in Asian males with ERECTILE DYSFUNCTION and CARDIO VASCULAR risk

              Efficacy and safety of sildenafil in patients with ERECTILE DYSFUNCTION and HYPERTENSION . Prognostic factors

              Efficacy and safety of topical Aprostadil Cream (Vitaros®) in HYPERTENSIVE , diabetic and CARDIAC patients with male ERECTILE DYSFUNCTION (ED)

              Efficacy and safety of vardenafil in the treatment of ERECTILE DYSFUNCTION in men with HYPERTENSION

              Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in men with ERECTILE DYSFUNCTION on antihypertensive therapy

              Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study

              Efficacy of Low Density Linear Shockwave Treatment in Severe Arteriogenic ERECTILE DYSFUNCTION Patients

              Efficacy of tadalafil in the treatment of ERECTILE DYSFUNCTION in HYPERTENSIVE men on concomitant thiazide diuretic therapy

              Efficacy of vardenafil for the treatment of ERECTILE DYSFUNCTION in men with HYPERTENSION : a meta-analysis of clinical trial data

              Efficacy of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION and arterial HYPERTENSION who are taking multiple antihypertensive treatments

              Elastic properties of the aorta in patients with erectile dysfunction: assessment by conventional and color tissue Doppler echocardiography

              Electrocardiographic abnormalities in patients with organic erectile dysfunction: comparison with an age-matched control group

              Elevation of asymmetrical dimethylarginine (ADMA) and coronary ARTERY disease in men with erectile dysfunction

              Elevation of asymmetrical dimethylarginine (ADMA) and coronary ARTERY disease in men with erectile dysfunction: Commentary

              Emergency department considerations regarding erectile dysfunction

              Emerging molecular targets for treatment of erectile dysfunction: VASCULAR and regenerative therapies on the horizon

              Endothelial antioxidant compound prolonged the endothelial antiapoptotic effects registered after tadalafil treatment in patients with arterial erectile dysfunction

              Endothelial cell activation in men with ERECTILE DYSFUNCTION without CARDIO VASCULAR risk factors and overt VASCULAR damage

              Endothelial colony forming cells from human umbilical cord BLOOD improved severe ERECTILE DYSFUNCTION in obese type II diabetic rats

              Endothelial dysfunction as a common link between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              Endothelial dysfunction links ERECTILE DYSFUNCTION to HEART disease

              Endothelial dysfunction, erectile dysfunction, and coronary HEART disease: the pathophysiologic and clinical linkage

              VASCULAR -risk.pdf”>Endothelial Dysfunction: A Concatenation Of Facts In, Erectile Dysfunction, Benign Prostatic Hyperplasia And CARDIO VASCULAR Risk

              Endothelial function in patients with VASCULOGENIC erectile dysfunction

              Endothelial function of brachial and cavernous arteries in patients with erectile dysfunction

              Endothelial microparticles and erectile dysfunction: an update

              Endothelial microparticles correlate with ERECTILE DYSFUNCTION in diabetic men

              Endothelial nitric oxide synthase polymorphisms are a risk factor for ERECTILE DYSFUNCTION of VASCULAR etiology

              VASCULAR /149/01720103″>ENDOTHELIAL-ERECTILE DYSFUNCTION AND CARDIO VASCULAR RISK FACTORS RELATIONSHIP

              Endothelin-1 (ET-1) contributes to ERECTILE DYSFUNCTION in DOCA-salt HYPERTENSIVE rats

              Endo VASCULAR approaches to penile arterial re VASCULAR ization for VASCULOGENIC erectile dysfunction

              Endo VASCULAR embolisation therapy in men with erectile impotence due to veno-occlusive dysfunction

              Endo VASCULAR Management of Priapism and Erectile Dysfunction

              Endo VASCULAR therapy for arteriogenic erectile dysfunction

              Endo VASCULAR therapy for erectile dysfunction—who benefits most? Insights from a single-center experience

              Endo VASCULAR therapy for VASCULOGENIC erectile dysfunction

              Endo VASCULAR Therapy for VASCULOGENIC Erectile Dysfunction: A Systematic Review and Meta-Analysis of Arterial and Venous Therapies

              Endo VASCULAR treatment for erectile dysfunction: an old paradigm revisited

              Endo VASCULAR Treatment of Erectile Dysfunction

              Endo VASCULAR treatment of ERECTILE DYSFUNCTION by arteriospongiosum traumatic fistula: case report

              Endo VASCULAR treatment of ERECTILE DYSFUNCTION by traumatic arteriospongious fistula: case report

              Endo VASCULAR treatment of ERECTILE DYSFUNCTION due to internal iliac ARTERY atherosclerotic

              Endo VASCULAR treatment of recurrent ERECTILE DYSFUNCTION due to venous occlusive disease

              Endo VASCULAR treatment of VASCULOGENIC erectile dysfunction

              Engaging patients in CARDIO VASCULAR disease risk reduction: from empathy to erectile dysfunction

              Enhanced External Counterpulsation in Patients with Coronary ARTERY Disease-Associated Erectile Dysfunction

              Enhanced External Counterpulsation in Patients with Coronary ARTERY Disease-Associated Erectile Dysfunction. Part Ⅰ: Effects of Risk Factors

              Enhanced external counterpulsation in patients with coronary ARTERY disease-associated erectile dysfunction. Part I: Effects of risk factors

              Enhanced external counterpulsation in patients with coronary ARTERY disease‐associated erectile dysfunction. Part II: Impact of disease duration and treatment courses

              Enrolling men, their doctors and partners: Individual and collective responses to erectile dysfunction

              Epidemiology of ERECTILE DYSFUNCTION in HYPERTENSION

              EPIDEMIOLOGY: ERECTILE DYSFUNCTION Is a Marker for CARDIO VASCULAR Disease: Results of the Minority Health Institute Expert Advisory Panel

              epidemiology: The prevalence of ERECTILE DYSFUNCTION among HYPERTENSIVE and prehypertensive men aged 25–40 years

              Erectile and Sex Hormone Dysfunction and CARDIO VASCULAR

              Erectile and Sex Hormone Dysfunction and CARDIO VASCULAR Consequences in CKD

              Erectile dysfunction (ED) as a marker for CARDIO VASCULAR diseases (CVD)

              Erectile dysfunction (ED) is a shared sexual concern of couples II: association of female partner characteristics with male partner ED treatment seeking and …

              Erectile Dysfunction (ED), Part I: Its Varieties, Prevalence, Causes, And Relationship Implications

              VASCULAR /49/00002413″>Erectile Dysfunction & Peripheral VASCULAR Disease: Arterial Inflow Therapy

              Erectile dysfunction a predictor of HEART disease

              Erectile dysfunction agents and nonarteritic anterior ischemic optic neuropathy

              Erectile dysfunction among HIV-infected men is associated with protease inhibitor containing HAART

              Erectile dysfunction among HYPERTENSIVE men in a rapidly developing country

              Erectile Dysfunction Among HYPERTENSIVE Patients in Yaounde, Cameroon

              Erectile dysfunction among male HYPERTENSIVE s in a tertiary health facility in South-West Nigeria

              Erectile dysfunction among men attending surgical outpatients Department in a Tertiary Hospital in South-Western Nigeria

              ERECTILE DYSFUNCTION AMONG THE HYPERTENSIVE S ATTENDING THE OUT-PATIENT CLINICS AT THE FEDERAL MEDICAL CENTRE OWO, ONDO …

              Erectile dysfunction and angiographic extent of coronary ARTERY disease in type II diabetic patients

              Erectile dysfunction and associated risk factors among young Mexican adults: The importance of partner availability

              Erectile dysfunction and asymptomatic coronary ARTERY disease: frequently detected by computed tomography coronary angiography but not by exercise …

              Erectile Dysfunction and CARDIO VASCULAR Assessment

              Erectile Dysfunction and CARDIO VASCULAR Complications: A Literature Review

              Erectile dysfunction and CARDIO VASCULAR considerations: Managing patients effectively with phosphodiesterase type 5 inhibitors

              Erectile dysfunction and CARDIO VASCULAR disease

              Erectile dysfunction and CARDIO VASCULAR disease in clinical practice

              Erectile dysfunction and CARDIO VASCULAR disease: A review

              Erectile dysfunction and CARDIO VASCULAR disease: a suitable case for treatment and prevention?

              Erectile dysfunction and CARDIO VASCULAR disease: efficacy and safety of phosphodiesterase type 5 inhibitors in men with both conditions

              Erectile dysfunction and CARDIO VASCULAR disease: focus on

              Erectile dysfunction and CARDIO VASCULAR disease: what do we know up to now?

              Erectile dysfunction and CARDIO VASCULAR diseases.

              Erectile dysfunction and CARDIO VASCULAR events in diabetic men: a meta-analysis of observational studies

              Erectile Dysfunction and CARDIO VASCULAR Risk

              Erectile dysfunction and CARDIO VASCULAR risk factors

              Erectile dysfunction and CARDIO VASCULAR risk factors in a Mediterranean diet cohort

              ERECTILE DYSFUNCTION AND CORONARY ARTERY DISEASE IN HYPERTENSIVE MEN: A DIFFERENT REALITY?: PP. 42.335

              Erectile dysfunction and coronary ARTERY disease in patients with diabetes

              Erectile dysfunction and coronary ARTERY disease prediction: Evidence‐based guidance and consensus

              Erectile dysfunction and coronary ARTERY disease: a relationship for disclosure

              Erectile dysfunction and coronary ARTERY disease: an association of higher risk in younger men

              Erectile dysfunction and coronary ARTERY disease: the CARDIAC window opens

              Erectile Dysfunction and Coronary ARTERY Disease: Two manifestations, one same underlying mechanism

              Erectile dysfunction and coronary HEART disease

              Erectile dysfunction and depressive mood in men with coronary HEART disease

              Erectile dysfunction and diabetes: a prelude to CARDIO VASCULAR disease: drug trends in diabetes

              Erectile dysfunction and essential HYPERTENSION : the same aging-related disorder?

              Erectile dysfunction and HEART disease 1: overview.

              Erectile dysfunction and HEART disease. 2: At-risk patients.

              Erectile dysfunction and HEART failure: the role of phosphodiesterase type 5 inhibitors

              Erectile dysfunction and HEART rate recovery. Is it autonomic nervous system?

              Erectile dysfunction and HYPERTENSION

              Erectile dysfunction and HYPERTENSION among adult males in Umudike, Nigeria: A study of prevalence and relationships

              Erectile dysfunction and HYPERTENSION : impact on CARDIO VASCULAR risk and treatment

              Erectile dysfunction and HYPERTENSION .

              Erectile dysfunction and incidence of CARDIO VASCULAR disease

              Erectile Dysfunction and Incidence of CARDIO VASCULAR Disease—Reply

              Erectile Dysfunction and Ischaemic HEART Disease

              Erectile Dysfunction and its association to CARDIO VASCULAR risk factors among men 60 years and above at primary care clinic, Riyadh, Saudi Arabia

              Erectile dysfunction and its influence on quality of life in patients with essential HYPERTENSION

              Erectile dysfunction and its relationship with CARDIO VASCULAR risk factors and disease

              Erectile dysfunction and its severity are related to the number of CARDIO VASCULAR risk factors

              Erectile dysfunction and later CARDIO VASCULAR disease in men with type 2 diabetes: prospective cohort study based on the ADVANCE (Action in Diabetes and VASCULAR  …

              Erectile dysfunction and lower urinary tract symptoms should trigger a metabolic screen and CARDIO VASCULAR risk estimation

              Erectile dysfunction and NO: variations of NO penile BLOOD levels before and after sildenafil treatment

              Erectile dysfunction and prostate brachytherapy doses to the penile bulb and neuro VASCULAR bundles

              Erectile dysfunction and relationships: views of men with ERECTILE DYSFUNCTION and their partners

              Erectile dysfunction and risk of CARDIO VASCULAR and all-cause mortality in the general population: A meta-analysis of cohort studies

              Erectile dysfunction and risk of CARDIO VASCULAR disease: meta-analysis of prospective cohort studies

              Erectile dysfunction and risk of clinical CARDIO VASCULAR events: a meta-analysis of seven cohort studies

              Erectile dysfunction and sex hormone changes in chronic obstructive PULMONARY disease patients

              Erectile dysfunction and silent coronary ARTERY disease: abnormal computed tomography coronary angiogram in the presence of normal exercise ECGs

              Erectile dysfunction and sleep apnea syndrome are risk factors of CARDIO VASCULAR diseases

              Erectile dysfunction and statin treatment in high CARDIO VASCULAR risk patients

              Erectile dysfunction and subclinical CARDIO VASCULAR disease

              Erectile dysfunction and subsequent CARDIO VASCULAR disease

              Erectile dysfunction and target organ damage in the early stages of HYPERTENSION

              Erectile dysfunction and testosterone deficiency as CARDIO VASCULAR risk factors?

              Erectile dysfunction and testosterone deficiency as gender-specific markers of cardiometabolic risk in minority and non-minority men: Potential role of social …

              Erectile dysfunction and the “window of curability”: a harbinger of CARDIO VASCULAR events

              Erectile dysfunction and the biochemical/molecular/regulation of human penile arteries

              Erectile dysfunction and the CARDIO VASCULAR patient: endothelial dysfunction is the common denominator

              Erectile dysfunction and the HEART –what’s new?

              Erectile dysfunction and undiagnosed diabetes, HYPERTENSION , and hypercholesterolemia

              Erectile Dysfunction and Various CARDIO VASCULAR Risk Factors in Diabetic Males-A Continued Study.

              Erectile Dysfunction and VASCULAR Disease

              Erectile dysfunction and VASCULAR disease: What is the connection?

              Erectile dysfunction and VASCULAR risk: Let’s get it right

              Erectile dysfunction arising from polyarteritis nodosa: a case report

              Erectile Dysfunction as a CARDIO VASCULAR Impairment

              Erectile dysfunction as a CARDIO VASCULAR risk factor in patients with diabetes

              Erectile Dysfunction as a CARDIO VASCULAR Risk Marker

              Erectile dysfunction as a complication of HEART failure

              Erectile dysfunction as a coronary ARTERY disease risk equivalent

              Erectile dysfunction as a generalized VASCULAR dysfunction

              Erectile dysfunction as a harbinger for increased cardiometabolic risk

              Erectile dysfunction as a harbinger of CARDIO VASCULAR events. Long-term VASCULAR protection with telmisartan

              Erectile dysfunction as a marker for CARDIO VASCULAR disease diagnosis and intervention: a cost analysis

              Erectile dysfunction as a marker for VASCULAR disease

              Erectile dysfunction as a marker of silent CARDIO VASCULAR disease in type-2 diabetic patients in Spain. The DIVA (DIabetes and VASCULAR disease) study

              Erectile dysfunction as a predictive factor for coronary ARTERY disease

              ERECTILE DYSFUNCTION AS A PREDICTIVE FACTOR OF CORONARY ARTERY DISEASE: A PROSPECTIVE STUDY

              Erectile dysfunction as a predictor for subsequent atherosclerotic CARDIO VASCULAR events: findings from a linked-data study

              Erectile dysfunction as a predictor of advanced VASCULAR age

              Erectile dysfunction as a predictor of asymptomatic coronary ARTERY disease in elderly men with type 2 diabetes

              ERECTILE DYSFUNCTION AS A PREDICTOR OF CARDIO VASCULAR DISEASE

              Erectile dysfunction as a predictor of CARDIO VASCULAR disease.

              Erectile dysfunction as a predictor of CARDIO VASCULAR events and death in diabetic patients with angiographically proven asymptomatic coronary ARTERY disease: a …

              Erectile dysfunction as a predictor of CARDIO VASCULAR risk

              Erectile dysfunction as a predictor of coronary ARTERY disease

              Erectile dysfunction as a predictor of early stage of coronary ARTERY disease

              Erectile dysfunction as a risk factor for coronary HEART disease: implications for prevention

              Erectile Dysfunction as a Risk Factor Predicting Coronary ARTERY Disease

              Erectile Dysfunction as a Sentinel Marker fo CARDIO VASCULAR Disease

              Erectile dysfunction as a sentinel symptom of CARDIO VASCULAR autonomic neuropathy in heavy drinkers

              Erectile dysfunction as a symptom of VASCULAR disease.

              Erectile Dysfunction as an ‘Early Diagnostic Window’for Asymptomatic Coronary ARTERY Disease

              VASCULAR -diseas-4″>Erectile dysfunction as an early marker for CARDIO VASCULAR disease

              Erectile Dysfunction as an Early Marker of Elevated BLOOD Glucose Levels and BLOOD Pressure in Malawian Men in a Rural Setting

              Erectile dysfunction as an early sign of CARDIO VASCULAR disease

              Erectile dysfunction as an independent predictor of future CARDIO VASCULAR events: the multi-ethnic study of atherosclerosis

              Erectile dysfunction as manifestation of endothelial changes in coronary ARTERY disease patients

              Erectile dysfunction as the first sign of systemic VASCULAR diseases and of organo VASCULAR arterial ischemic diseases. Guidelines and Challenge of the Angiology …

              Erectile Dysfunction Associated with CARDIO VASCULAR Risk Factors

              Erectile dysfunction associated with pregabalin add-on treatment in patients with partial seizures: five case reports

              Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis.

              ERECTILE DYSFUNCTION AT PRESENTATION AS AN OPPORTUNITY FOR CARDIO VASCULAR DISEASE INTERVENTION: A COST ANALYSIS

              Erectile dysfunction can improve the effectiveness of the current guidelines for the screening for asymptomatic coronary ARTERY disease in diabetes

              Erectile dysfunction can predict CARDIO VASCULAR disease

              Erectile dysfunction can predict coronary ARTERY disease

              Erectile dysfunction can signal impending HEART disease

              Erectile Dysfunction Complicating CARDIO VASCULAR Risk Factors and Disease

              Erectile dysfunction correlates with left ventricular function and precedes CARDIO VASCULAR events in CARDIO VASCULAR high‐risk patients

              ERECTILE DYSFUNCTION DRUG (PHOSPHODIESTERASE-5 INHIBITORS) ASSOCIATED WITH NON-ARTERITIC ANTERIOR ISCHAEMIC OPTIC …

              Erectile dysfunction drugs and non-arteritic anterior ischemic optic neuropathy: is there a cause and effect relationship?

              Erectile dysfunction drugs and nonarteritic anterior ischemic optic neuropathy

              Erectile dysfunction heralds onset of CARDIO VASCULAR disease.

              Erectile Dysfunction in 101 Consecutive HYPERTENSIVE Patients and 86 Normotensive Controls

              Erectile dysfunction in a group of congolese HYPERTENSIVE patients

              Erectile dysfunction in a sample of patients attending a psychiatric outpatient department

              Erectile dysfunction in anterior urethral strictures after urethroplasty with reference to VASCULAR parameters

              Erectile dysfunction in Arab countries. Part I: Prevalence and correlates

              Erectile dysfunction in Arab countries. Part II: Diagnosis and treatment

              Erectile dysfunction in CARDIO VASCULAR diseases

              Erectile dysfunction in CARDIO VASCULAR risk population

              Erectile dysfunction in cerebro VASCULAR stroke patients

              Erectile dysfunction in chronic kidney disease: part one

              Erectile dysfunction in cirrhosis is impacted by liver dysfunction, portal HYPERTENSION , diabetes and arterial HYPERTENSION

              Erectile dysfunction in congenital HEART disease

              Erectile dysfunction in coronary ARTERY disease and HEART failure

              Erectile dysfunction in diabetes mellitus: a risk factor for CARDIO VASCULAR disease

              Erectile dysfunction in essential arterial HYPERTENSION and effects of sildenafil: results of a Spanish national study

              Erectile dysfunction in HEART disease patients

              Erectile dysfunction in HEART failure patients

              Erectile dysfunction in HEART failure patients: a critical reappraisal

              Erectile dysfunction in HEART failure rats is associated with increased neurogenic contractions in cavernous tissue and internal pudendal ARTERY

              Erectile dysfunction in high‐risk HYPERTENSIVE patients treated with beta‐blockade agents

              Erectile dysfunction in HYPERTENSION and CARDIO VASCULAR disease

              Erectile dysfunction in HYPERTENSIVE patient in Togo: cross-sectional study in 100 patients in the Cardiology Department of the University Hospital Campus of …

              Erectile dysfunction in HYPERTENSIVE rats results from impairment of the relaxation evoked by neurogenic carbon monoxide and nitric oxide

              ERECTILE DYSFUNCTION IN MALE GERIATRIC POPULATION WITH ARTERIAL HYPERTENSION IN TEGUCIGALPA HONDURAS

              Erectile dysfunction in male patients with severe chronic obstructive PULMONARY disease

              Erectile dysfunction in men with angiographically documented coronary ARTERY disease

              Erectile dysfunction in men with congenital HEART disease

              Erectile Dysfunction in Men with Essential Arterial HYPERTENSION

              Erectile dysfunction in men with high-normal BLOOD pressure

              Erectile dysfunction in Nigerian HYPERTENSIVE s.

              Erectile dysfunction in patients under antihypertensive treatment

              Erectile dysfunction in patients with arterial HYPERTENSION . CARDIO VASCULAR risk and impact on their quality of life

              Erectile dysfunction in patients with CARDIO VASCULAR disease

              Erectile Dysfunction in Patients with CARDIO VASCULAR Disease.

              Erectile Dysfunction in Patients with Chronic Obstructive PULMONARY Disease

              Erectile dysfunction in patients with coronary ARTERY disease

              Erectile dysfunction in patients with HYPERTENSION : management tactics

              Erectile dysfunction in patients with ischemic HEART disease (review)

              Erectile dysfunction in patients with plaque psoriasis: the relation of depression and CARDIO VASCULAR factors

              Erectile dysfunction in primary care: a focus on cardiometabolic risk evaluation and stratification for future CARDIO VASCULAR events

              Erectile dysfunction in primary care: Sexual health inquiry and CARDIO VASCULAR risk factors among patients with no previous CARDIO VASCULAR events

              Erectile dysfunction in PULMONARY tuberculosis: is it a common association?

              Erectile dysfunction in PULMONARY tuberculosis: Is there an association?

              Erectile dysfunction in Qatar: Prevalence and risk factors in 1,052 participants—A pilot study

              Erectile dysfunction in smokers: a penile dynamic and VASCULAR study

              Erectile dysfunction in spontaneously HYPERTENSIVE rats: pathophysiological mechanisms

              Erectile dysfunction in the cardiology practice—a patients’ perspective

              Erectile dysfunction in the CARDIO VASCULAR patient

              Erectile dysfunction in the case of CARDIO VASCULAR disease

              Erectile dysfunction in the patients with CARDIO VASCULAR disease

              Erectile dysfunction in the trajectory of CARDIO VASCULAR disease

              Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and CARDIO VASCULAR risk factors in the Look AHEAD trial

              Erectile dysfunction increases CARDIO VASCULAR risk: time to reduce it

              Erectile dysfunction is a signal of risk for CARDIO VASCULAR disease: A primary care view

              Erectile dysfunction is an early predictor of CARDIO VASCULAR diseases in men with obstructive sleep apnea

              Erectile dysfunction is associated with a high prevalence of hyperlipidemia and coronary HEART disease risk

              ERECTILE DYSFUNCTION IS ASSOCIATED WITH ENDOTHELIAL CELL ACTIVATION ALSO IN ABSENCE OF VASCULAR RISK FACTORS

              Erectile Dysfunction is Associated With Retinopathy in Diabetic Men: Two Manifestations of a Systemic Micro- VASCULAR Disease

              Erectile dysfunction is associated with subclinical carotid VASCULAR disease in young men lacking widely-known risk factors

              Erectile dysfunction is associated with subsequent CARDIO VASCULAR and respiratory mortality in cohort of 1,436 Chinese elderly men

              Erectile dysfunction is not independently associated with CARDIO VASCULAR death: data from the vitamins and lifestyle (VITAL) study

              Erectile dysfunction is positively correlated with mean platelet volume and platelet count, but not with eosinophil count in peripheral BLOOD

              Erectile dysfunction is prevalent, and underreported in male HYPERTENSIVE subjects

              Erectile dysfunction links to CARDIO VASCULAR disease–defining the clinical value.

              Erectile Dysfunction Management for the Future Arthur L. Burnett, MD

              Erectile dysfunction may be an early sign of HEART disease, suggests new research

              Erectile dysfunction may improve by BLOOD pressure control in patients with high-risk HYPERTENSION

              Erectile dysfunction may predict coronary ARTERY disease: relationship between coronary ARTERY calcium scoring and ERECTILE DYSFUNCTION severity

              Erectile dysfunction medication induced-changes in plasma levels of homocysteine and antioxidant enzyme activities as risk factors for CARDIO VASCULAR  …

              Erectile dysfunction medication use in veterans eligible for medicare part D

              Erectile dysfunction medications and treatment for cardiometabolic risk factors: a pharmacoepidemiologic study

              Erectile dysfunction might be associated with chronic periodontal disease: two ends of the CARDIO VASCULAR spectrum

              Erectile dysfunction might predict silent unobstructive coronary ARTERY disease

              Erectile dysfunction of sclerodermic patients correlates with digital VASCULAR damage

              Erectile dysfunction of VASCULAR cause: statistical evaluation on the Plurimetabolic Syndrome’s risk factors and their correlation with penile eco-doppler rates.

              Erectile dysfunction Part 2: Managing men unresponsive to PDE5 inhibitors

              Erectile Dysfunction Precedes and Is Associated with Severity of Coronary ARTERY Disease among A sian I ndians

              Erectile dysfunction precedes coronary ARTERY endothelial dysfunction in rats fed a high‐fat, high‐sucrose, Western pattern diet

              Erectile dysfunction precedes other systemic VASCULAR diseases due to incompetent cavernous endothelial cell-cell junctions

              Erectile Dysfunction Predicts CARDIO VASCULAR Events as an Independent Risk Factor: A Systematic Review and Meta-Analysis

              Erectile Dysfunction Predicts CARDIO VASCULAR Events in High Risk Patients Receiving Telmisartan, Ramipril or Both

              Erectile dysfunction predicts CARDIO VASCULAR events in high-risk patients receiving telmisartan, ramipril, or both: The ONgoing Telmisartan Alone and in …

              Erectile dysfunction predicts CARDIO VASCULAR risk in men

              Erectile dysfunction predicts coronary HEART disease in type 2 diabetes

              Erectile dysfunction predicts generalised CARDIO VASCULAR disease: Evidence from a case–control study

              Erectile Dysfunction Predicts High Risk Findings on Myocardial Perfusion SPECT Imaging in Men without Prior HEART Disease

              Erectile dysfunction predicts peripheral arterial disease as measured by screening ankle brachial index testing

              Erectile dysfunction prevalence and sexual function status in patients with chronic obstructive PULMONARY disease

              Erectile dysfunction prospectively associated with CARDIO VASCULAR disease in the Dutch general population: results from the Krimpen Study

              Erectile dysfunction scores are lower in type 2 diabetes mellitus but not correlate with carotis intima media ticknes or coronary arter disease

              Erectile dysfunction severity and prediction of CARDIO VASCULAR events and all-cause mortality: a systematic review and meta-analysis of cohort studies

              Erectile dysfunction severity and SYNTAX score in coronary ARTERY disease

              Erectile dysfunction severity as a risk marker for CARDIO VASCULAR disease hospitalisation and all-cause mortality: a prospective cohort study

              Erectile dysfunction therapy in special populations and applications: coronary ARTERY disease

              Erectile dysfunction vs. physical capacity and physical activity at invasive treated patients with ischemic HEART disease

              Erectile dysfunction–early sign of CARDIO VASCULAR disease

              Erectile Dysfunction-A Missed Part of Benign Prostate Hyperplasia

              Erectile dysfunction—a CARDIO VASCULAR disease?

              Erectile dysfunction—overview from a CARDIO VASCULAR perspective

              Erectile dysfunction, a new symptom for the cardiologist

              Erectile dysfunction, and risk factors of CARDIO VASCULAR disease

              ERECTILE DYSFUNCTION, ARTERIAL HYPERTENSION AND ANTIHYPERTENSIVE THERAPY: P 339

              Erectile dysfunction, cardiology at the epicenter

              Erectile dysfunction, CARDIO VASCULAR diseases and depression: Interaction of therapy

              Erectile dysfunction, CARDIO VASCULAR risk, and the primary care clinician

              Erectile dysfunction, depression, and ischemic HEART disease: does the existence of one component of this triad necessitate inquiring the other two?(CME)

              Erectile dysfunction, diabetes and CARDIO VASCULAR risk

              Erectile dysfunction, endothelium dysfunction, and micro VASCULAR damage in patients with systemic sclerosis

              ERECTILE DYSFUNCTION, ITS CLINICAL CORRELATES AND PERCEIVED IMPACT ON PARTNERS OF AFFECTED MEN ATTENDING THE GENERAL …

              Erectile dysfunction, like diabetes, should be considered a ‘cardio VASCULAR equivalent’

              Erectile dysfunction, loss of libido and low sexual frequency increase the risk of CARDIO VASCULAR disease in men with low testosterone

              Erectile dysfunction, metabolic syndrome and arterial disease. Clinical–pathological relation by carotid ultrasonography

              Erectile dysfunction, metabolic syndrome, and CARDIO VASCULAR risks: facts and controversies

              Erectile dysfunction, penile atherosclerosis, and coronary ARTERY vasculopathy in HEART transplant recipients

              Erectile dysfunction, quality of life, and partnership in prostate cancer

              Erectile dysfunction, testosterone deficiency, and risk of coronary HEART disease in a cohort of men living with HIV in Belgium

              Erectile dysfunction, VASCULAR risk, and cognitive performance in late middle age.

              Erectile dysfunction: a disease marker for CARDIO VASCULAR disease

              Erectile dysfunction: a marker of early coronary HEART disease

              Erectile Dysfunction: A Marker of Peripheral VASCULAR Disease?

              Erectile dysfunction: a marker of silent coronary ARTERY disease

              Erectile dysfunction: a marker of subclinic coronary ARTERY disease?

              Erectile dysfunction: a potential useful marker for CARDIO VASCULAR disease

              Erectile dysfunction: a sentinel marker for CARDIO VASCULAR disease in primary care

              Erectile dysfunction: a significant health need in patients with coronary HEART disease

              Erectile dysfunction: a syndrome heralds HEART attacks

              Erectile dysfunction: a VASCULAR disease in the field of urology

              Erectile dysfunction: a warning sign of silent VASCULAR disease

              Erectile dysfunction: a window of opportunity for preventing VASCULAR disease?

              Erectile dysfunction: a window to the HEART

              Erectile dysfunction: an early marker for HYPERTENSION ? A longitudinal study in spontaneously HYPERTENSIVE rats

              Erectile dysfunction: an early sign of CARDIO VASCULAR disease

              Erectile dysfunction: another window to the HEART ?

              Erectile dysfunction: CARDIO VASCULAR risk and the role of the cardiologist.

              Erectile dysfunction: CARDIO VASCULAR risk procedure

              Erectile dysfunction: does insulin resistance play a part?

              Erectile dysfunction: Endothelial nitric oxide synthase expression is reduced in mononuclear cells from cavernous BLOOD

              ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION in HEART Failure: Correlation with Severity, Exercise Performance, Comorbidities, and HEART Failure Treatment

              ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION Severity as a Risk Predictor for Coronary ARTERY Disease

              ERECTILE DYSFUNCTION: ERECTILE DYSFUNCTION Severity Might be Associated with Poor CARDIO VASCULAR Prognosis in Diabetic Men

              Erectile dysfunction: heritability and cognitive and physiological correlates of the subclinical VASCULAR disorder

              Erectile dysfunction: indicator of end-organ damage in CARDIO VASCULAR patients

              Erectile dysfunction: main article

              Erectile dysfunction: pathophysiologic mechanisms pointing to underlying CARDIO VASCULAR disease

              Erectile dysfunction: prevalence, risk factors and involvement of antihypertensive drugs intervention

              Erectile dysfunction: risk factor or manifestation of CARDIO VASCULAR disease?

              Erectile dysfunction: the earliest sign of generalized VASCULAR disease?

              Erectile dysfunction: The impact on the female partner and on the couple: The role of the urologist [Disturbi dell’erezione: Impatto sulla donna e sulla coppia: Il ruolo …

              Erectile dysfunction: the perspectives of patients and partners on counselling

              Erectile Dysfunction: The Tip of a VASCULAR Risk Iceberg–How common is CARDIO VASCULAR disease among men who present with erectile dysfunction?

              Erectile dysfunction: ultrasound evaluation and CARDIO VASCULAR risk assessment

              Erectile dysfunction: Why is it the ignored symptom of CARDIO VASCULAR disease?

              Erectile dysfunction. Part 1: investigation and management

              Erectile VASCULAR dysfunction and analysis of the risk factors related to it: clinical experience.

              Erection, erectile dysfunction: what has HEART got to do with it?

              Erratum: HEART rate and BLOOD pressure interactions in the development of ERECTILE DYSFUNCTION in high-risk CARDIO VASCULAR patients by Mario T Kratz et al …

              Establishment of arteriogenic ERECTILE DYSFUNCTION rat model and its pathogenesis

              Estimated CARDIO VASCULAR risk and arteriogenic erectile dysfunction

              et al. Non-arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction. Br J Ophthalmol 2006; 90: 154e7. This article has been

              Evaluating a continuous medical education program to improve general practitioners awareness and practice on ERECTILE DYSFUNCTION as a CARDIO VASCULAR risk factor

              Evaluating the treatment satisfaction of vardenafil in men with ERECTILE DYSFUNCTION and female partners by the Treatment Satisfaction Scale

              Evaluation and management of ERECTILE DYSFUNCTION in the HYPERTENSIVE patient

              Evaluation of ambulatory CARDIAC rehabilitation influence on the intensity of ERECTILE DYSFUNCTION in patients with ischemic HEART disease

              Evaluation of arterial stiffness and CARDIAC function in patients with VASCULAR erectile dysfunction: acute effects of phosphodiesterase-5 inhibitor tadalafil

              Evaluation of BLOOD platelet count and function in patients with erectile dysfunction

              Evaluation of endothelial function with brachial ARTERY ultrasound in men with or without ERECTILE DYSFUNCTION and classified as intermediate risk according to the …

              Evaluation of ERECTILE DYSFUNCTION and associated CARDIO VASCULAR risk using structured questionnaires in Chinese type 2 diabetic men

              Evaluation of Helicine Arteries in Patients with ERECTILE DYSFUNCTION Using Color Doppler Ultrasonography

              Evaluation Of Linear Shock Wave Therapy In Patients With VASCULOGENIC ERECTILE DYSFUNCTION In The Slovenian Population

              Evaluation of penile re VASCULAR ization for erectile dysfunction: a 10-year follow-up

              Evaluation of penile VASCULAR status in men with epilepsy with erectile dysfunction

              Evaluation of tadalafil in men with ERECTILE DYSFUNCTION taking antihypertensive medication

              Evaluation of the Nervous and VASCULAR Systems in ERECTILE DYSFUNCTION Patients after Electric Injuries

              Evaluation of VASCULAR smooth muscle and corpus cavernosum on hypercholesterolemia. Is resveratrol promising on erectile dysfunction?

              Evaluation of VASCULOGENIC erectile dysfunction: an angiographic atlas

              Evaluations of ERECTILE DYSFUNCTION before and after on-pump coronary ARTERY bypass graft surgery

              Exercise prevents Western diet-associated ERECTILE DYSFUNCTION and coronary ARTERY endothelial dysfunction: response to acute apocynin and sepiapterin treatment

              Exercise prevents Western-diet associated erectile and coronary ARTERY endothelial dysfunction mediated by NADPH oxidase

              Experimental Research of Huoxue Qiwei Granules in the Treatment of ERECTILE DYSFUNCTION Caused by Arteriosclerosis

              Expression of the Apelin–APJ Pathway and Effects on Erectile Function in a Mouse Model of VASCULOGENIC Erectile Dysfunction

              External mechanical devices and VASCULAR surgery for erectile dysfunction

              Extracorporeal Shock Waves Therapy Delivered by Aries Improves ERECTILE DYSFUNCTION in Spontaneously HYPERTENSIVE Rats Through Penile Tissue …

              Facing ERECTILE DYSFUNCTION due to Prostate Cancer Treatment: Perspectives of Men and Their Partners

              Factors affecting the increased prevalence of ERECTILE DYSFUNCTION in Greek HYPERTENSIVE compared with normotensive subjects

              Factors associated with sex hormones and ERECTILE DYSFUNCTION in male Taiwanese participants with obesity

              Feasibility of dynamic 3-D color Doppler ultrasound for imaging penile VASCULAR change in renal transplant patients with ERECTILE DYSFUNCTION responding to sildenafil

              Female partners confronted with erectile dysfunction. A series of 137 patients

              FEMALE PARTNERS’ATTITUDES ARE ASSOCIATED WITH TREATMENT SEEKING FOR ERECTILE DYSFUNCTION (ED) IN MEN WITH ED

              Female sexual dysfunction, voiding symptoms and depression: common findings in partners of men with erectile dysfunction

              Female sexual partners of men with erectile dysfunction: Biopsychosocial characteristics and quality of life

              Fertility Related Quality of Life, Gonadal Function and ERECTILE DYSFUNCTION in Male Partners of Couples with Unexplained Infertility

              Fibrous hamartoma of corpus cavernosum: a rare cause of congenital penile curvature associated with erectile dysfunction

              Five-year prospective study on CARDIO VASCULAR events, in patients with ERECTILE DYSFUNCTION and hypotestosterone

              FJVIS 35. Sexual Dysfunction After Aortoiliac Surgery: Does Endo VASCULAR Repair Preserve Erectile Function?

              Flowchart of examination of erectile dysfunction

              Folic acid supplementation improves erectile function in patients with idiopathic VASCULOGENIC ERECTILE DYSFUNCTION by lowering peripheral and penile homocysteine …

              Formulation of Double-layer Tadalafil and Amlodipine Complex Tablets to Treat ERECTILE DYSFUNCTION and HYPERTENSION

              Frequency of sexual activity and CARDIO VASCULAR risk in subjects with erectile dysfunction: Cross-sectional and longitudinal analyses

              Frequency of sexual activity and CARDIO VASCULAR risk in subjects with erectile dysfunction: Cross‐sectional and longitudinal analyses

              Frequency of VASCULOGENIC ERECTILE DYSFUNCTION with color doppler sonography following intracavernosal injection of prostaglandin E1

              FTY720 supplementation partially improves ERECTILE DYSFUNCTION in rats with streptozotocin-induced type 1 diabetes through inhibition of endothelial dysfunction and …

              Functional and structural changes in internal pudendal arteries underlie ERECTILE DYSFUNCTION induced by androgen deprivation

              Functional characterization of platelets in patients with arterial erectile dysfunction

              G-protein β3 subunit gene 825C/T polymorphism and its association with the presence, severity, and duration of VASCULOGENIC erectile dysfunction

              GENDER DIFFERENCES IN ATTITUDES OF PARTNERS OF MEN WITH ERECTILE DYSFUNCTION IN THE MEN’S ATTITUDES TO LIFE EVENTS AND …

              Graded association between aortic stiffness, wave reflections, and duration of VASCULOGENIC erectile dysfunction

              Graded Association Between Large ARTERY Stiffness and ERECTILE DYSFUNCTION Severity and Duration in Essential HYPERTENSIVE Men

              GW24-e3520 Association of CARDIO VASCULAR disease and erectile dysfunction: share the same risk factors?

              GW25-e3095 The association between CARDIO VASCULAR disease and ERECTILE DYSFUNCTION among middle-aged and elderly men in south china

              GW26-e0790 ERECTILE DYSFUNCTION may be the first clinical sign of sub-clinical ARTERIOSCLEROSIS in young men

              GW27-e0510 ERECTILE DYSFUNCTION and androgen deficiency in men with high CARDIO VASCULAR risk and metabolic disorders

              H 002 HYPERTENSION AND ERECTILE DYSFUNCTION

              Health Promotion for African-American Men: Improving awareness of the link between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              Heart disease and erectile dysfunction

              Heart disease and erectile dysfunction: Management at a nurse-led clinic

              Heart disease in erectile dysfunction

              Heart disease risk factors predict ERECTILE DYSFUNCTION 25 years later (the Rancho Bernardo Study)

              Heart disease risk factors predict ERECTILE DYSFUNCTION 25 years later: the Rancho Bernardo Study

              Heart rate and BLOOD pressure interactions in the development of ERECTILE DYSFUNCTION in high-risk CARDIO VASCULAR patients

              Heart rate recovery, CARDIAC rehabilitation and ERECTILE DYSFUNCTION in males with ischaemic HEART disease

              Heart rate recovery, CARDIAC rehabilitation, and ERECTILE DYSFUNCTION in males with ischemic HEART disease/Author’s Reply

              Heart rate reduction with ivabradine improves ERECTILE DYSFUNCTION in parallel to decrease in atherosclerotic plaque load in ApoE-knockout mice

              Heart Rate Variability in Male Sexual Arousal and Erectile Dysfunction

              Heart rate variability in men with erectile dysfunction

              Help-seeking Pattern of ERECTILE DYSFUNCTION Patients at Urology Outpatient Clinic Cipto Mangunkusumo National Referral Hospital Jakarta and Its Associated Factors …

              Hemodynamic evaluation of the penile arterial system in patients with ERECTILE DYSFUNCTION using power Doppler imaging

              HEPATIC STEATOSIS IS INDEPENDENTLY ASSOCIATED WITH ERECTILE DYSFUNCTION: ONE MORE LINK BETWEEN THE LIVER AND CARDIO VASCULAR  …

              Hepatic steatosis is independently associated with erectile dysfunction: One more link between the liver and CARDIO VASCULAR risk?

              Hexahydropyrazino [1’2′; 1, 6] pyrido [3, 4-b] indole-1, 4-diones for the treatment of CARDIO VASCULAR disorders and erectile dysfunction

              High triglycerides predicts arteriogenic ERECTILE DYSFUNCTION and major adverse CARDIO VASCULAR events in subjects with sexual dysfunction

              High-tone electric muscles stimulation of thigh augments the impaired penile BLOOD flow of diabetic patients without improving symptoms of erectile dysfunction

              High-tone electric muscles stimulation of thigh augments the impaired penile BLOOD flow of diabetic patients without improving symptoms of erectile dysfunction.

              How does ivabradine effect ERECTILE DYSFUNCTION in patients with HEART failure?

              How to save a life during a clinic visit for ERECTILE DYSFUNCTION by modifying CARDIO VASCULAR risk factors

              How to treat ERECTILE DYSFUNCTION complicated with CARDIO VASCULAR disease using sildenafil citrate?

              How to treat HYPERTENSIVE patient with erectile dysfunction?

              HP-03-004 Establishing the safety profile in sexual partners of a new topical glyceryl trinitrate gel for the treatment of erectile dysfunction

              HP-07-007 Unveiling the role of vasculogenesis in diabetic ERECTILE DYSFUNCTION using a bone marrow transplantation model: preliminary results

              Hypertension and erectile dysfunction

              HYPERTENSION AND ERECTILE DYSFUNCTION: NEW INSIGHTS IN HEART FAILURE PATIENTS

              Hypertension is more prevalent in men with erectile dysfunction

              Hypertension might be a risk factor for erectile dysfunction: a meta‐analysis

              Hypertension, anti‐hypertensive drug therapy and ERECTILE DYSFUNCTION in diabetes

              Hypertension, antihypertensive therapy, and erectile dysfunction

              Hypertension, obesity, erectile dysfunction. What kind of drug to choose

              Hypertension: the link between ERECTILE DYSFUNCTION and coronary ARTERY disease

              Hypertensive medication and erectile dysfunction

              I am a male in my late 50s. I have HEART disease and erectile dysfunction. Are the two related?

              IIEF-5 cannot be used as a tool for differential diagnosis of VASCULOGENIC erectile dysfunction

              Immediate-and late-hemodynamic coronary effects of tadalafil in men with ERECTILE DYSFUNCTION and coronary ARTERY disease

              Impact of ERECTILE DYSFUNCTION (ED) on sexual life of female partners: assessment with the Index of Sexual Life (ISL) questionnaire

              Impact of Lipid and BLOOD Pressure Reduction on ERECTILE DYSFUNCTION in Persons at Intermediate Risk for CARDIO VASCULAR Disease

              Impact of tadalafil once daily in men with erectile dysfunction—including a report of the partners’ evaluation

              Impaired arteriogenic rather than veno-occlusive mechanisms are responsible for ERECTILE DYSFUNCTION in diabetics

              Impaired brachial ARTERY endothelium-dependent and-independent vasodilation in men with ERECTILE DYSFUNCTION and no other clinical CARDIO VASCULAR disease

              Impaired VASCULAR reactivity in patients with erectile dysfunction

              Impairment of shear-stress-mediated vasodilation of cavernous arteries in erectile dysfunction

              Implantation of Autologous Bone Marrow-derived Cells Improves ERECTILE DYSFUNCTION in Spontaneously HYPERTENSIVE Rats

              Implantation of bioresorbable VASCULAR scaffold for the treatment of pudendal ARTERY stenosis and erectile dysfunction

              Implants, mechanical devices, and VASCULAR surgery for erectile dysfunction

              Importance of the ERECTILE DYSFUNCTION Questionnaire for Geriatric Cardiology Outpatients

              Improved penile histology by phalloidin stain: circular and longitudinal cavernous smooth muscles, dual-endothelium arteries, and erectile dysfunction-associated …

              Improved spontaneous erectile function in men with mild‐to‐moderate arteriogenic ERECTILE DYSFUNCTION treated with a nightly dose of sildenafil for one year: A …

              Improvement in quality of sexual life in female partners of men with ERECTILE DYSFUNCTION treated with sildenafil citrate: findings of the Index of Sexual Life (ISL) in a …

              Improvement in sexual quality of life of the female partner following vardenafil treatment of men with erectile dysfunction: A randomized, double‐blind, placebo …

              Improvement of ERECTILE DYSFUNCTION by Re VASCULAR ization Surgery Following Urethroplasty in Patients with Pelvic Fracture

              In the “Heart” of Erectile Dysfunction

              Incidence of ERECTILE DYSFUNCTION in 800 HYPERTENSIVE patients: a multicenter Egyptian national study

              Incidence of extragenital VASCULAR disease in patients with ERECTILE DYSFUNCTION of arterial origin

              Incidence of extragenital VASCULAR disease in patients with ERECTILE DYSFUNCTION of arterial origin.

              Incidental findings during computed tomographic angiography diagnostic work-up in patients with arteriogenic erectile dysfunction

              Increased erythrocyte aggregation in men with coronary ARTERY disease and erectile dysfunction

              Increased expression of endothelial-platelet dysfunctional pathway in patients with arterial erectile dysfunction.

              Increased expression of insulin-like growth factor-binding protein-3 is implicated in ERECTILE DYSFUNCTION in two-kidney one-clip HYPERTENSIVE rats after …

              Independent determinants of coronary ARTERY disease in ERECTILE DYSFUNCTION patients

              Inflammation, metabolic syndrome, erectile dysfunction, and coronary ARTERY disease: common links

              Influence of age and changes over time on erectile dysfunction: Results from two large cross-sectional surveys 11 years apart

              Influence of eNOS gene on CARDIO VASCULAR risk in ERECTILE DYSFUNCTION patients

              Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction

              Influence of VASCULAR Comorbidities and Race on ERECTILE DYSFUNCTION After Prostate Cancer Radiation Therapy

              Influence of VASCULAR comorbidities and race on ERECTILE DYSFUNCTION after prostate cancer radiotherapy

              Influence of VASCULAR comorbities and race on ERECTILE DYSFUNCTION after prostate cancer radiotherapy.

              Inhibiting BLOOD pressure drop in the treatment of erectile dysfunction

              Inhibition of NADPH Oxidase by Apocynin Alleviates ERECTILE DYSFUNCTION in HYPERTENSIVE Rats

              Initial validation of a novel rat model of VASCULOGENIC ERECTILE DYSFUNCTION with generalized atherosclerosis

              Integrating partners into ERECTILE DYSFUNCTION treatment: improving the sexual experience for the couple

              Interactions between drugs for ERECTILE DYSFUNCTION and drugs for CARDIO VASCULAR disease

              Interactions between lower urinary tract symptoms and CARDIO VASCULAR risk factors determine distinct patterns of erectile dysfunction: a latent class analysis

              Internal pudendal ARTERY stenoses and erectile dysfunction: correlation with angiographic coronary ARTERY disease

              Interrelation of ERECTILE DYSFUNCTION with obesity in patients with arterial HYPERTENSION .

              Interrelationships between ERECTILE DYSFUNCTION and smoking in essential HYPERTENSIVE patients

              Intima-media thickening of common carotid arteries is a risk factor for severe ERECTILE DYSFUNCTION in men with VASCULAR risk factors but no clinical evidence of …

              Intima‐media thickness of carotid arteries and ERECTILE DYSFUNCTION in hemodialysis patients

              Intima–media thickness and BLOOD flow rate in arteries of the penis in men with ERECTILE DYSFUNCTION after two months treatment with vardenafil: 116

              Intracavernous injection of human umbilical cord BLOOD mononuclear cells improves ERECTILE DYSFUNCTION in streptozotocin-induced diabetic rats

              Intracavernous injections for ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases and failure or contraindications for sildenafil citrate

              Introduction: ERECTILE DYSFUNCTION and CARDIO VASCULAR risk factors.

              Inverse correlation between testosterone and ventricle ejection fraction, hemodynamics and exercise capacity in HEART failure patients with erectile dysfunction

              Investigating women’s preference for sildenafil or tadalafil use by their partners with erectile dysfunction: The partners’ preference study

              Investigative models in erectile dysfunction: A state‐of‐the‐art review of current animal models

              Invited Comments on Billups, K. et al. ERECTILE DYSFUNCTION Is a Marker for CARDIO VASCULAR Disease: Results of the Minority Health Institute Expert Advisory Panel

              Irradiation of the Pudendal Arteries Induces ERECTILE DYSFUNCTION in Patients Treated by Brachytherapy for Prostate Cancer

              Is chronic obstructive PULMONARY disease a risk factor for erectile dysfunction? A cross-sectional, comparative study

              Is ERECTILE DYSFUNCTION a predictor of CARDIO VASCULAR events or stroke? A prospective study using a validated questionnaire

              Is ERECTILE DYSFUNCTION a sentinel symptom for CARDIO VASCULAR autonomic neuropathy in patients with type 2 diabetes?

              Is ERECTILE DYSFUNCTION an early indicator of CARDIO VASCULAR disease

              Is ERECTILE DYSFUNCTION an early precursor of silent coronary ARTERY disease?

              Is ERECTILE DYSFUNCTION an independent risk factor of coronary HEART disease or another clinical manifestation of progressive atherosclerosis?

              Is ERECTILE DYSFUNCTION an indicator for increased risk of coronary HEART disease and stroke?

              Is ERECTILE DYSFUNCTION linked to neuro VASCULAR changes evoked by air bone pollutants exposure?

              Is ERECTILE DYSFUNCTION predictive of peripheral VASCULAR disease?

              Is ERECTILE DYSFUNCTION really a clinically useful predictor of CARDIO VASCULAR disease?

              Is ERECTILE DYSFUNCTION the “tip of the iceberg” of a systemic VASCULAR disorder?

              Is high cholesterol a risk for erectile dysfunction? Results based on the penile BLOOD flow index (PBFI)

              Is metabolic syndrome a useless category in subjects with high CARDIO VASCULAR risk? Results from a cohort study in men with erectile dysfunction

              Is obesity a further CARDIO VASCULAR risk factor in patients with erectile dysfunction?

              Is penile atherosclerosis the link between ERECTILE DYSFUNCTION and CARDIO VASCULAR risk? An autopsy study

              Is Self-Report of ERECTILE DYSFUNCTION Associated with Severity, CARDIO VASCULAR Disease Risk Factors, and Depression?

              Is serum uric acid level correlated with ERECTILE DYSFUNCTION in coronary ARTERY disease patients?

              Is the relationship between cigarette smoking and male ERECTILE DYSFUNCTION independent of CARDIO VASCULAR disease? Findings from a population-based cross-sectional …

              Is there a concordance between carotid and penile cavernosal ARTERY intima-media thickness in patients with erectile dysfunction?

              Is there a link between ERECTILE DYSFUNCTION and coronary ARTERY disease?

              Is there a relationship between penile VASCULOGENIC erectile dysfunction, platelet functions and eosinophil count?

              Is there a relationship between severity of coronary ARTERY disease and severity of erectile dysfunction?

              Isolated polyarteritis nodosa of the genitourinary tract presenting with severe erectile dysfunction: a case report with long-term follow-up

              Johnson & Åsberg: Enrolling Men, their Doctors, and Partners: Individual and Collective Responses to Erectile Dysfunction

              l-Arginine and tetrahydrobiopterin, but not sodium nitrite partially restored ERECTILE DYSFUNCTION in aged rats

              Lack of predictive correlation between peripheral arterial tone and colour flow Doppler parameters in men with erectile dysfunction.

              LC–MS/MS software for screening unknown ERECTILE DYSFUNCTION drugs and analogs: artificial neural network classification, peak-count scoring, simple similarity search …

              Lesion pattern in patients with ERECTILE DYSFUNCTION of suspected arterial origin: an angiographic study

              Letter by Li et al Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR Events: The Multi-Ethnic Study of …

              Letter by Nunes Regarding Article,“Clinical Cardiology: Physician Update: ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease”

              Letter by Su and Li Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR Events: The Multi-Ethnic Study of …

              Letter Regarding Article by Gazzaruso et al,“Relationship Between ERECTILE DYSFUNCTION and Silent Myocardial Ischemia in Apparently Uncomplicated Type …

              Letter regarding the article “the impact of hypomagnesemia on ERECTILE DYSFUNCTION in elderly, non-diabetic, stage 3 and 4 chronic kidney disease patients: a …

              Levitra-test in diagnosis of VASCULOGENIC erectile dysfunction

              Lifestyle Changes, Erectile Dysfunction, and Female Sexual Dysfunction: HEART Health and Sexual Health

              Lifestyle management of erectile dysfunction: the role of CARDIO VASCULAR and concomitant risk factors

              Lifestyle modification in ERECTILE DYSFUNCTION and HYPERTENSION

              Lifestyle modifications and pharmacotherapy for CARDIO VASCULAR risk factors are associated with improvements in erectile dysfunction

              Linking CARDIO VASCULAR disease, ERECTILE DYSFUNCTION and pre-eclampsia: NO problem

              Linking ERECTILE DYSFUNCTION and coronary ARTERY disease

              Lipoprotein‐associated phospholipase A 2 levels are associated with ERECTILE DYSFUNCTION in patients without known coronary ARTERY disease

              Liver & gallbladder: based ERECTILE DYSFUNCTION (part two)

              Liver & gallbladder: based erectile dysfunction:(part one)

              Loadable Polymeric Particles for Therapeutic Use in ERECTILE DYSFUNCTION and Methods of Preparing and Using the Same

              Local delivery of COMP-angiopoietin-1 protein as a novel therapeutic strategy for VASCULAR disease-induced erectile dysfunction

              VASCULAR -erectile-dysfunction-patients-20-months-follow-up/”>Long Term Efficacy of Low Intensity Linear Focused Shockwave Therapy for VASCULAR ERECTILE DYSFUNCTION Patients: 20 months follow-up

              Losartan improves ERECTILE DYSFUNCTION in diabetic patients: a clinical trial

              Losartan preserves erectile function by suppression of apoptosis and fibrosis of corpus cavernosum and corporal veno-occlusive dysfunction in diabetic rats

              VASCULAR -erectile-dysfunction-patients/”>Low Intensity Linear Focused Shockwave Therapy: a New Treatment to Improve the Quality of Life of VASCULAR ERECTILE DYSFUNCTION Patients

              Low-dose tadalafil improves arterial erectile dysfunction

              Low-energy shock wave therapy ameliorates ERECTILE DYSFUNCTION in a pelvic neuro VASCULAR injuries rat model

              Low-energy Shock Wave Therapy—A Novel Treatment Option for ERECTILE DYSFUNCTION in Men With CARDIO VASCULAR Disease

              Low-intensity extracorporeal shock wave therapy of VASCULOGENIC erectile dysfunction–three-week treatment in a cohort of North Italian patients

              Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients With VASCULOGENIC Erectile Dysfunction: A Triplex

              Low-intensity shockwave therapy improves hemodynamic parameters in patients with VASCULOGENIC erectile dysfunction: a triplex ultrasonography-based sham …

              Low‐Intensity Extracorporeal Shock Wave Therapy in VASCULAR Disease and Erectile Dysfunction: Theory and Outcomes

              Lower urinary tract symptoms in patients with erectile dysfunction: is there a VASCULAR association?

              Lower urinary tract symptoms, benign prostatic hyperplasia/benign prostatic enlargement and erectile dysfunction: are these conditions related to VASCULAR dysfunction …

              Male ERECTILE DYSFUNCTION and CARDIO VASCULAR disease: Is there an intimate nexus?

              Male ERECTILE DYSFUNCTION and microalbuminuria in adult nigerians with essential HYPERTENSION

              Male sexuality and CARDIO VASCULAR risk. A cohort study in patients with erectile dysfunction

              Management of ERECTILE DYSFUNCTION in HYPERTENSION : Tips and tricks

              Management of ERECTILE DYSFUNCTION in patients who failed prior VASCULAR intervention

              Management of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases: from the discussion of safety to potentially beneficial effects

              Management of ERECTILE DYSFUNCTION in patients with preexisting CARDIO VASCULAR disease

              Management of Erectile Dysfunction: An Under-recognition of HYPERTENSION

              Management of erectile dysfunction: do not forget HYPERTENSION

              Management of Erectile Dysfunction: Do Not Forget HYPERTENSION —Reply

              Managing ERECTILE DYSFUNCTION in HEART failure

              Managing ERECTILE DYSFUNCTION in HYPERTENSION : the effects of a continuous training programme on biomarker of inflammation

              Managing ERECTILE DYSFUNCTION in HYPERTENSIVE patients

              Managing ERECTILE DYSFUNCTION in Patients With CARDIO VASCULAR Diseases: The Efficacy and Safety of Phosphodiesterase-5 Inhibitors

              Mean platelet volume and platelet distribution as a diagnostic marker for penile VASCULAR disease in patients with erectile dysfunction

              Mean platelet volume might be an effective indicator of arterial erectile dysfunction

              Measurement of endothelial dysfunction via peripheral arterial tonometry predicts VASCULOGENIC erectile dysfunction

              Mechanism of androgen in improving ERECTILE DYSFUNCTION in castrated rats by regulating androgen receptor/ VASCULAR endothelial growth factor

              Mechanisms of VASCULOGENIC ERECTILE DYSFUNCTION after kidney transplantation

              Mediterranean diet linked to improved CARDIO VASCULAR function in ERECTILE DYSFUNCTION patients.

              Men with type 2 diabetes and ERECTILE DYSFUNCTION are a particular risk group for LUTS-results of the Witten Diabetes Survey

              Metabolic syndrome in men with low testosterone levels: relationship with CARDIO VASCULAR risk factors and comorbidities and with erectile dysfunction

              Metabolic syndrome/cardio VASCULAR disease and ERECTILE DYSFUNCTION (ED)

              Microcirculatory changes in penis with VASCULOGENIC erectile dysfunction

              Micro VASCULAR complications in diabetic erectile dysfunction: do we need other alternatives?

              Micro VASCULAR endothelial dysfunction predicts the development of ERECTILE DYSFUNCTION in men with coronary atherosclerosis without critical stenoses

              VASCULAR _function_and_incident_erectile.1.aspx”>Micro VASCULAR function and incident erectile dysfunction: a new perspective for their relationship

              MODERATE OR SEVERE ERECTILE DYSFUNCTION IS ASSOCIATED WITH SEVERE CORONARY ARTERY DISEASE AMONG CHEST PAIN …

              Modifiable risk factors for erectile dysfunction: an assessment of the awareness of such factors in patients suffering from ischaemic HEART disease

              Molecular basis of veno-occlusion and the molecular pathology of VASCULOGENIC erectile dysfunction

              Morphologic findings and BLOOD flow parameters of penile vasculature in patients with erectile dysfunction

              Morphological and functional evidence for the contribution of the pudendal ARTERY in aging-induced erectile dysfunction

              Moulik PK, Hardy KJ: HYPERTENSION , anti-hypertensive drug therapy and ERECTILE DYSFUNCTION in diabetes

              MP-03.09: The COUPLE-project: pooled analysis of satisfaction with vardenafil treatment in men with ERECTILE DYSFUNCTION and their partners

              MP-03.18: Vardenafil improves treatment satisfaction and sexual pleasure in men with ERECTILE DYSFUNCTION and their partners

              MP-03.20: Female partners’ attitudes are associated with treatment seeking for ERECTILE DYSFUNCTION (ED) in men with ED

              MP-11.08: ERECTILE DYSFUNCTION Severity as a Surrogate Marker for Coronary ARTERY Disease

              MP25-16 PENILE RE VASCULAR IZATION SURGERY IN PATIENTS WITH DIABETIC ERECTILE DYSFUNCTION: LONG TERM RESUTS

              MP40-16 ONE OUT OF THREE MEN SEEKING MEDICAL HELP FOR ERECTILE DYSFUNCTION HAS BLOOD GLUCOSE LEVELS SUGGESTIVE FOR …

              MP76-04 ANDROGENIC THERAPY IN TREATING PATIENTS WITH VASCULOGENIC ERECTILE DYSFUNCTION

              Multidisciplinary management of VASCULAR erectile dysfunction

              N-acetylcysteine ameliorates the ERECTILE DYSFUNCTION caused by chronic intermittent hypoxia in rats: partly involvement of endoplasmic reticulum stress

              N16 VASCULAR disorders in cavernosal bodies limit the effectiveness of treatment of ERECTILE DYSFUNCTION following radical prostatectomy

              NADPH oxidase activation: A mechanism of HYPERTENSION ‐associated erectile dysfunction

              Nanoparticle improved stem cell therapy for ERECTILE DYSFUNCTION in a rat model of cavernous nerve injury

              Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction

              Natural history of ERECTILE DYSFUNCTION in the spontaneously HYPERTENSIVE rat: A longitudinal in vivo study

              NDP103: MANAGEMENT OF ERECTILE DYSFUNCTION IN PATIENTS WHO FAILED PRIOR VASCULAR INTERVENTION

              Near-infrared spectroscopy to assess penile BLOOD flow: a possible novel technique for the diagnosis of VASCULOGENIC erectile dysfunction

              Nebivolol dilates human penile arteries and reverses ERECTILE DYSFUNCTION in diabetic rats through enhancement of nitric oxide signaling

              Nebivolol versus other beta blockers in patients with HYPERTENSION and erectile dysfunction

              Negative stress echocardiographic study predicts excellent long-term prognosis in patients with erectile dysfunction

              Neural and VASCULAR alterations in the penis of diabetic rats with erectile dysfunction

              Neurogenic erectile dysfunction: State of the art!

              New immunophenotype of BLOOD endothelial progenitor cells and endothelial microparticles in patients with arterial ERECTILE DYSFUNCTION and late‐onset hypogonadism

              New immunophenotype of circulating endothelial progenitor cells and endothelial microparticles in patients with ERECTILE DYSFUNCTION and metabolic syndrome: effects …

              New insights into HYPERTENSION -associated erectile dysfunction

              Nitroxyl anion as a novel relaxant molecule in the rat pudendal ARTERY and metformin as treatment for angiotensin II-induced erectile dysfunction

              NO problem: arterial and venous endothelial function and erectile dysfunction.

              Nocturnal penile erections: the role of RigiScan in the diagnosis of VASCULAR erectile dysfunction

              Nocturnal systolic BLOOD pressure pattern of type 2 diabetic HYPERTENSIVE men with erectile dysfunction: a cross sectional study from Northern Sri Lanka

              Non-arteritic anterior ischemic optic neuropathy and the treatment of erectile dysfunction

              Non-arteritic anterior ischemic optic neuropathy associated with ERECTILE DYSFUNCTION medications

              Non-arteritic anterior ischemic optic neuropathy, ERECTILE DYSFUNCTION drugs, and amiodarone: is there a relationship?

              VASCULAR _imaging_for_erecti20160605-32372-1g95bhe.pdf”>Non-invasive VASCULAR imaging for erectile dysfunction

              Non‐arteritic anterior ischaemic optic neuropathy and the treatment of erectile dysfunction

              Nonarteritic Anterior Ischemic Optic Neuropathy and ERECTILE DYSFUNCTION Drugs: Is There an Elephant in the Bedroom?

              Nonarteritic Anterior Ischemic Optic Neuropathy and the Treatment of Erectile Dysfunction

              Nonarteritic anterior ischemic optic neuropathy with PDE-5 inhibitors for erectile dysfunction

              NONINVASIVE IDENTIFICATION OF VASCULOGENIC ERECTILE DYSFUNCTION USING REACTIVE HYPEREMIA PERIPHERAL ARTERIAL …

              Nonresponse to PDE5 inhibitors in erectile dysfunction. Part 2: alternative therapeutic strategies

              Nonresponse to phosphodiesterase 5 inhibitors in erectile dysfunction. Part 1: related factors

              Not Only Diabetes Mellitus, but also Impaired Glucose Tolerance is Associated with ERECTILE DYSFUNCTION in HYPERTENSIVE Patients

              Novel therapy for arteriogenic erectile dysfunction.

              Obstructive Sleep Apnea Associated With ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease

              Obstructive Sleep Apnea Associated With ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease–Reply–I

              On call. My wife and I both enjoy the” Harvard Men’s Health Watch” newsletter. We’ve read that ERECTILE DYSFUNCTION can be a warning for future HEART disease in men. I’ …

              OP-041 HEART Rate Recovery in Primary Erectile Dysfunction

              OP-114 [AJC» Preventive cardiology] ERECTILE DYSFUNCTION Severity and SYNTAX Score in Coronary ARTERY Disease

              OR 37: Relationship of arterial elasticity and ERECTILE DYSFUNCTION in HYPERTENSIVE men

              OR 38: Sildenafil citrate has mild nitrate-like hemodynamic effects in patients with coronary ARTERY disease and erectile dysfunction

              Oral l‐citrulline supplementation improves erectile function in rats with acute arteriogenic erectile dysfunction

              Original immunophenotype of BLOOD endothelial progenitor cells and microparticles in patients with isolated arterial ERECTILE DYSFUNCTION and late onset hypogonadism …

              ORIGINAL RESEARCH–ERECTILE DYSFUNCTION: Is the Relationship Between Cigarette Smoking and Male ERECTILE DYSFUNCTION Independent of CARDIO VASCULAR  …

              ORIGINAL RESEARCH–ERECTILE DYSFUNCTION: Posttraumatic Nonischemic Priapism Treated with Autologous BLOOD Clot Embolization

              Outcome of penile re VASCULAR ization for arteriogenic ERECTILE DYSFUNCTION after pelvic fracture urethral injuries

              OUTCOMES ASSESSMENT: Further Psychometric Validation of the Sexual Life Quality Questionnaire for Men with ERECTILE DYSFUNCTION and Their Partners on a …

              Oxidative stress and molecular reactions in arteriogenic erectile dysfunction

              Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants

              VASCULAR _disease_on_obesity_and_penile_erectile_dysfunction/links/56a277cd08ae232fb201af0c.pdf”>Oxidative stress, endothelial dysfunction and VASCULAR disease on obesity and penile erectile dysfunction

              P-01-010 Evaluation of BLOOD platelet count and function in patients with erectile dysfunction

              P-01-011 VASCULAR and chronological age in subjects with erectile dysfunction: a longitudinal study

              P-01-013 The first patient-focussed smartphone application about ERECTILE DYSFUNCTION also thought as a research tool: IDI application

              P-01-017 Therapeutic correction testosterone deficiency in HYPERTENSIVE men with ERECTILE DYSFUNCTION and depression

              P-01-036 Female partners confronted with erectile dysfunction. A series of 137 patients.

              P-01-046 Low intensity extracorporeal shock wave therapy in patients with VASCULOGENIC erectile dysfunction: A placebo-controlled cross-over study in oral …

              P-01-051 Evaluation of the effectiveness of low-energy shock wave therapy in diabetic patients with VASCULAR erectile dysfunction

              P-03-041 ERECTILE DYSFUNCTION treatment of a patient with coronary HEART disease in early age

              P-10: Different effect of valsartan and lisinopril on sildenafil use in HYPERTENSIVE men with erectile dysfunction

              P-275: ERECTILE DYSFUNCTION is related to systolic BLOOD pressure even in the normal BLOOD pressure levels

              P-313: Efficacy and safety of tadalafil in men with ERECTILE DYSFUNCTION with and without HYPERTENSION

              P-379: Determinants of ERECTILE DYSFUNCTION in patients with essential HYPERTENSION

              P-39: Long-term sildenafil administration improves aortic stiffness in patients with ERECTILE DYSFUNCTION of VASCULAR origin

              P-405: Prevalence of asymptomatic coronary ARTERY disease in men with VASCULOGENIC erectile dysfunction: A prospective angiographic study

              P-42: Efficacy and safety of Vardenafil, a selective phosphodiesterase 5 inhibitor, in men with ERECTILE DYSFUNCTION on antihypertensive therapy

              P-581: Relationship between ERECTILE DYSFUNCTION and antihypertensive medications

              P-62: Efficacy of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION and arterial HYPERTENSION who are taking multiple antihypertensive treatments

              P-64: Safety of VIAGRA®(sildenafil citrate) in men with ERECTILE DYSFUNCTION and arterial HYPERTENSION who are taking multiple antihypertensive treatments

              P. 034 ERECTILE DYSFUNCTION IS RELATED TO ARTERIAL STIFFNESS AND MARKERS OF SYSTEMIC VASCULAR INFLAMMATION AND …

              P1404Carotid atherosclerosis, aortic stiffness and penile VASCULAR damage in patients with erectile dysfunction: Relation to low density lipoprotein levels and statin …

              P2 purinoceptor subtype changes in patients with VASCULOGENIC erectile dysfunction

              P2642 Optimal BLOOD pressure control in relation to target organ physiology in HYPERTENSIVE men with erectile dysfunction

              P2644 Coronary atherosclerotic burden and risk of major adverse CARDIAC events in HYPERTENSIVE patients with erectile dysfunction

              P3004Differences in macro VASCULAR and micro VASCULAR changes between treated and never treated HYPERTENSIVE males with erectile dysfunction

              P4408Coronary ARTERY disease in asymptomatic obese patients with erectile dysfunction

              P4456Association between glucose metabolic status and global arterial function and early structural changes in men with erectile dysfunction

              P4738 ERECTILE DYSFUNCTION in patients with HEART failure with reduced ejection fraction: prevalence and associated factors

              VASCULAR -disease-patients-erectile/298/00130762″>P499Subclinical VASCULAR disease in patients with erectile dysfunction

              P5345 Association and prevalence of post-stroke ERECTILE DYSFUNCTION with CARDIO VASCULAR risk factors and co-morbidities

              P6413 Prevalence of ERECTILE DYSFUNCTION in patients coronary ARTERY disease and approach of this subject in cardiology consultation

              P806 High normal BLOOD pressure and VASCULAR parameters in patients with erectile dysfunction

              Partner responses to sildenafil citrate (Viagra) treatment of erectile dysfunction

              Partner responses to sildenafil treatment of erectile dysfunction

              Partner satisfaction and successful treatment outcomes for men with ERECTILE DYSFUNCTION (ED)

              Pathophysiologic Investigation of VASCULOGENIC ERECTILE DYSFUNCTION Using Newly Developed Rat Model

              Pathophysiological mechanisms of ERECTILE DYSFUNCTION in HYPERTENSIVE rats

              Pathophysiology, evaluation and treatment of erectile dysfunction: review article/Fisiopatologia, avaliacao e tratamento da disfuncao eretil: artigo de revisao

              Patterns of Cavernosal Arterial Flow in Patients with Erectile Dysfunction, as Evaluated by Color Doppler Flowmetry

              PD27-03 TIGHTER BLOOD PRESSURE CONTROL IS ASSOCIATED WITH LOWER INCIDENCE OF ERECTILE DYSFUNCTION IN HYPERTENSIVE MEN

              PD28-07 HEART HEALTHY DIET AND ERECTILE DYSFUNCTION IN THE HEALTH PROFESSIONALS FOLLOW-UP STUDY

              PD28-09 PERCUTANEOUS ANGIOPLASTY OF INTERNAL PUDENDAL ARTERIES FOR THE TREATMENT OF ERECTILE DYSFUNCTION NOT RESPONSIVE TO …

              PD45-09 EARLY DETECTION OF CARDIO VASCULAR DISEASE (CVD) RISK IN MEN WITH ERECTILE DYSFUNCTION (ED) IS FACILITATED USING …

              PDE-5 Inhibitors and the Increase Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Males with Erectile Dysfunction

              PDE5 inhibitors for the treatment of ERECTILE DYSFUNCTION in patients with HYPERTENSION

              PDE5 inhibitors in treatment of ERECTILE DYSFUNCTION and CARDIO VASCULAR safety

              Peak systolic velocity in patients with arterial ERECTILE DYSFUNCTION and peripheral arterial disease

              Peak systolic velocity of cavernosal ARTERY of the penis before and after papaverine injection in erectile dysfunction.

              Penile Arterial Insufficiency and Long-standing ERECTILE DYSFUNCTION are Associated both Independently and Additively with Increased Aortic Stiffness and Carotid …

              Penile arterial waveform analyzing system for early identification of young adults with high risk of erectile dysfunction

              Penile ARTERY 18F-NaF Uptake and Erectile Dysfunction

              Penile ARTERY shunt syndrome: A novel cause of ERECTILE DYSFUNCTION after penile re VASCULAR ization surgery

              Penile BLOOD change after oral medication of Korean red ginseng in ERECTILE DYSFUNCTION patients

              PENILE DOPPLER ULTRASOUND EVALUATION OF PATIENTS WITH ERECTILE DYSFUNCTION, HYPERTENSION AND/OR DIABETES MELLITUS: A …

              Penile Doppler ultrasound predicting CARDIO VASCULAR disease in men with erectile dysfunction

              Penile doppler ultrasound predicts CARDIO VASCULAR events in men with erectile dysfunction

              Penile duplex pharmaco‐ultrasonography of cavernous arteries in men with ERECTILE DYSFUNCTION and generalized atherosclerosis

              PENILE EXTENSIBILITY, OFFICE FAST TEST FOR ASSESSMENT OF PENILE FIBROSIS IN VASCULOGENIC ERECTILE DYSFUNCTION (ED)

              Penile hemodynamics in health and VASCULOGENIC erectile dysfunction

              Penile re VASCULAR ization for erectile dysfunction: a systematic review and meta-analysis of effectiveness and complications

              Penile re VASCULAR ization for treatment of ERECTILE DYSFUNCTION secondary to blunt perineal trauma

              Penile re VASCULAR ization in VASCULOGENIC ERECTILE DYSFUNCTION (ED): Long‐term follow‐up

              Penile re VASCULAR ization surgery for arteriogenic erectile dysfunction: the long‐term efficacy rate calculated by survival analysis

              Penile re VASCULAR ization surgery in erectile dysfunction

              Penile VASCULAR impairment in ERECTILE DYSFUNCTION patients with metabolic syndrome: penile Doppler ultrasound findings

              Penile VASCULAR surgery for treating erectile dysfunction: current role and future direction

              VASCULAR -interventions.html”>Penile venous stripping surgery is a viable option for ERECTILE DYSFUNCTION after unsuccessful VASCULAR interventions

              Percutaneous angioplasty of internal pudendal arteries for the treatment of ERECTILE DYSFUNCTION not responsive to pharmacological therapy. Initial …

              Percutaneous intervention therapy for VASCULAR erectile dysfunction

              PERICARDIAL FAT AND ERECTILE DYSFUNCTION IN PATIENTS WITH OBESITY, OBSTRUCTIVE SLEEP APNEA AND ARTERIAL HYPERTENSION

              Periodontal disease and VASCULOGENIC erectile dysfunction: a longitudinal health-examinee cohort study in South Korea

              Peripheral arterial disease and ERECTILE DYSFUNCTION in primary care

              Peripheral atherosclerosis in patients with arterial erectile dysfunction

              Peripheral VASCULAR disease and ERECTILE DYSFUNCTION as predictors of mortality in HEART failure patients

              Pharmaceutical care for one patient with diabetes mellitus complicating HYPERTENSION and erectile dysfunction.

              Pharmacogenetics of erectile dysfunction: navigating into uncharted waters

              Pharmacologic therapy for ERECTILE DYSFUNCTION and its interaction with the CARDIO VASCULAR system

              Pharmacotherapy of erectile dysfunction: focus on CARDIO VASCULAR safety

              PHARMACOTHERAPY: Hemodynamic Effects of Sildenafil Citrate and Isosorbide Mononitrate in Men with Coronary ARTERY Disease and Erectile Dysfunction

              Phenotypic assessment of endothelial microparticles in diabetic and nondiabetic men with erectile dysfunction

              Phosphodiesterase inhibition: ERECTILE DYSFUNCTION is only part of the story.

              Phosphodiesterase type 5 in men with VASCULOGENIC and post‐radical prostatectomy erectile dysfunction: is there a molecular difference?

              Photoacoustic imaging: A potential new tool for diagnosing VASCULOGENIC erectile dysfunction

              Photoplethysmography analysis of ARTERY properties in patients presenting with established erectile dysfunction

              Physical Exercise in the Management of ERECTILE DYSFUNCTION in Patients with HEART Failure

              Physiology of penile vasculature: endothelium and erectile dysfunction

              PIH15 BARRIERS TO COMMUNICATION ABOUT ERECTILE DYSFUNCTION IN PATIENTS TAKING ANTIHYPERTENSIVE MEDICATIONS

              PL 41. The impact of glycosylated serum protein on endothelial dysfunction and VASCULAR erectile dysfunction

              Plasma chitotriosidase activity and arteriogenic erectile dysfunction: association with the presence, severity, and duration

              Plasma levels of endothelin‐1, angiotensin II, nitric oxide and prostaglandin E2 in the venous and cavernosal BLOOD of patients with erectile dysfunction

              Plasma myeloperoxidase in patients with ERECTILE DYSFUNCTION of arteriogenic-and non-arteriogenic origin: association with markers of endothelial dysfunction.

              Platelet indices in VASCULOGENIC erectile dysfunction

              Plexiform neurofibroma of the penis associated with ERECTILE DYSFUNCTION due to arterial steeling

              PM076 ERECTILE DYSFUNCTION Was Not Related With the Arterial Stiffness

              PO-01-015 One out of three men seeking medical help for ERECTILE DYSFUNCTION has BLOOD glucose levels suggestive for undiagnosed hyperglycaemia …

              PO-01-057 Prognostic value of penile duplex ultrasound in patients started on sildenafil for erectile dysfunction

              POD-05.04: A congenital factor in the development of erectile dysfunction: pelvic ARTERY variations

              Pomegranate juice causes a partial improvement through lowering oxidative stress for ERECTILE DYSFUNCTION in streptozotocin-diabetic rat

              Poor response to alprostadil ICI test is associated with arteriogenic ERECTILE DYSFUNCTION and higher risk of major adverse CARDIO VASCULAR events

              Postcompression test in diagnosis of VASCULOGENIC erectile dysfunction

              Poster 32: Effect of EECP on ERECTILE DYSFUNCTION in Patients with Coronary ARTERY Disease

              Potentials for the correction of endothelial and ERECTILE DYSFUNCTION in patients after coronary ARTERY bypass grafting

              PP-020 The Relation between ERECTILE DYSFUNCTION and Extent of Coronary ARTERY Disease in the Patients with Stable Coronary ARTERY Disease

              PP-105 Deterioration of HEART Rate Recovery Index in Patients with Erectile Dysfunction

              VASCULAR _ORIGIN.396.aspx”>PP. 02.06: ERECTILE DYSFUNCTION OF VASCULAR ORIGIN AND CARDIO VASCULAR RISK FACTORS

              PP. 41.13: ERECTILE DYSFUNCTION AS AN INDEX OF HYPERTENSIVE MICRO AND MACRO VASCULAR ALTERATIONS

              Predicting ERECTILE DYSFUNCTION following surgical correction of Peyronie’s disease without inflatable penile prosthesis placement: VASCULAR assessment and …

              PREDICTION OF CARDIO VASCULAR EVENTS AND ALL-CAUSE MORTALITY WITH ERECTILE DYSFUNCTION: A SYSTEMATIC REVIEW AND META-ANALYSIS …

              Prediction of CARDIO VASCULAR events and all-cause mortality with erectile dysfunction: a systematic review and meta-analysis of cohort studies

              Prediction of CARDIO VASCULAR events with aortic stiffness in patients with erectile dysfunction

              Prediction of clinical efficacy of levitra (vardenafil) in patients with arteriogenic erectile dysfunction

              Prediction of coronary HEART disease by ERECTILE DYSFUNCTION in men referred for nuclear stress testing

              Predictive value of peak systolic velocity of cavernous ARTERY in diagnosis of arterial insufficiency in erectile dysfunction.

              Premature Ejaculation and ERECTILE DYSFUNCTION in Male Partners of Infertile Couples: Prevalence and Correlation

              Presence of LDL modified by myeloperoxidase in the penis in patients with VASCULAR erectile dysfunction: a preliminary study

              Presence of LDL Modified by Myeloperoxidase in the Penis in Patients with VASCULAR Erectile Dysfunction: A Preliminary Study. Eur Urol 51 (1): 262-9; …

              Prevalence and Association between ERECTILE DYSFUNCTION and Coronary ARTERY Disease

              Prevalence and CARDIO VASCULAR disease risk differences for ERECTILE DYSFUNCTION patients by three metabolic syndrome definitions

              Prevalence and risk factors for ERECTILE DYSFUNCTION in men with diabetes, HYPERTENSION , or both diseases: a community survey among 1,412 Israeli men

              Prevalence ERECTILE DYSFUNCTION in patients with HYPERTENSION

              Prevalence of asymptomatic coronary ARTERY disease in men with VASCULOGENIC erectile dysfunction: a prospective angiographic study

              Prevalence of CARDIO VASCULAR risk factors in erectile dysfunction

              Prevalence of ERECTILE DYSFUNCTION Among 7689 Patients With Diabetes or HYPERTENSION , or Both

              Prevalence of ERECTILE DYSFUNCTION among HYPERTENSIVE and nonhypertensive Qatari men

              Prevalence of ERECTILE DYSFUNCTION among treated HYPERTENSIVE males

              Prevalence of ERECTILE DYSFUNCTION and associated factors in Korean older adults with coronary ARTERY disease

              Prevalence of ERECTILE DYSFUNCTION in a cohort of Italian HYPERTENSIVE subjects

              Prevalence of ERECTILE DYSFUNCTION in diabetic and HYPERTENSIVE patients in our region: A preliminary report

              Prevalence of ERECTILE DYSFUNCTION in Indigent Systolic HEART Failure Patients on Standard Medical Therapy in a Rural Disease Management Clinic

              Prevalence of ERECTILE DYSFUNCTION in men diagnosed with HEART failure: implications for practice

              Prevalence of ERECTILE DYSFUNCTION in men with ischemic HEART disease in a tertiary hospital in malaysia.

              Prevalence of ERECTILE DYSFUNCTION in Spanish primary care setting and its association with CARDIO VASCULAR risk factors and CARDIO VASCULAR diseases. SIMETAP-ED study

              Prevalence of ERECTILE DYSFUNCTION in systolic HEART failure patients in a developing country: Tbilisi, Georgia, Eastern Europe

              Prevalence of ERECTILE DYSFUNCTION in VASCULAR surgery patients

              Prevalence of internal pudendal ARTERY disease in diabetic patients with ERECTILE DYSFUNCTION and angiographically documented multi-vessel coronary ARTERY  …

              Prevalence of risk factors of CARDIO VASCULAR diseases in men with erectile dysfunction. Are they as frequent as we believe?

              Prevention and management of CARDIO VASCULAR disease and erectile dysfunction: toward a common patient-centered, care model

              Prevention and treatment of ERECTILE DYSFUNCTION using lifestyle changes and dietary supplements: what works and what is worthless, part I.

              Prevention and treatment of ERECTILE DYSFUNCTION using lifestyle changes and dietary supplements: what works and what is worthless, part II

              Prevention of CARDIO VASCULAR disease by the early identification of erectile dysfunction

              Prevention of VASCULOGENIC ERECTILE DYSFUNCTION in Rat Model by the Chronic Administration of Oral Rho Kinase Inhibitor

              Primary ARTERY erectile dysfunction: one case report

              Progesterone reduces ERECTILE DYSFUNCTION in sleep-deprived spontaneously HYPERTENSIVE rats

              Prognostic factors for the VASCULAR components of ERECTILE DYSFUNCTION in patients on renal replacement therapy

              Prognostic utility of ERECTILE DYSFUNCTION for CARDIO VASCULAR disease in younger men and those with diabetes

              Progress of Study on HYPERTENSION , Antihypertensive Drugs and ERECTILE DYSFUNCTION [J]

              Progression of ERECTILE DYSFUNCTION as a sentinel for downstream diabetes and CARDIO VASCULAR disease: Longitudinal results from the MMAS

              Prolactin levels independently predict major CARDIO VASCULAR events in patients with erectile dysfunction

              Protection of penile VASCULAR endothelial function: a new strategy for the management of erectile dysfunction

              PS-04-006 The beneficial effect of hydrogen sulfide donor, sodium hydrosulfide on ERECTILE DYSFUNCTION in l-name-induced HYPERTENSIVE rats

              PS-04-016 Injecting BLOOD components for erectile dysfunction

              PS-07-002 Penile VASCULAR alterations and carotid atherosclerosis in patients with erectile dysfunction: The effect of cholesterol levels and statin therapy

              PS-07-003 High triglycerides predicts arteriogenic ERECTILE DYSFUNCTION and major adverse CARDIO VASCULAR events in subjects with sexual dysfunction

              PS-07-007 Autologous adipose tissue derived stromal VASCULAR fraction of cells for treatment of VASCULOGENIC erectile dysfunction

              PS-07-009 Low intensity extracorporeal shock wave therapy in French patients with VASCULOGENIC erectile dysfunction: Comparison of different energy …

              PS-08-002 Analysis of the knowledge of relation between modifiable risk factors and ERECTILE DYSFUNCTION in patients with ischaemic HEART disease who …

              PS-08-003 VASCULAR and chronological age in subjects with erectile dysfunction: a cross-sectional study

              PS-08-011 Longitudinal risk of developing CARDIO VASCULAR diseases among patients with erectile dysfunction: Which patients deserve more attention?

              PS-08-014 Assessment of the treatment efficacy of the low-energy shock wave therapy in patients with VASCULAR erectile dysfunction

              PS-08-016 Can intracavernosal botulinum toxin injection salvage VASCULAR ERECTILE DYSFUNCTION patients not responding to oral and intracavernous therapy …

              Psychologic Aspects of ERECTILE DYSFUNCTION in HEART Patients

              Psychological and interpersonal correlates in men with ERECTILE DYSFUNCTION and their partners: a pilot study of treatment outcome with sildenafil

              Pudendal Arteriography for Erectile Dysfunction

              Pudendal ARTERY angioplasty for the treatment of complex ERECTILE DYSFUNCTION in males

              Pudendal ARTERY stenting for complex ERECTILE DYSFUNCTION in males

              Pudendal ARTERY stenting for male erectile dysfunction

              Pudendal nerve and internal pudendal ARTERY damage may contribute to radiation-induced erectile dysfunction

              Pulmonary fibrosis induces ERECTILE DYSFUNCTION in rats

              Pulse pressure independently predicts major CARDIO VASCULAR events in younger but not in older subjects with erectile dysfunction

              PWH6 PATIENT AND PARTNER TREATMENT SATISFACTION SCALE (TSS) IN ERECTILE DYSFUNCTION

              Quality of life in ERECTILE DYSFUNCTION patients and their partners responding to tadalafil versus sildenafil citrate

              R46L polymorphism in the PCSK9 gene: Relationship to lipid levels, subclinical VASCULAR disease, and erectile dysfunction

              Racial disparities in ERECTILE DYSFUNCTION among participants in the California Men’s Health Study

              Radiation diagnostics of arteriovenous erectile dysfunction: history and development

              Radiation dose to the neuro VASCULAR bundles or penile bulb does not predict ERECTILE DYSFUNCTION after prostate brachytherapy

              Radiologic anatomy of arteriogenic erectile dysfunction: a systematized approach

              Randomized trial of CPAP and vardenafil on erectile and arterial function in men with obstructive sleep apnea and erectile dysfunction

              Re: Association between Treatment for ERECTILE DYSFUNCTION and Death or CARDIO VASCULAR Outcomes after Myocardial Infarction

              Re: Associations of Carotid ARTERY Plaque with Lower Urinary Tract Symptoms and Erectile Dysfunction

              Re: Does any Association Exist between Chronic Obstructive PULMONARY Disease and Erectile Dysfunction? The DECODED Study

              Re: Endo VASCULAR Therapy for Erectile Dysfunction—Who Benefits Most? Insights from a Single-Center Experience

              Re: ERECTILE DYSFUNCTION and CARDIO VASCULAR Events in Diabetic Men: A Meta-Analysis of Observational Studies

              Re: ERECTILE DYSFUNCTION and Coronary ARTERY Disease: An Association of Higher Risk in Younger Men

              Re: ERECTILE DYSFUNCTION and Later CARDIO VASCULAR Disease in Men With Type 2 Diabetes: Prospective Cohort Study Based on the ADVANCE (Action in Diabetes and …

              Re: ERECTILE DYSFUNCTION can Improve the Effectiveness of the Current Guidelines for the Screening for Asymptomatic Coronary ARTERY Disease in Diabetes

              Re: ERECTILE DYSFUNCTION Is Positively Correlated with Mean Platelet Volume and Platelet Count, But Not with Eosinophil Count in Peripheral BLOOD

              Re: Erectile Dysfunction, VASCULAR Risk, and Cognitive Performance in Late Middle Age

              VASCULAR _Disease__Eur_Urol_2014%3B65:968_78_”>Re: Giorgio Gandaglia, Alberto Briganti, Graham Jackson, et al. A Systematic Review of the Association Between ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease …

              Re: Low-Intensity Shockwave Therapy Improves Hemodynamic Parameters in Patients with VASCULOGENIC Erectile Dysfunction: A Triplex Ultrasonography-Based …

              Re: Outcome of penile re VASCULAR ization for arteriogenic ERECTILE DYSFUNCTION after pelvic fracture urethral injuries

              Re: oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants

              Re: Penile duplex pharmaco‐ultrasonography of cavernous arteries in men with ERECTILE DYSFUNCTION and generalized atherosclerosis

              Re: Prognostic Utility of ERECTILE DYSFUNCTION for CARDIO VASCULAR Disease in Younger Men and Those with Diabetes

              Re: Relationship of Asymmetric Dimethylarginine With Penile Doppler Ultrasound Parameters in Men With VASCULOGENIC Erectile Dysfunction

              Re: Sexual Activity and ERECTILE DYSFUNCTION in Elderly Men With Angiographically Documented Coronary ARTERY Disease

              Re: Subclinical VASCULAR Disease and Subsequent Erectile Dysfunction: The Multiethnic Study of Atherosclerosis (MESA)

              Re: Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with ERECTILE DYSFUNCTION and VASCULAR risk

              Re: The Influence of Internal Iliac ARTERY Occlusion after Endo VASCULAR Abdominal Aneurysm Repair on Buttock Claudication and Erectile Dysfunction: A Matched Case …

              Re: the prevalence of HYPERTENSION , hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction.

              Re: the Princeton III Consensus recommendations for the management of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              Re: The VASCULAR and Neurogenic Factors Associated with ERECTILE DYSFUNCTION in Patients after Pelvic Fractures

              Re: Tighter BLOOD Pressure Control is Associated with Lower Incidence of ERECTILE DYSFUNCTION in HYPERTENSIVE Men

              Re: VASCULAR and Chronological Age in Men with Erectile Dysfunction: A Longitudinal Study.

              Re: Vasculogenesis and Diabetic Erectile Dysfunction: How Relevant is Glycemic Control?

              Re: Weaker Masturbatory Erection May Be a Sign of Early CARDIO VASCULAR Risk Associated with ERECTILE DYSFUNCTION in Young Men without Sexual Intercourse

              RE:“CIGARETTE SMOKING AND ERECTILE DYSFUNCTION AMONG CHINESE MEN WITHOUT CLINICAL VASCULAR DISEASE”

              Relation between HYPERTENSION and erectile dysfunction: a meta-analysisof cross-section studies

              Relation of C-reactive protein and other CARDIO VASCULAR risk factors to penile VASCULAR disease in men with erectile dysfunction

              Relation of ERECTILE DYSFUNCTION to angiographic coronary ARTERY disease

              Relation of Postexercise Reduction of Arterial BLOOD Pressure and ERECTILE DYSFUNCTION in Patients with Coronary HEART Disease

              Relationship Between ERECTILE DYSFUNCTION and Asymptomatic Coronary Plaque Burden Among Men Presenting for an Electron Beam Tomographic HEART Scan

              Relationship between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              Relationship between ERECTILE DYSFUNCTION and silent coronary ARTERY disease: detection with multidetector computed tomography coronary angiography

              Relationship between ERECTILE DYSFUNCTION and silent myocardial ischemia in type 2 diabetic patients with no known macro VASCULAR complications

              Relationship between Erectile Dysfunction, CARDIO VASCULAR Risk Factors, and Silent Myocardial Ischemia in Type 2 Diabetes: Insights from the DIAD Study

              Relationship Between Erectile Dysfunction, Diabetes and Dyslipidemia in HYPERTENSIVE -Treated Men

              Relationship between hyperuricemia and ERECTILE DYSFUNCTION on HYPERTENSION patients

              RELATIONSHIP BETWEEN OBSTRUCTIVE SLEEP APNOEA AND ERECTILE DYSFUNCTION IN PATIENTS WITH ARTERIAL HYPERTENSION

              Relationship between sleep disorders and erectile dysfunction, depression and quality of life in male patients with systolic HEART failure

              Relationship between treatment of ERECTILE DYSFUNCTION and future risk of CARDIO VASCULAR disease: A nationwide cohort study

              Relationship between VASCULAR damage degrees and endothelial progenitor cells in patients with erectile dysfunction: effect of vardenafil administration and PDE5 …

              Relationship of asymmetric dimethylarginine with penile Doppler ultrasound parameters in men with VASCULOGENIC erectile dysfunction

              Relationship of BLOOD pressure and ERECTILE DYSFUNCTION in men without previously diagnosed HYPERTENSION

              Relieving symptoms of ERECTILE DYSFUNCTION and attaining sexual wellness and health of the sexual VASCULAR system with proanthocyanidins

              RENIN AND ALDOSTERONE IN NEVER-TREATED HYPERTENSIVE S WITH ERECTILE DYSFUNCTION: PP. 25.300

              Research Article Tadalafil Transdermal Delivery with Alpha-lipoic Acid Self Nanoemulsion for Treatment of ERECTILE DYSFUNCTION by Diabetes Mellitus

              Response and Rebuttal to Editorial Comment on “ VASCULAR and Chronological Age in Men With Erectile Dysfunction: A Longitudinal Study”

              Response by Uddin et al to Letters Regarding Article,“Erectile Dysfunction as an Independent Predictor of Future CARDIO VASCULAR Events: The Multi-Ethnic …

              Response to Letter Regarding Article,“Clinical Cardiology: Physician Update: ERECTILE DYSFUNCTION and CARDIO VASCULAR Disease”

              RETRACTED: Association between ERECTILE DYSFUNCTION and coronary ARTERY disease and it’s severity

              Retracted: Impact of polymorphisms in the oestrogen receptors alpha and beta (ESR 1, ESR 2) genes on risk of VASCULOGENIC erectile dysfunction

              Retracted: Impact of polymorphisms in the oestrogen receptors alpha and beta (ESR1, ESR2) genes on risk of VASCULOGENIC erectile dysfunction

              Re VASCULAR ization in ERECTILE DYSFUNCTION due to Pelvic Trauma

              Review of ERECTILE DYSFUNCTION and CARDIO VASCULAR risk.

              Rhythmic Oscillations of Human Penile Bioimpedance in Healthy Individuals and in Patients with VASCULAR Erectile Dysfunction

              Risk factors for ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

              Risk factors of ERECTILE DYSFUNCTION and penile VASCULAR changes after surgical repair of penile fracture

              Risk factors of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases

              Risk of Melanoma With Phosphodiesterase Type 5 Inhibitor Use Among Patients With Erectile Dysfunction, PULMONARY HYPERTENSION , and Lower Urinary Tract …

              Role of 2D Strain in the Early Identification of CARDIAC Dysfunction and in the Risk Stratification of Arteriogenic ERECTILE DYSFUNCTION Patients

              Role of Colour Doppler Ultrasound Examination of Cavernosal ARTERY in Cases of Suspected VASCULOGENIC Cause of Erectile Dysfunction

              Role of exercise treadmill testing in the management of erectile dysfunction: a joint CARDIO VASCULAR /erectile dysfunction clinic

              Role of female partners in the diagnosis and treatment of erectile dysfunction

              Role of high sensitive troponin in diagnosing subclinical coronary ARTERY disease in patients with erectile dysfunction

              Role of methylenetetrahydrofolate reductase gene polymorphisms (C677T, A1298C, and G1793A) in the development of early onset VASCULOGENIC erectile dysfunction

              Role of pelvic floor muscle exercises in management of ERECTILE DYSFUNCTION in patients with chronic obstructive PULMONARY disease

              Role of penile VASCULAR insufficiency in ERECTILE DYSFUNCTION in renal transplant recipients

              Role of the cardiologist: clinical aspects of managing erectile dysfunction

              Role of Traditional CARDIO VASCULAR Risk Factors for the Occurrence of ERECTILE DYSFUNCTION in Patients with Coronary ARTERY Disease

              Rupture of an Artificial Urinary Sphincter Secondary to Use of a Vacuum Pump for Erectile Dysfunction

              S047: Could ERECTILE DYSFUNCTION predict future coronary ARTERY disease among gensini or syntax scores?

              S141 The effect of losartan on fibrosis occurred in an castrated male rats model of veno-occlusive erectile dysfunction

              S64 Interrelationships between ERECTILE DYSFUNCTION and smoking in men with HYPERTENSION

              Safety and efficacy of sildenafil citrate in men with ERECTILE DYSFUNCTION and HYPERTENSION who are taking multiple antihypertensive treatments

              Safety and efficacy of vardenafil, a selective phosphodiesterase 5 inhibitor, in patients with ERECTILE DYSFUNCTION and arterial HYPERTENSION treated with multiple …

              Safety and six-month durability of angioplasty for isolated penile ARTERY stenoses in patients with erectile dysfunction: a first-in-man study

              Safety, Efficacy, and Patient and Partner Acceptability of Vardenafil Orally Disintegrating Tablets for the Treatment of Erectile Dysfunction.

              Salvage of end-stage ERECTILE DYSFUNCTION using VASCULAR ized fibula as autologous implant

              Screening for ERECTILE DYSFUNCTION and associated CARDIO VASCULAR risk factors in Israeli men

              Screening for ERECTILE DYSFUNCTION as part of periodic examination programs—Concept and implementation

              Screening for ischemic HEART disease in patients with erectile dysfunction: role of penile Doppler ultrasonography

              Scrutiny of CARDIO VASCULAR risk factors by assessing arterial stiffness in ERECTILE DYSFUNCTION patients

              Second consensus conference on CARDIO VASCULAR risk factors and erectile dysfunction

              Self‐rated health and classical risk factors for coronary HEART disease predict development of ERECTILE DYSFUNCTION 25 years later

              Serum adropin as a predictive biomarker of ERECTILE DYSFUNCTION in coronary ARTERY disease patients

              Serum Arginase II level can be a novel indicator for ERECTILE DYSFUNCTION in patients with VASCULOGENIC erectile dysfunction: a comparative study

              Serum Arginase-2 Level in Patients with VASCULOGENIC Erectile Dysfunction

              Serum endocan as a predictive biomarker of CARDIO VASCULAR risk in ERECTILE DYSFUNCTION patients

              Serum from patients with ERECTILE DYSFUNCTION and VASCULAR risk factors triggered an oxidative stress-dependent mitochondrial apoptotic pathway in ex vivo expanded …

              Serum from patients with ERECTILE DYSFUNCTION inhibits circulating angiogenic cells from healthy men: relationship with CARDIO VASCULAR risk, endothelial damage and …

              Serum Levels of Asymmetric Dimethylarginine and Testosterone Among Egyptian Type 2 Diabetic Men with ERECTILE DYSFUNCTION as Risk Markers for Coronary ARTERY  …

              Serum levels of human growth hormone during different penile conditions in the cavernous and systemic BLOOD of healthy men and patients with erectile dysfunction

              Severe depressive symptoms and CARDIO VASCULAR risk in subjects with erectile dysfunction

              Severity of coronary ARTERY disease and symptoms of ERECTILE DYSFUNCTION in males with a positive exercise treadmill test

              Severity of female sexual dysfunction in partners of men after radical prostatectomy correlates with erectile function of the male partner

              Sex, erectile dysfunction, and the HEART : a growing problem

              Sex, The HEART and Erectile Dysfunction

              Sex, the HEART and Erectile Dysfunction: Pocketbook

              Sexual activity and CARDIO VASCULAR disease, ERECTILE DYSFUNCTION as a predictor of ischemic HEART disease

              Sexual activity and ERECTILE DYSFUNCTION in elderly men with angiographically documented coronary ARTERY disease

              Sexual activity, erectile dysfunction, and incident CARDIO VASCULAR events

              Sexual dysfunction and chronic obstructive PULMONARY disease: Is the severity of ERECTILE DYSFUNCTION related to PULMONARY functions and body mass index?

              Sexual Dysfunction And Chronic Obstructive PULMONARY Disease: Is The Severity Of ERECTILE DYSFUNCTION Related To The Forced Expiratory Volume In One Second …

              Sexual dysfunction in women partners of men with erectile dysfunction

              Sexual experience of female partners of men with erectile dysfunction: the female experience of men’s attitudes to life events and sexuality (FEMALES) study

              Sexual function, satisfaction, and association of ERECTILE DYSFUNCTION with CARDIO VASCULAR disease and risk factors in CARDIO VASCULAR high-risk patients: substudy of the …

              Sexual life quality of spinal cord-injured men receiving pharmacological treatment for ERECTILE DYSFUNCTION and their partners

              Shock Wave Therapy in VASCULOGENIC Erectile Dysfunction. Androl Gynecol: Curr Res 7: 1

              Should ERECTILE DYSFUNCTION be considered as a sign of occult coronary ARTERY disease?

              Should men with mild ERECTILE DYSFUNCTION be closely evaluated for CARDIO VASCULAR diseases in the Korean population?

              Should patients with ERECTILE DYSFUNCTION be evaluated for CARDIO VASCULAR disease?

              Shugan Yiyang capsule increases the expressions of VEGF, IGF and Akt1 in the rat model of arteriogenic erectile dysfunction

              Significance of phentolamine redosing during prostaglandin E1 penile color Doppler ultrasonography in diagnosis of VASCULAR erectile dysfunction

              Sildenafil (Viagra): new data, new confidence in treating ERECTILE DYSFUNCTION in the CARDIO VASCULAR patient

              Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction

              Sildenafil citrate for ERECTILE DYSFUNCTION in men receiving multiple antihypertensive agents: a randomized controlled trial

              Sildenafil citrate for ERECTILE DYSFUNCTION in men with diabetes and CARDIO VASCULAR risk factors: a retrospective analysis of pooled data from placebo-controlled trials

              Sildenafil citrate in the treatment of ERECTILE DYSFUNCTION associated with HYPERTENSION

              Sildenafil citrate vs intracavernous alprostadil for patients with arteriogenic erectile dysfunction: a randomised placebo controlled study

              Sildenafil for ERECTILE DYSFUNCTION in the Middle East: observational analysis of patients with diabetes and/or HYPERTENSION treated in the clinical practice setting

              Sildenafil improves quality of life in men with HEART failure and erectile dysfunction

              Sildenafil is well tolerated by ERECTILE DYSFUNCTION patients taking antihypertensive medications, including those on multidrug regimens

              Sildenafil: from angina to ERECTILE DYSFUNCTION to PULMONARY HYPERTENSION and beyond

              Small-vessel lower extremity arterial disease and erectile dysfunction: The Rancho Bernardo study

              Smart material based penile stimulation ERECTILE DYSFUNCTION assistance device

              Smoking causes ERECTILE DYSFUNCTION through VASCULAR disease

              Socio-demographic and psychosocial correlates of ERECTILE DYSFUNCTION among HYPERTENSIVE patients

              Standard operating procedures for VASCULAR surgery in erectile dysfunction: re VASCULAR ization and venous procedures

              Standardization of VASCULAR assessment of erectile dysfunction

              Standardization of VASCULAR assessment of erectile dysfunction: standard operating procedures for duplex ultrasound

              Strategies in the oral pharmacotherapy of male ERECTILE DYSFUNCTION viewed from bench and bedside (Part I)

              Strategies in the oral pharmacotherapy of male ERECTILE DYSFUNCTION viewed from bench and bedside (Part II)

              Stratification of penile VASCULAR pathologies in patients with Peyronie’s disease and in men with ERECTILE DYSFUNCTION according to age: a comparative study

              STRESS IMAGING IN A MAN WITH HYPERTROPHIC CARDIOMYOPATHY AND ERECTILE DYSFUNCTION

              Stress imaging in men with hypertrophic cardiomyopathy and erectile dysfunction

              Structure elucidation of phototransformation products of unapproved analogs of the ERECTILE DYSFUNCTION drug sildenafil in artificial freshwater with UPLC‐Q Exactive …

              Study of Carotid Intimal Medial Thickness by Ultrasonography as A Marker of Subclinical Atherosclerosis in Males with VASCULOGENIC Erectile Dysfunction

              Subclinical coronary ARTERY atherosclerosis and endothelial dysfunction are not predictors of ERECTILE DYSFUNCTION in HIV-infected males

              Subclinical coronary ARTERY atherosclerosis in patients with erectile dysfunction

              Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of ERECTILE DYSFUNCTION in young man with low risk of coronary HEART  …

              Subclinical endothelial dysfunction and low‐grade inflammation play roles in the development of ERECTILE DYSFUNCTION in young men with low risk of coronary HEART  …

              Subclinical VASCULAR disease and subsequent erectile dysfunction: the Multiethnic Study of Atherosclerosis (MESA)

              Subclinical VASCULAR disease in patients with erectile dysfunction: correlation with high sensitivity C-reactive protein levels

              Superparamagnetic iron oxide nanoparticle targeting of adipose tissue-derived stem cells in diabetes-associated erectile dysfunction

              Surgical Treatments for VASCULOGENIC Erectile Dysfunction

              Surveillance of CARDIO VASCULAR risk factors for outpatients in different ERECTILE DYSFUNCTION severity

              Switching from Nitrate Therapy to Ranolazine in Patients with Coronary ARTERY Disease Receiving Phosphodiesterase Type-5 Inhibitors for Erectile Dysfunction

              Sympathetic Skin Response in Patients with VASCULAR Erectile Dysfunction

              Systems and methods for preventing, managing and/or treating peripheral neuropathy, peripheral VASCULAR disease, erectile dysfunction, urinary incontinence, cellulite …

              T02-O-07 Do female partners’ attitudes affect treatment-seeking behaviour and treatment utilisation in men with erectile dysfunction? The Females study

              T05-O-04 Association between ERECTILE DYSFUNCTION and coronary ARTERY disease

              T09-O-19 CARDIO VASCULAR risk in patients with erectile dysfunction

              T09-O-44 Consistent benefits with vardenafil in men with ERECTILE DYSFUNCTION and their partners: the couples-project

              T09-P-01 After the treatment of women with vaginismus: dealing with ERECTILE DYSFUNCTION in their partners

              Tadalafil for ERECTILE DYSFUNCTION associated with CARDIO VASCULAR diseases

              Tadalafil once daily in the management of erectile dysfunction: patient and partner perspectives

              Tadalafil Once-Daily: Patient and Partner Perspective in the Management of Erectile Dysfunction

              Tadalafil treatment had a modest effect on endothelial cell damage and repair ability markers in men with ERECTILE DYSFUNCTION and VASCULAR risk

              TCT-515 PUDENDAL ARTERY ANGIOPLASTY FOR THE TREATMENT OF COMPLEX ERECTILE DYSFUNCTION IN MALES

              Testing endothelial function of brachial and cavernous arteries in patients with erectile dysfunction

              Testosterone and CARDIO VASCULAR risk in patients with erectile dysfunction

              Testosterone deficiency in patients with erectile dysfunction: When should a higher CARDIO VASCULAR risk be considered?

              Testosterone level and endothelial dysfunction in patients with VASCULOGENIC erectile dysfunction

              Testosterone Replacement Enhances Internal Pudendal ARTERY Relaxation to Reverse ERECTILE DYSFUNCTION in a Rat Model of Androgen Deprivation Therapy

              The application of spiral multislice computer tomography at the complex diagnosis of VASCULOGENIC erectile dysfunction

              The ARTERY size hypothesis: a macro VASCULAR link between ERECTILE DYSFUNCTION and coronary ARTERY disease

              The article:” Is there a link between soft drinks and erectile dysfunction?”

              The assessment of sexual function in women with male partners who have erectile dysfunction

              The assessment of VASCULAR risk in men with erectile dysfunction: the role of the cardiologist and general physician

              The association between chronic periodontitis and VASCULOGENIC erectile dysfunction: a systematic review and meta‐analysis

              The association between ERECTILE DYSFUNCTION and CARDIO VASCULAR risk in men with Type 2 diabetes in primary care: it is a matter of age

              The association between ERECTILE DYSFUNCTION and peripheral arterial disease as determined by screening ankle-brachial index testing

              The association of arterial stiffness with ERECTILE DYSFUNCTION in middle-aged men with metabolic syndrome

              The association of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease: a systematic critical review

              THE ASSOCIATION OF ERECTILE DYSFUNCTION WITH HEART DISEASE

              The association of glomerular filtration rate and ERECTILE DYSFUNCTION with severity of coronary ARTERY disease in patients presenting with chest pain

              The association of Intron 4 VNTR and Glu298Asp polymorphisms of the nitric oxide synthetase 3 gene and VASCULOGENIC ERECTILE DYSFUNCTION in Turkish men

              The Association of Subclinical VASCULAR Disease and ERECTILE DYSFUNCTION at 9-Year Assessment: The Multi-Ethnic Study of Atherosclerosis (MESA)

              The burden of ERECTILE DYSFUNCTION in HYPERTENSIVE men attending a general out patient unit in a rural Nigerian hospital

              The choice of antihypertensive drugs in patients with erectile dysfunction

              The Comparison of the Effects of Nebivolol and Metoprolol on ERECTILE DYSFUNCTION in the Cases with Coronary ARTERY Bypass Surgery

              The correlation between CARDIO VASCULAR risk factors and penile hemodynamic parameters in men with erectile dysfunction

              The correlation between ERECTILE DYSFUNCTION and the severity of coronary ARTERY involvement in patients with coronary ARTERY disease

              The correlation between high sensitivity C-reactive protein and ERECTILE DYSFUNCTION patients with HYPERTENSION treated with vardenafil

              The correlation between HYPERTENSION , lipid metabolism and erectile dysfunction

              THE CORRELATION OF ERECTILE DYSFUNCTION AND INTIMAMEDIA THICKNESS OF COMMON CAROTID ARTERIES

              The cure security and effectiveness of ERECTILE DYSFUNCTION with low CARDIO VASCULAR risk factors

              The Dark Side of Testosterone Deficiency: Diabetes, Metabolic Syndrome, CARDIO VASCULAR Disease and Erectile Dysfunction: 30

              The difference of HEART rate recovery between males with and without erectile dysfunction

              The direction and severity of penile curvature does not have an impact on concomitant VASCULOGENIC ERECTILE DYSFUNCTION in patients with Peyronie’s disease

              The Effect of Atorvastatin on the Male HYPERTENSIVE Patients with Erectile Dysfunction

              The Effect of CARDIO VASCULAR Risk Factors on the Patient with ERECTILE DYSFUNCTION and Diabetes and the Response to Phosphodiesterase Type 5 Inhibitors.

              The effect of lifestyle modification and CARDIO VASCULAR risk factor reduction on erectile dysfunction: a systematic review and meta-analysis

              The Effect of Modified CARDIAC Rehabilitation on ERECTILE DYSFUNCTION and Coping with Stress in Men Undergoing Coronary ARTERY Bypass Graft (CABG): A Clinical Trial

              The Effect of Nebivolol on ERECTILE DYSFUNCTION with Dipper and Non Dipper HYPERTENSIVE Patients

              The effect of non-dipper pattern of HYPERTENSION on erectile dysfunction

              The Effect of Partial Bladder Outlet Obstruction on ERECTILE DYSFUNCTION in the Rat Corpus Cavernosum

              THE EFFECT OF THE METHOD OF ED DIAGNOSIS ON PREDICTION OF CARDIO VASCULAR EVENTS WITH ERECTILE DYSFUNCTION

              The effect of treatment in men with ERECTILE DYSFUNCTION on female partner’s sexual function

              The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the CARDIO VASCULAR response to …

              The effect of VASCULAR endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction

              The effect of VASCULAR risk factors on penile VASCULAR status in men with erectile dysfunction

              The Effects of Metabolic Syndrome on Severity of ERECTILE DYSFUNCTION in Patients with Chronic Obstructive PULMONARY Disease

              The effects of risk factors for VASCULAR disease on LUTS and erectile dysfunction

              The Efficacy of the Intima-media Thickness (IMT) to Predict CARDIO VASCULAR Disease in VASCULOGENIC ERECTILE DYSFUNCTION Patients

              The engineering analysis of bioheat equation and penile hemodynamic relationships in the diagnosis of erectile dysfunction: part I—theoretical study and …

              The engineering analysis of bioheat equation and penile hemodynamic relationships in the diagnosis of erectile dysfunction: part II—model optimization using …

              The ERECTILE DYSFUNCTION among Congolese HYPERTENSIVE Patients

              The ERECTILE DYSFUNCTION as a CARDIO VASCULAR risk factor

              The ERECTILE DYSFUNCTION as a marker of CARDIO VASCULAR disease: a review

              The erectile–endothelial dysfunction nexus: new opportunities for CARDIO VASCULAR risk prevention

              The evolution of VASCULAR testing in erectile dysfunction

              The expanding sphere of primary prevention for coronary ARTERY disease in persons with erectile dysfunction

              The female partner’s satisfaction with sildenafil citrate treatment of erectile dysfunction

              The HelpED study: Impact of change in erection hardness on the sexual function and quality of life of female partners of men with erectile dysfunction

              The impact of depression, microvasculopathy, and fibrosis on development of ERECTILE DYSFUNCTION in men with systemic sclerosis

              The impact of ERECTILE DYSFUNCTION on female partners: A qualitative investigation

              The Importance of valsartan in the treatment of hypertonic patients with erectile dysfunction

              The Incidence of Nonarteritic Anterior Ischemic Optic Neuropathy in Men Using Sildenafil Citrate for ERECTILE DYSFUNCTION Is Not Different From the Expected Incidence …

              The influence of different metabolic syndrome definitions in predicting VASCULOGENIC erectile dysfunction: is there a role for the index of central obesity?

              The influence of Internal iliac ARTERY occlusion after endo VASCULAR abdominal aneurysm repair on buttock claudication and erectile dysfunction: a matched case-control …

              The Influence of Socioeconomic Status on the Presence and Degree of ERECTILE DYSFUNCTION in Men With Coronary ARTERY Disease—A Cross-Sectional Study

              The interlinked depression, erectile dysfunction, and coronary HEART disease syndrome in older men: a triad often underdiagnosed.

              The Intimate Link Between ERECTILE DYSFUNCTION and HEART Disease

              The link between ERECTILE DYSFUNCTION (ED) and CARDIO VASCULAR disease (CVD): what a urologist needs to know

              THE LINK BETWEEN ERECTILE DYSFUNCTION AND CARDIO VASCULAR DISEASE IN SOUTHERN CHINA PATIENTS WITH METABOLIC SYNDROME

              The link between periodontitis and ERECTILE DYSFUNCTION (vasculogenic impotence).

              The link between VASCULOGENIC erectile dysfunction, coronary ARTERY disease, and peripheral ARTERY disease: role of metabolic factors and endo VASCULAR  …

              VASCULAR -disease/24/01222926″>The links between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              The Metabolic Investigation of Erectile Dysfunction: Cardiometabolic Risk Stratification

              The metabolic syndrome and erectile dysfunction: multiple VASCULAR risk factors and hypogonadism

              The pathophysiology of ERECTILE DYSFUNCTION related to endothelial dysfunction and mediators of VASCULAR function

              The penile BLOOD flow index in the assessment of patients with erectile dysfunction: importance of associated risk factors

              The predictive value of arteriogenic ERECTILE DYSFUNCTION for coronary ARTERY disease in men

              The predictivity of ischemic HEART disease in patients with arteriogenic erectile dysfunction

              The prevalence of ERECTILE DYSFUNCTION among angiographically detected patients of coronary ARTERY disease in North-India

              The prevalence of ERECTILE DYSFUNCTION in HEART failure patients by race and ethnicity

              The prevalence of ERECTILE DYSFUNCTION in the primary care setting: importance of risk factors for diabetes and VASCULAR disease

              The prevalence of HYPERTENSION , hyperlipidemia, diabetes mellitus and depression in men with erectile dysfunction

              The Princeton III Consensus recommendations for the management of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              The Prognostic Role of ERECTILE DYSFUNCTION for CARDIO VASCULAR Events

              The Real-Life Safety and Efficacy of vardenafil (REALISE) study: results in men from Europe and overseas with ERECTILE DYSFUNCTION and CARDIO VASCULAR or metabolic …

              The relation between ERECTILE DYSFUNCTION and extent of coronary ARTERY disease in the patients with stable coronary ARTERY disease

              The relation between metabolic syndrome (hypercholesterolemia, dyslipidemia, HYPERTENSION ) and erectile dysfunction

              The Relationship among Thiazide Like Diuretic, Uric Acid and ERECTILE DYSFUNCTION in HYPERTENSIVE Subjects

              The relationship between dietary intake and endothelial function among VASCULOGENIC ERECTILE DYSFUNCTION population

              The relationship between endothlial ABD erectile dysfunction, levels of testosterone and CARDIO VASCULAR events in the follow-up

              The relationship between neo VASCULAR age-related macular degeneration and erectile dysfunction

              The Relationship between Systemic HYPERTENSION and Erectile Dysfunction

              The relationship between uric acid and ERECTILE DYSFUNCTION in HYPERTENSIVE subjects

              The relationship of ERECTILE DYSFUNCTION and subclinical CARDIO VASCULAR disease: A systematic review and meta-analysis

              The research of selenium on phenotype reversion of corpus cavernosum smooth muscle cells in HYPERTENSIVE rats with erectile dysfunction

              The risk of coronary HEART disease in men with erectile dysfunction

              The risk of ERECTILE DYSFUNCTION in chronic obstructive PULMONARY disease

              The risk of ERECTILE DYSFUNCTION in chronic obstructive PULMONARY disease: a population-based cohort study in Taiwan

              The Role ERECTILE DYSFUNCTION Plays in CARDIO VASCULAR Diseases

              The Role of Scoparone from Artemisia capillaris on Erectile Dysfunction

              The role of serum testosterone testing: routine hormone analysis is an essential part of the initial screening of men with erectile dysfunction

              The role of the partner in ERECTILE DYSFUNCTION and its treatment

              The role of the sexual partner in managing erectile dysfunction

              The safety of 5-phosphodiesterase inhibitors in the treatment of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

              The SIAMS-ED trial: a national, independent, multicentre study on cardiometabolic and hormonal impairment of men with ERECTILE DYSFUNCTION treated with vardenafil

              The start of pharmacological activity after sublingual administration of sildenafil citrate in 30 patients affected by erectile dysfunction.

              The Swedish medical discourse: Impotence, ERECTILE DYSFUNCTION and Viagra in Läkartidningen

              The temporal relationship between ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              The treatment and psychology of ERECTILE DYSFUNCTION in coronary HEART disease

              The treatment of ERECTILE DYSFUNCTION study: focus on treatment satisfaction of patients and partners

              The treatment satisfaction scale: A multidimensional instrument for the assessment of treatment satisfaction for ERECTILE DYSFUNCTION patients and their partners

              The triad of endothelial dysfunction, CARDIO VASCULAR disease, and erectile dysfunction: clinical implications

              The triad: erectile dysfunction-endothelial dysfunction-cardio VASCULAR disease

              The use of intracavernous injection and audiovisual sexual stimulation during real-time pharmacopenile Doppler ultrasonography in VASCULOGENIC erectile dysfunction

              THE USE OF RIGISCAN® EXAMINATION IN DIAGNOSING PATIENTS WITH ERECTILE DYSFUNCTION IN JAKARTA

              The value of dynamic color duplex scanning in the diagnosis of VASCULAR erectile dysfunction

              The value of international index of erectile function-5 in assessment of the severity of VASCULOGENIC erectile dysfunction

              The VASCULAR and neurogenic factors associated with ERECTILE DYSFUNCTION in patients after pelvic fractures

              The VASCULAR system and ERECTILE DYSFUNCTION in diabetes—the role of penile Doppler

              Therapeutic effect of an interval exercise training program in the management of ERECTILE DYSFUNCTION in HYPERTENSIVE patients

              Therapy of ERECTILE DYSFUNCTION (ED) with Sildenafil improves quality of life (QoL) and partnership (QoP)

              Therapy of ERECTILE DYSFUNCTION by sildenafil (viagra) in patients after orthotopic HEART transplantation

              There is a link between ERECTILE DYSFUNCTION and HEART failure: it could be inflammation

              There is no correlation between ERECTILE DYSFUNCTION and dose to penile bulb and neuro VASCULAR bundles following real-time low-dose-rate prostate brachytherapy

              THIS ARTICLE HAS BEEN RETRACTED Physical therapy for premature ejaculation, ERECTILE DYSFUNCTION and chronic pelvic pain syndrome

              Tighter BLOOD Pressure Control Is Associated with Lower Incidence of ERECTILE DYSFUNCTION in HYPERTENSIVE Men

              Time course of development of ERECTILE DYSFUNCTION and coronary ARTERY endothelial dysfunction in response to a western diet: influence of endothelial nitric oxide …

              TIME COURSE OF ERECTILE DYSFUNCTION AND SERIAL CHANGES OF BLOOD MARKER OF ENDOTHELIAL ACTIVATION IN STREPTOZOTOSIN …

              Topically applied curcumin-loaded nanoparticles treat ERECTILE DYSFUNCTION in a rat model of Type-2 diabetes

              Transperineal ultrasound imaging of the internal pudendal ARTERY in arteriogenic erectile dysfunction

              Traumatic VASCULOGENIC erectile dysfunction: role of penile microarterial bypass surgery

              Treatment by stem cell therapy of ERECTILE DYSFUNCTION of diabetic origin: State of the art

              Treatment of ERECTILE DYSFUNCTION by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)

              Treatment of ERECTILE DYSFUNCTION in males with moderate HEART failure: Impact on depressive symptoms.

              Treatment of ERECTILE DYSFUNCTION in men with HEART disease

              Treatment of ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR disease

              Treatment of ERECTILE DYSFUNCTION in patients with essential HYPERTENSION and ischemic HEART disease

              Treatment of ERECTILE DYSFUNCTION in patients with ischemic HEART disease and angina of effort

              Treatment of ERECTILE DYSFUNCTION in the Elderly With Phosphodiesterase Type 5 Inhibitors: CARDIO VASCULAR Implications

              Treatment of VASCULOGENIC ERECTILE DYSFUNCTION with Piezowave2 device. Application of low intensity shockwaves using novel linear shockwave tissue …

              Treatment program for ERECTILE DYSFUNCTION in patients with CARDIO VASCULAR diseases

              Triad of Health Status, Depression and ERECTILE DYSFUNCTION in HEART Failure Patients: Is it Applicable to Hispanics?

              Two birds with one stone: regular use of PDE5 inhibitors for treating male patients with ERECTILE DYSFUNCTION and CARDIO VASCULAR diseases

              Type 5 phosphodiesterase inhibitors in the treatment of ERECTILE DYSFUNCTION and CARDIO VASCULAR disease

              Umbelliferone isolated from Zosima absinthifolia roots partially restored ERECTILE DYSFUNCTION in streptozotocin-induced diabetic rats

              Unfavourable endothelial and inflammatory state in ERECTILE DYSFUNCTION patients with or without coronary ARTERY disease

              Uninsured Patients With Nonischemic HEART Failure Have Higher Rates of Erectile Dysfunction

              Update on drug interactions with phosphodiesterase-5 inhibitors prescribed as first-line therapy for patients with ERECTILE DYSFUNCTION or PULMONARY HYPERTENSION

              Uric acid level and ERECTILE DYSFUNCTION in patients with coronary ARTERY disease

              Uric acid may cause of ERECTILE DYSFUNCTION in HYPERTENSIVE patients?

              Use of impaza in the treatment of ERECTILE DYSFUNCTION in patients with essential HYPERTENSION and CHD

              Use of moxaverin for treating erectile dysfunction, forms of dementia or diseases associated to an arteriosclerotic occlusion

              Use of nanoparticles to monitor human mesenchymal stem cells transplanted into penile cavernosum of rats with erectile dysfunction

              Use of VASCULAR endothelial growth factor in the treatment of erectile dysfunction

              Usefulness of an abnormal aortic/penile index to predict the presence of coronary ARTERY disease in ERECTILE DYSFUNCTION patients

              Usefulness of electromyography of the cavernous corpora (CC EMG) in the diagnosis of arterial erectile dysfunction

              Uses of VASCULAR endothelial growth factor in the treatment of erectile dysfunction

              USING VASCULAR ASSESSMENT IN MEN WITH PEYRONIE’S DISEASE TO PREDICT DELAYED ERECTILE DYSFUNCTION AFTER REPAIR WITHOUT …

              Using zidena in the treatment of ERECTILE DYSFUNCTION associated with stress-induced arterial HYPERTENSION in workers of locomotive teams

              Vacuum erection device in treatment of organic ERECTILE DYSFUNCTION and penile VASCULAR differences between patients with DM type I and DM type II

              Valsartan treatment reverses ERECTILE DYSFUNCTION in diabetic rats

              Value of Color Doppler Ultrasonography in the Diagnosis of VASCULAR Erectile Dysfunction

              Vardenafil for ERECTILE DYSFUNCTION in men with HYPERTENSION … . Taurine supplementation improves ERECTILE function in rats with streptozotocin-induced type 1 DIABETES via amelioration of penile fibrosis and endothelial DYSFUNCTION

              … 5 phosphodiesterase inhibitor suppressed the apoptosis of corporal smooth muscle through the facilitation of akt signaling in DIABETIC ERECTILE DYSFUNCTION

              … A POTENCY TO PROTECT ERECTILE FUNCTION BY MINIMIZING OXIDATIVE STRESS IN A RAT MODEL OF DIABETIC ERECTILE DYSFUNCTION

              … Abstracts: 30 The influence of DIABETES on self-reported ERECTILE function, attitudes and treatment seeking in men with ERECTILE DYSFUNCTION : the multinational Men’s …

              … Ameliorates ERECTILE Function and Cavernosal Endothelial Function by Promoting Autophagy of Corpus Cavernosal Endothelial Cells in DIABETIC ERECTILE DYSFUNCTION  …

              … ANALYSIS OF THE EFFICACY AND SAFETY OF ONCE-DAILY TADALAFIL IN MEN WITH ERECTILE DYSFUNCTION WITH OR WITHOUT DIABETES  …

              … and safety of low-intensity shockwave therapy plus tadalafil 5 mg once daily in men with type 2 DIABETES mellitus and ERECTILE DYSFUNCTION : a matched-pair …

              … ARE ELEVATED IN TYPE 2 DIABETIC PATIENTS AGED LESS THAN 45 YEARS OLD AND CORRELATED WITH ERECTILE DYSFUNCTION BUT NOT LOWER …

              … ASSESSMENT OF CORPORA CAVERNOSA TISSUE IN DIABETIC AND NON- DIABETIC PATIENTS WITH ERECTILE DYSFUNCTION

              … ASSESSMENT OF SILDAFENIL FOR THE MANAGEMENT OF PATIENTS WITH ERECTILE DYSFUNCTION (ED) SECONDARYTO DIABETES  …

              … associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with DIABETIC ERECTILE DYSFUNCTION : a double-blind …

              … concentrated materials from mulberry fruit have a potency to protect ERECTILE function by minimizing oxidative stress in a rat model of DIABETIC ERECTILE DYSFUNCTION

              … Effect of DIABETES Mellitus Treatment and Good Glycemic Control on the ERECTILE Function in Men with DIABETES Mellitus‐Induced ERECTILE DYSFUNCTION : A Pilot Study

              … effect of two intracavernous autologous bone marrow derived mesenchymal stem cells injections in DIABETIC patients with ERECTILE DYSFUNCTION : an open label phase I …

              … EFFECTS OF ADIPOSE-DERIVED STEM CELLS-BASED MICRO-TISSUES ON ERECTILE DYSFUNCTION IN STREPTOZOTOCIN-INDUCED DIABETIC  …

              … endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing ERECTILE DYSFUNCTION in DIABETIC rats

              …  ERECTILE FUNCTION AFTER ON-DEMAND 20 MG TADALAFIL VS. DAILY 5 MG TADALAFIL IN MEN WITH ERECTILE DYSFUNCTION AND DIABETES : A …

              … function through attenuation of oxidative stress, restoration of Akt activity and protection of endothelial and smooth muscle cells in DIABETIC rats with ERECTILE DYSFUNCTION

              … Improves ERECTILE DYSFUNCTION in Rats With Streptozotocin-Induced Type 1 DIABETES Through Inhibition of Corporal Fibrosis and Endothelial DYSFUNCTION

              … Improves ERECTILE Function in Rats With Streptozotocin-Induced Type 1 DIABETES via Amelioration of Penile Fibrosis and Endothelial DYSFUNCTION (J Sex Med 2016; 13 …

              … improves parameters of endothelial inflammation and of hypogonadism in male patients with type 2 DIABETES and ERECTILE DYSFUNCTION : a randomized, double …

              … Improves Parameters of Endothelial Inflammation and of Hypogonadism in Male Patients with Type 2 DIABETES and ERECTILE DYSFUNCTION : A Randomized, Double-Blind …

              … IN THE CORPUS CAVERNOSUM OF DIABETIC MEN WITH IMPOTENCE AND ITS OVEREXPRESSION INDUCES ERECTILE DYSFUNCTION IN RATS

              … Inhibitor Suppressed the Apoptosis of Corporal Smooth Muscle Through the Facilitation Of AKT Signaling in DIABETIC ERECTILE DYSFUNCTION

              … Inhibitor Suppresses Apoptosis of Corporal Smooth Muscle by Potentiating Akt Signalling in a Rat Model of DIABETIC ERECTILE DYSFUNCTION

              … into functional interaction between GNB3 C825T and eNOS T‐786C, G894T gene polymorphisms and association with susceptibility to DIABETIC ERECTILE DYSFUNCTION

              … Life Events and Sexuality study: The influence of DIABETES on self‐reported ERECTILE function, attitudes and treatment‐seeking patterns in men with ERECTILE DYSFUNCTION

              … May Ameliorate ERECTILE Function in Rats With Streptozotocin–Induced Type 1 DIABETES by Inducing Autophagy and Inhibiting Apoptosis, Endothelial DYSFUNCTION , and …

              … NOVEL IN VITRO THREE DIMENTIONAL SCAFFOLDLESS MODEL OF CAVERNOUS TISSUE FOR STUDY OF DIABETIC ERECTILE DYSFUNCTION

              … OF COMP-ANGIOPOIETIN-1 PROTEIN AS A NOVEL THERAPEUTIC STRATEGY FOR TYPE II DIABETES -INDUCED ERECTILE DYSFUNCTION

              … OF LONGNONCODING RIBONUCLEIC ACID EXPRESSION PATTERNS IN CORPUS CAVERNOSUM OF DIABETIC RATS WITH ERECTILE DYSFUNCTION BY …

              … of mahogany (Swietenia macrophylla) and axlewood (Anogeissus leiocarpus) stem bark on some enzymes implicated in ERECTILE DYSFUNCTION and type‐2 DIABETES

              … OF PHOSPHODIESTERASE-5 IMPROVES THERAPEUTIC EFFICACY OF ADIPOSE-DERIVED STEM CELLS FOR ERECTILE DYSFUNCTION IN DIABETIC RATS

              … Peyronie’s disease is a relatively common condition, with an incidence of 3-9%. It is often associated with DIABETES and ERECTILE DYSFUNCTION (ED). This condition …

              … POSSIBLE MECHANISM OF EXTRACORPOREAL SHOCK WAVE THERAPY ON STREPTOZOTOCIN INDUCED DIABETIC ERECTILE DYSFUNCTION  …

              … RECEPTOR ANTAGONIST ON VEGF SIGNALING IN DIABETIC PENIS: A POSSIBLE CLINICAL IMPLICATION FOR DIABETES ERECTILE DYSFUNCTION

              … SERUM C-REACTIVE PROTEIN LEVELS AND RESPONSE RATE TO TADALAFIL 5 MG ONCE DAILY IN ERECTILE DYSFUNCTION PATIENTS WITH DIABETES

              … services for men with DIABETES and ERECTILE DYSFUNCTION : M McMurray, M Davies. What do men with DIABETES and ERECTILE DYSFUNCTION think about the …

              … STRESS-INDUCED SYSTEMIC AND CAVERNOSAL MOLECULAR ALTERATIONS–THEIR ROLE IN THE PROGRESSION OF DIABETIC ERECTILE DYSFUNCTION

              … Supplementation Improves ERECTILE Function in Rats with Streptozotocin-Induced Type 1 DIABETES via Amelioration of Penile Fibrosis and Endothelial DYSFUNCTION “.

              … treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with DIABETIC ERECTILE DYSFUNCTION : a double-blind …

              … with a type 5 phosphodiesterase inhibitor suppresses apoptosis of corporal smooth muscle by potentiating Akt signalling in a rat model of DIABETIC ERECTILE DYSFUNCTION

              04 Relationship between ERECTILE DYSFUNCTION and silent myocardial ischemia in DIABETIC patients: a multidetector computed tomography coronary …

              06 LISWT Might Improve the Genitoperineal Sensation and ERECTILE DYSFUNCTION in Neurogenic and DIABETIC Patients

              079 Separate or Combined Treatments with Human Bone Marrow-Derived Stem Cells and Substance P of ERECTILE DYSFUNCTION in a Rat Model of DIABETES

              081 Intracavernous Injection of Adipose-derived Stem Cells (ASCs) Improves ERECTILE DYSFUNCTION in DIABETIC Rats Animal Model

              101 Determining Factors Associated with Early Onset of ERECTILE DYSFUNCTION (ED) in Men with Type 1 DIABETES

              1014 Adipose derived stem cells ameliorate DIABETIC ERECTILE DYSFUNCTION in three dimensional culture model of cavernous tissue

              1027 POTENTIAL ROLE OF MIR-93 IN TYPE II DIABETES MELLITUS-INDUCED ERECTILE DYSFUNCTION

              1043: Phosphorylated Endothelial Nitric Oxide Synthase Regulatory Mechanisms in the Pathogenesis of DIABETES -Associated ERECTILE DYSFUNCTION

              1044: Gene Expression Changes Associated with ERECTILE DYSFUNCTION in a Rat Model of Type I DIABETES

              1046: Intrinsic and Extrinsic Apoptotic Pathways are Employed in Neuropatidc and DIABETIC Models of ERECTILE DYSFUNCTION

              1053: Effects of Antioxidants (A-Lipoic Acid and Selenium) in Prevention of ERECTILE DYSFUNCTION in Streptozotocin-Induced DIABETIC Rats

              1076: Smooth Muscle Specific Expression of HSLO Restores ERECTILE DYSFUNCTION in DIABETIC and Aged Rats

              108: Increased Superoxide Formation with Simulated Low-Grade Systemic Inflammation: Implications for ERECTILE DYSFUNCTION in Obesity and Pre- DIABETES

              DYSFUNCTION &ots=UOSxeaTk07&sig=XN8BocnsoAhyxe4Kx6wFmFhIYjs”>11 ERECTILE DYSFUNCTION in Older Adults with DIABETES

              1144 SEVERE ERECTILE DYSFUNCTION IS A SIGNIFICANT RISK FACTOR FOR OVERACTIVE BLADDER IN MEN WITH TYPE 2 DIABETES

              117 Adherence of Primary Care Physicians to the Canadian DIABETES Association Clinical Practice Guidelines for ERECTILE DYSFUNCTION and Hypogonadism

              1203: Apoptotic Pathways are Employed in Neuropathic and DIABETIC Models of ERECTILE DYSFUNCTION

              124 Serum C-reactive protein levels and response rate to tadalafil 5 mg once daily in ERECTILE DYSFUNCTION patients with DIABETES

              1329 DIABETIC MEN ARE MORE LIKELY TO REQUIRE MORE AGGRESSIVE TREATMENT FOR ERECTILE DYSFUNCTION

              1411: Rhoa/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: Novel Mechanism for DIABETIC -Associated ERECTILE DYSFUNCTION

              1413: Altered Rock-I and Rock-II Expression in a DIABETIC Model of ERECTILE DYSFUNCTION : The BB/WOR Rat

              1420: Detrimental Effect of Cigarette Smoking on ERECTILE DYSFUNCTION in the Rat is Contingent to DIABETES as Co-Morbidity

              1424: Oxidative Stress and Antioxidant Therapy: Their Potential for Salvage Therapy in DIABETES Associated ERECTILE DYSFUNCTION

              16: How should ERECTILE DYSFUNCTION in DIABETES be managed?

              1672 EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETIC MEN IN KOREA: A MULTI-CENTER …

              170 Triad of Depression, DIABETES and CVD among ERECTILE DYSFUNCTION Patients from DBPC Trials Beginning at Age 18 and Evaluating Change across …

              194 DIABETES and ERECTILE DYSFUNCTION : A Special Population Analysis from a Penile Doppler Cohort of 1000 Patients

              218 Inhibition of microRNA-92a improved ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats via suppressing oxidative stress and endothelial DYSFUNCTION

              249 Preliminary Study on the Relationship Between Gut Microbiota and Type 2 DIABETIC ERECTILE DYSFUNCTION of Sprague-Dawley Rats

              273 Melatonin receptor-mediated ameliorative effect against ERECTILE DYSFUNCTION in rats with streptozotocin-induced type 1 DIABETES

              276 Adipose-derived stem cell-derived exosomes ameliorate ERECTILE DYSFUNCTION in a rat model of type 2 DIABETES

              312 EFFECT OF VARDENAFIL TREATMENT IN THE PLASMA PROTEOME OF PATIENTS WITH ERECTILE DYSFUNCTION AND DIABETES MELLITUS

              370 EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES : A MULTI …

              389 Penile Tissue Nicotinamide Phosphoribosyltransferase (Nampt) as a Potential Player in the ERECTILE DYSFUNCTION of Type 1 DIABETIC Rats

              395 Calpain Inhibition Improves DIABETIC ERECTILE DYSFUNCTION in Rats

              492 Linking endothelial progenitor cells and DIABETIC ERECTILE DYSFUNCTION

              493 Inhibition of phosphodiesterase-5 improves therapeutic efficacy of adipose-derived stem cells for ERECTILE DYSFUNCTION in DIABETIC rats

              595 Is the Oral Glucose Tolerance Test a valid tool for DIABETES mellitus screening in males with ERECTILE DYSFUNCTION ?

              602 A comparison of baseline ERECTILE function after on-demand 20 mg tadalafil vs daily 5 mg tadalafil in men with ERECTILE DYSFUNCTION and DIABETES : A …

              620 Detection of neurogenic ERECTILE DYSFUNCTION in DIABETIC patients with Uroflowmetry

              651 LISWT might improve the genitoperineal sensation and ERECTILE DYSFUNCTION In neurogenic and DIABETIC patients

              703 GENOME WIDE ASSOCIATION STUDY IDENTIFIES NOVEL GENES FOR ERECTILE DYSFUNCTION RISK USING THE EPIDEMIOLOGY OF DIABETES  …

              790: Progenitor Cell-Derived Endothelial Cell Therapy Restores DIABETES Associated ERECTILE DYSFUNCTION

              802 INFLIXIMAB PROTECTS AGAINST DIABETIC ERECTILE DYSFUNCTION BY NEUTRALIZING TNF-α IN A RAT MODEL

              890 Treatment of DIABETES mellitus-induced ERECTILE DYSFUNCTION using endothelial progenitor cells genetically modified with human telomerase reverse …

              924 CHANGES IN THE PLASMA PROTEOME OF PATIENTS WITH ERECTILE DYSFUNCTION AND DIABETES MELLITUS AFTER VARDENAFIL TREATMENT

              955: Serum Biomarkers of Endothelial Function and Oxidative Stress after Daily Dosing of Sildenafil in Type 2 DIABETIC Men with ERECTILE DYSFUNCTION

              96 TEN-YEAR PERSPECTIVE ON THERAPY FOR ERECTILE DYSFUNCTION IN MEN WITH DIABETES : VASTLY IMPROVED BUT STILL NOT FOR ALL.

              DYSFUNCTION _In_Male_ DIABETIC _Patients_in_Western_UP/links/5b745b0d299bf14c6da8a002/A-Case-Series-on-Low-Testosterone-Levels-And-Erectile- DYSFUNCTION -In-Male- DIABETIC -Patients-in-Western-UP.pdf”>A Case Series on Low Testosterone Levels And ERECTILE DYSFUNCTION In Male DIABETIC Patients in Western UP

              A comprehensive review of ERECTILE DYSFUNCTION in men with DIABETES

              A meta-analysis on efficacy and tolerability of sildenafil for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              A possible new risk factor in DIABETIC patients with ERECTILE DYSFUNCTION : homocysteinemia

              A rat animal model of type-II DIABETES induced ERECTILE DYSFUNCTION

              A study of relation of serum testosterone levels and ERECTILE DYSFUNCTION in male patients in type 2 DIABETES mellitus

              A study on effect of inhibitors of AGE S in the treatment of ERECTILE DYSFUNCTION induced by DIABETES mellitus

              A Therapeutic confirmatory study to assess the safety and efficacy of Zydena®(Udenafil) for the treatment of ERECTILE DYSFUNCTION in male patients with DIABETES mellitus

              AB095. Increased expression of TMEM16A/Ano1 chloride channel associated with DIABETIC ERECTILE DYSFUNCTION

              AB157. Treatment of DIABETIC ERECTILE DYSFUNCTION by using endothelial progenitor cells genetically modified by human telomerase reverse transcriptase

              AB196. The long-term administration of tadalafil on STZ-induced DIABETIC rats with ERECTILE DYSFUNCTION via local antioxidative mechanism

              AB230. Calpain inhibition improves DIABETIC ERECTILE DYSFUNCTION in rats

              AB240. Therapeutic effects of adipose-derived stem cells-based micro-tissues on ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

              Aberrant expression of Wnt family contributes to the pathogenesis of DIABETES ‐induced ERECTILE DYSFUNCTION

              Activation of the NGF/TrkA signaling pathway attenuates DIABETIC ERECTILE DYSFUNCTION

              Acupuncture for ERECTILE DYSFUNCTION in a non- DIABETIC haemodialysis patient: a case report

              Acupuncture in the Treatment of ERECTILE DYSFUNCTION among a DIABETIC Population of Sildenafil Citrate Non-Respnder

              Addition of metformin to sildenafil treatment for ERECTILE DYSFUNCTION in eugonadal non DIABETIC men with insulin resistance. A prospective, randomized, double‐blind …

              Adherence to Mediterranean diet and ERECTILE DYSFUNCTION in men with type 2 DIABETES

              Adipose-derived adult stem cells and new technique for intracavernosal injection for ERECTILE DYSFUNCTION : novel approach to treat DIABETES mellitus. Erectus Shot …

              Adipose-derived stem cell-derived exosomes ameliorate ERECTILE DYSFUNCTION in a rat model of type 2 DIABETES

              Adipose-Derived Stem Cells for the Treatment of DIABETIC ERECTILE DYSFUNCTION in the ZDF Type-II DIABETIC Fatty Rat

              Advanced glycation end-products: a common pathway in DIABETES and age-related ERECTILE DYSFUNCTION

              Advances in DIABETIC ERECTILE DYSFUNCTION

              Advances in etiology of DIABETES mellitus and ERECTILE DYSFUNCTION

              Advances in Etiology of DIABETES Mellitus and ERECTILE DYSFUNCTION [J]

              Advances in pathogenesis and treatment of DIABETIC ERECTILE DYSFUNCTION

              Age-related androgen deficiency and ERECTILE DYSFUNCTION in men of the reproductive age presenting with type 2 DIABETES mellitus

              Albuminuria is an independent risk factor of ERECTILE DYSFUNCTION in men with type 2 DIABETES

              Alcohol consumption and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: Baseline data from the Dogo Study

              DIABETIC -penis/2626/00076734″>ALTERED CAVEOLIN EXPRESSION IN DIABETIC PENIS: POSSIBLE ROLE IN ERECTILE DYSFUNCTION

              Altered Penile Caveolin Expression in DIABETES : Potential Role in ERECTILE DYSFUNCTION

              An assessment of ERECTILE DYSFUNCTION among male DIABETIC s attending Temba Community Health Centre, Pretoria

              An audit of prevalence and management of ERECTILE DYSFUNCTION and LUTS in a DIABETES clinic?

              DIABETES onthenet.com/uploads/resources/dotn/_master/1128/files/pdf/dpc12-6-363-6.pdf”>An audit of self-awareness of ERECTILE DYSFUNCTION in DIABETES

              DIABETES .com/article/S1499-2671(14)00368-2/abstract”>An Intervention to Empower DIABETES Nurse Educators to Address ERECTILE DYSFUNCTION

              An investigation of ERECTILE DYSFUNCTION in 208 patients with type Ⅱ DIABETES mellitus [J]

              Analysis of correlative risk factors for DIABETIC ERECTILE DYSFUNCTION in patients

              Androgen deficiency and ERECTILE DYSFUNCTION in patients with type 2 DIABETES

              Androgen pattern in patients with type 2 DIABETES -associated ERECTILE DYSFUNCTION : impact of metabolic control

              Androgen, estrogen, and progesterone receptor gene regulation during DIABETIC ERECTILE DYSFUNCTION and insulin treatment

              Angiotensin II silencing alleviates ERECTILE DYSFUNCTION through down-regulating the Rhoa/Rho kinase signaling pathway in rats with DIABETES mellitus

              Antioxidant treatment with quercetin ameliorates ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

              APPRAISAL OF MALE ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS

              Approach to the clarification of ERECTILE DYSFUNCTION in the DIABETIC Rat Penis

              Are phosphodiesterase inhibitors effective and safe for men with DIABETES and ERECTILE DYSFUNCTION ?

              Assessing Adherence to Annual Dilated Eye Exam Recommendations in Patients with DIABETES and ERECTILE DYSFUNCTION

              Assessing the Association between Impaired Fasting Glucose, DIABETES , and ERECTILE DYSFUNCTION : The CANSED Study

              Assessment and treatments for ERECTILE DYSFUNCTION in DIABETES

              Assessment of ERECTILE DYSFUNCTION and associated psychological distress in Chinese men with type 2 DIABETES mellitus

              Assessment of ERECTILE DYSFUNCTION in DIABETIC patients

              Assessment of quality of life and ERECTILE DYSFUNCTION in a sample of DIABETIC Egyptian men

              Assessment of the efficacy of combination therapy with folic acid and tadalafil for the management of ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus

              Association between comorbidity and ERECTILE DYSFUNCTION in patients with DIABETES

              DIABETES medicine.com/articles/may_2008/DI%20May%2008%2015-16.pdf”>Association between glycemic control and ERECTILE DYSFUNCTION amongst Nigerian DIABETIC patients

              association between polymorphism of endothe-lial nitric oxide synthase gene and type 2 DIABETIC patients with ERECTILE DYSFUNCTION

              Association between sarcopenia and ERECTILE DYSFUNCTION in males with type II DIABETES mellitus

              Association of Age and Duration of DIABETES with ERECTILE DYSFUNCTION Among Men with Type 2 DIABETES and Established Coronary Disease in the BARI 2D Trial.

              Association of ERECTILE DYSFUNCTION and determinants of health related quality of life among men with type 2 DIABETES

              Association of glycemic control with risk of ERECTILE DYSFUNCTION in men with type 2 DIABETES

              Association of hypogonadism and type II DIABETES in men attending an outpatient ERECTILE DYSFUNCTION clinic

              Association of pupil responses with severity of ERECTILE DYSFUNCTION in DIABETES mellitus

              DIABETES journals.org/content/25/8/1458.short”>Association of type and duration of DIABETES with ERECTILE DYSFUNCTION in a large cohort of men

              ATTITUDES AND TREATMENT SEEKING IN MEN WITH ERECTILE DYSFUNCTION AND DIABETES

              AVANAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETIC MEN: RESULTS OF A PHASE 3, MULTI-CENTER, RANDOMIZED …

              Avanafil for the treatment of ERECTILE DYSFUNCTION : a multicenter, randomized, double-blind study in men with DIABETES mellitus

              B cell lymphoma-2-modified bone marrow-derived mesenchymal stem cells transplantation for the treatment of DIABETES mellitus-induced ERECTILE DYSFUNCTION in a rat …

              BASIC SCIENCE: Enhancement of Both EDHF and NO/cGMP Pathways Is Necessary to Reverse ERECTILE DYSFUNCTION in DIABETIC Rats

              Beneficial effect of low dose medical ozone in the type 2 DIABETIC aging male with ERECTILE DYSFUNCTION : Abstract ID:# 0058

              Beneficial effect of PEDF-transfected ADSCs on ERECTILE DYSFUNCTION in a streptozotocin- DIABETIC rat model

              Benefits from Fruit/Vegetable Consumption on ERECTILE DYSFUNCTION among DIABETIC Albanian Men

              Bergamot polyphenolic fraction counteracts ERECTILE DYSFUNCTION occurring in patients suffering from type 2 DIABETES

              Biochemical parameters among type 2 DIABETIC patients complaining of ERECTILE DYSFUNCTION

              Biochemical Parameters among Type 2 DIABETIC Patients with ERECTILE DYSFUNCTION in Gaza City

              Blockade of toll-like receptor 4 attenuates ERECTILE DYSFUNCTION in DIABETIC rats

              Calcitonin gene-related peptide induces phenotypic transformation of corpus cavernosum smooth muscle cells in DIABETIC rats with ERECTILE DYSFUNCTION

              Calcium dobesilate for the treatment of ERECTILE DYSFUNCTION in men with DIABETES mellitus

              Cavernosal tissue nitrite, nitrate, malondialdehyde and glutathione levels in DIABETIC and non‐ DIABETIC ERECTILE DYSFUNCTION

              DYSFUNCTION – DIABETIC -rats/21/00124910″>CAVERNOUS NERVE AND ERECTILE DYSFUNCTION IN DIABETIC RATS: EFFECTS OF TREATMENT WITH ERYTHROPOIETIN-DELTA

              Centrally mediated ERECTILE DYSFUNCTION in rats with type 1 DIABETES : role of angiotensin II and superoxide

              Changes of nNOS and AchE expression in penis and spinal cord of rats with DIABETES mellitus–caused ERECTILE DYSFUNCTION

              Characterization of corpus cavernosum smooth muscle cell phenotype in DIABETIC rats with ERECTILE DYSFUNCTION

              Chinese Medicine Leading to ERECTILE DYSFUNCTION When Treating DIABETES Mellitus

              Chronic administration of sildenafil modified the impaired VEGF system and improved the ERECTILE function in rats with DIABETIC ERECTILE DYSFUNCTION

              Chronic sildenafil in men with DIABETES and ERECTILE DYSFUNCTION

              Circulating endothelial progenitor cells in type 1 DIABETIC patients with ERECTILE DYSFUNCTION

              Circulating monocyte oxidative activity is increased in patients with type 2 DIABETES and ERECTILE DYSFUNCTION

              Clinical and psychological predictors of incidence of self-reported ERECTILE DYSFUNCTION in patients with type 2 DIABETES

              Clinical aspects of ERECTILE DYSFUNCTION in patients with type 2 DIABETES mellitus

              Clinical efficacy of Apomorphine SL in ERECTILE DYSFUNCTION of DIABETIC men

              Clinical evaluation of ERECTILE DYSFUNCTION in DIABETIC patients by IIEF5 Score

              Clinical observation of combined therapeutic effect of lipo-PGE1 and mecobalamin on DIABETES mellitus patients with ERECTILE DYSFUNCTION [J]

              Clinical Observation of Modified Tao Hong Siwu Decoction Combined with Lipo-prostaglandin E1 for DIABETES Mellitus Patients with ERECTILE DYSFUNCTION

              Clinical Observation on the Treatment of ⅡType DIABETIC ERECTILE DYSFUNCTION by Yishen Huoxue Decoction Combined with Glucose-lowering [J]

              Clinical profile of type 2 DIABETIC patients suffering of ERECTILE DYSFUNCTION

              Clinical significance and expression of microRNA in DIABETIC patients with ERECTILE DYSFUNCTION

              Clinical significance of serum testosterone levels in young and middle-aged men with type 2 DIABETES mellitus accompanied by ERECTILE DYSFUNCTION

              Clinical Study for Treatment of Penis ERECTILE DYSFUNCTION with Shenqijiangtang powder in Type 2 DIABETES Mellitus Patients

              Clinical study on ERECTILE DYSFUNCTION in DIABETIC and non- DIABETIC subjects and its management with Ficus relegiosa Linn.

              Clinical treatment of ERECTILE DYSFUNCTION in type 2 DIABETIC patients in the high-altitude area

              DIABETES journals.org/content/28/7/1739.abstract”>Clinical, socioeconomic, and lifestyle parameters associated with ERECTILE DYSFUNCTION among DIABETIC men

              Combination of mesenchymal stem cell injection with icariin for the treatment of DIABETES -associated ERECTILE DYSFUNCTION

              Combined sildenafil with vacuum erection device therapy in the management of DIABETIC men with ERECTILE DYSFUNCTION after failure of first‐line sildenafil monotherapy

              Commentary on–“Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC patients with ERECTILE DYSFUNCTION  …

              Comparative efficacy and safety of phosphodiesterase type 5 inhibitors for ERECTILE DYSFUNCTION in DIABETIC men: A Bayesian network meta-analysis of randomized …

              Comparison between vardenafil plus testosterone undecanoate and vardenafil alone in the treatment of DIABETIC patients with ERECTILE DYSFUNCTION [J]

              Comparison of efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETES patients with ERECTILE DYSFUNCTION

              Comparison of Improving Effects for DIABETIC ERECTILE DYSFUNCTION according to the Anti-Glycemic Agents: Phlorizin and Insulin

              Comparison of the effects of epalrestat plus sildenafil with sildenafil alone on ERECTILE DYSFUNCTION in type 2 DIABETIC patients [J]

              Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC patients with ERECTILE DYSFUNCTION

              Comparison of the first intake of vardenafil and tadalafil in patients with DIABETIC neuropathy and DIABETIC ERECTILE DYSFUNCTION

              Comparison of the therapeutic effects of adipose‑derived and bone marrow mesenchymal stem cells on ERECTILE DYSFUNCTION in DIABETIC rats

              Compounded Treatments for ERECTILE DYSFUNCTION : A Common Complication of DIABETES

              Constitutive NOS uncoupling and NADPH oxidase upregulation in the penis of type 2 DIABETIC men with ERECTILE DYSFUNCTION

              Contractile mechanisms in DIABETES -related ERECTILE DYSFUNCTION

              Coping with ERECTILE DYSFUNCTION -related distress in men with type 2 DIABETES mellitus

              Coronary flow velocity reserve reduction is comparable in patients with ERECTILE DYSFUNCTION and in patients with impaired fasting glucose or well-regulated DIABETES  …

              CORPUS CAVERNOSUM ELECTROMYOGRAPHY IN PATIENTS WITH DIABETES AND ERECTILE DYSFUNCTION

              Correction of DIABETES mellitus-induced ERECTILE DYSFUNCTION with adipose tissue-derived stem cells modified with the DDAH2 gene in a rat model

              Correlation between brain-derived neurotrophic factor expression in the nerve system and ERECTILE DYSFUNCTION in DIABETIC rats

              Correlation between nNOS expression and ERECTILE DYSFUNCTION in experimental DIABETES mellitus rats of different ages

              Correlation of Adiponectin With Testosterone in Patients With and Without Type 2 DIABETES and ERECTILE DYSFUNCTION

              DIABETIC _Men_with_Erectile_ DYSFUNCTION /links/02bfe50fe9c55493dd000000/Correlation-of-Increased-Lipid-Peroxidation-with-Serum-Gonadotropins-and-Testosterone-Levels-in-Type-2- DIABETIC -Men-with-Erectile- DYSFUNCTION .pdf”>Correlation of increased lipid peroxidation with serum gonadotropins and testosterone levels in type 2 DIABETIC men with ERECTILE DYSFUNCTION

              Correlation of nerve growth factor expression with ERECTILE DYSFUNCTION in DIABETIC rats

              Current opinions on the relationships between atherosclerosis, type 2 DIABETES mellitus and ERECTILE DYSFUNCTION

              Current Views on the Treatment Algorithm in Patients with DIABETES Mellitus and ERECTILE DYSFUNCTION

              Daily Oral l-Arginine Plus Tadalafil in DIABETIC Patients with ERECTILE DYSFUNCTION : A Double-Blinded, Randomized, Controlled Clinical Trial

              Daily tadalafil prevents ERECTILE DYSFUNCTION in DIABETIC men

              Decreased endogenous hydrogen sulfide generation in penile tissues of DIABETIC rats with ERECTILE DYSFUNCTION

              Decreased expression of pigment epithelium-derived factor related to the pathogenesis of DIABETES -associated ERECTILE DYSFUNCTION

              Density and distribution of connexin 43 in corpus cavernosum tissue from DIABETIC and hypogonadal patients with ERECTILE DYSFUNCTION

              Depressive symptoms and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: the Dogo Study

              Determinants of ERECTILE DYSFUNCTION in type 2 DIABETES

              DIABETES and ERECTILE DYSFUNCTION

              DIABETES and ERECTILE DYSFUNCTION in Morocco: epidemiological study among outpatients

              DIABETES and ERECTILE DYSFUNCTION in Olmsted County, Minnesota

              DIABETES induced ERECTILE DYSFUNCTION and apoptosis in penile crura are recovered by insulin treatment in rats

              DIABETES Mellitus (Type 2), ERECTILE DYSFUNCTION and DIABETIC Neuropathy: Georgian Point of View and Experience for Treatment of Such Patients

              DIABETES mellitus and ERECTILE DYSFUNCTION

              DIABETES mellitus and ERECTILE DYSFUNCTION in Japanese men

              DIABETES Mellitus Type 2, ERECTILE DYSFUNCTION and Glutathione Levels

              DIABETES severity, metabolic syndrome, and the risk of ERECTILE DYSFUNCTION

              DIABETES -associated ERECTILE DYSFUNCTION

              DIABETES -induced ERECTILE DYSFUNCTION : epidemiology, pathophysiology and management

              DIABETES -induced ERECTILE DYSFUNCTION : mechanisms and therapy [J]

              DIABETES ,_Dizzy_Spells,_and_Erectile_ DYSFUNCTION .6.aspx”> DIABETES , Dizzy Spells, and ERECTILE DYSFUNCTION as Presenting Symptoms in a Patient With Pheochromocytoma

              DIABETES , obesity and ERECTILE DYSFUNCTION : field overview and research priorities

              DIABETES , obesity, and ERECTILE DYSFUNCTION

              DIABETIC ERECTILE DYSFUNCTION

              DIABETIC ERECTILE DYSFUNCTION

              DIABETIC ERECTILE DYSFUNCTION – an indicator of generalised endothelial function per se?

              DIABETIC ERECTILE DYSFUNCTION as a risk factor for DIABETIC neuropathy: ISMH World Congress 2010 Abstract 174

              DIABETIC -medicine-supplement/diames/2002/04/002/ DIABETIC -erectile- DYSFUNCTION -indicator/178/00137695″> DIABETIC ERECTILE DYSFUNCTION –an indicator of generalized endothelial function?

              DIABETIC peripheral neuropathy and prevalence of ERECTILE DYSFUNCTION in Japanese patients aged< 65 years with type 2 DIABETES mellitus: The Dogo Study

              DIABETIC polyneuropathy as the only DIABETES related complication associated with higher likelihood and more severe forms of ERECTILE DYSFUNCTION in T2D

              DIABETIC polyneuropathy as the only DIABETES related complication associated with higher likelihood and more severe forms of ERECTILE DYSFUNCTION in type 2 DIABETES

              DIABETIC retinopathy as a predictor for ERECTILE DYSFUNCTION amongst male DIABETIC s: Abstract ID:# 0071

              DIABETIC -men-with-erectile- DYSFUNCTION ,8,3242,0,1.html”>Diagnosis and treatment of DIABETIC men with ERECTILE DYSFUNCTION

              Diagnosis of ERECTILE DYSFUNCTION can be used to improve screening for Type 2 DIABETES mellitus

              Differential expression of nerve injury-induced protein 1 (Ninjurin 1) in in vivo and in vitro models for DIABETIC ERECTILE DYSFUNCTION

              Differentially expressed microRNAs in the corpus cavernosum from a murine model with type 2 DIABETES mellitus-associated ERECTILE DYSFUNCTION

              Discussion of correlative factors and risk in patients with DIABETIC ERECTILE DYSFUNCTION

              Doppler Evaluation Of ERECTILE DYSFUNCTION In DIABETIC Patient With Intracavernousal Alprostadil (Caverject®) Injection

              Double blind placebo controlled crossover clinical trial of sildenafil citrate in patients with DIABETES mellitus and ERECTILE DYSFUNCTION

              Downregulated lncRNA-MIAT confers protection against ERECTILE DYSFUNCTION by downregulating lipoprotein lipase via activation of miR-328a-5p in DIABETIC rats

              Dyslipidaemia as a risk factor for ERECTILE DYSFUNCTION in type 2 DIABETES mellitus patients

              Dyslipidemia as an Early Harbinger of ERECTILE DYSFUNCTION in Type 2 DIABETIC s

              Early administration of phosphodiesterase 5 inhibitors after induction of DIABETES in a rat model may prevent ERECTILE DYSFUNCTION

              ED 06. The long-term administration of tadalafil on STZ-induced DIABETIC rats with ERECTILE DYSFUNCTION via local antioxidative mechanism

              ED 20. Neurotrophic effect of bone marrow mesenchymal stem cells for ERECTILE DYSFUNCTION in DIABETIC rats

              ED 30. Effects of the testosterone replacement therapy and tadalafil on Chinese patients of DIABETIC ERECTILE DYSFUNCTION with hypogonadism

              ED PHARMACOTHERAPY: Efficacy and Safety of Flexible‐Dose Vardenafil in Men with Type 1 DIABETES and ERECTILE DYSFUNCTION

              Effect of bone marrow mesenchymal stem cells on improving ERECTILE DYSFUNCTION in DIABETIC rats [J]

              Effect of icarisid II on DIABETIC rats with ERECTILE DYSFUNCTION and its potential mechanism via assessment of AGEs, autophagy, mTOR and the NO–cGMP …

              Effect of Ik kinases in DIABETIC ERECTILE DYSFUNCTION of rat

              Effect of oxidative stress and iNOS on DIABETIC ERECTILE DYSFUNCTION [J]

              Effect of oxidative stress on DIABETIC ERECTILE DYSFUNCTION in rats

              Effect of propionyl-l-carnitine, l-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of ERECTILE DYSFUNCTION in DIABETES

              Effect of Psoralea corylifolia Linn in sexual ERECTILE DYSFUNCTION in DIABETIC rats

              Effect of rutin on DIABETIC ‐induced ERECTILE DYSFUNCTION : Possible involvement of testicular biomarkers in male rats

              Effect of tadalafil on ERECTILE DYSFUNCTION in male patients with DIABETES mellitus

              Effect of Tetrandrine on ERECTILE Function of Rats with DIABETIC ERECTILE DYSFUNCTION

              Effect of Transdermal Testosterone or Alpha-Lipoic Acid on ERECTILE DYSFUNCTION and Quality of Life in Patients with Type 2 DIABETES Mellitus/Эффект …

              Effect of Yishen Decoction on Penial Ultrastructure and nNOS Expression Level in DIABETIC ERECTILE DYSFUNCTION Rats

              Effect of YiShenHuoXueTang on albuginea penis fibroelastic tissue in DIABETIC ERECTILE DYSFUNCTION rats′

              Effects of a Topical Saffron (Crocus sativus L) Gel on ERECTILE DYSFUNCTION in DIABETIC s: A Randomized, Parallel-Group, Double-Blind, Placebo-Controlled Trial

              EFFECTS OF A TOPICAL SAFFRON (CROCUS SATIVUS L) GEL ON ERECTILE DYSFUNCTION IN DIABETIC S: A RANDOMIZED, PARALLEL-GROUP, PLACEBO …

              Effects of a water‐soluble curcumin protein conjugate vs. pure curcumin in a DIABETIC model of ERECTILE DYSFUNCTION

              Effects of angiotensin II on male rats with DIABETIC ERECTILE DYSFUNCTION

              Effects of Moxibustion on Apoptosis of Penile ERECTILE Tissue in ERECTILE DYSFUNCTION Rats with DIABETES Mellitus [J]

              Effects of moxibustion on ERECTILE function and AGEs in DIABETIC rats with ERECTILE DYSFUNCTION [J]

              Effects of moxibustion on ERECTILE function and NO-cGMP pathway in DIABETIC rats with ERECTILE DYSFUNCTION

              Effects of moxibustion on serum AGEs in DIABETIC rats with ERECTILE DYSFUNCTION [J]

              Effects of next-generation low-energy extracorporeal shockwave therapy on ERECTILE DYSFUNCTION in an animal model of DIABETES

              Effects of phosphodiesterase 5 inhibitor on ERECTILE DYSFUNCTION induced by DIABETES and selective serotonin reuptake inhibitors in rats

              Effects of sildenafil on ERECTILE DYSFUNCTION in the aged men with DIABETES

              DIABETES journals.org/content/25/12/2159.short”>Effects of tadalafil on ERECTILE DYSFUNCTION in men with DIABETES

              Effects of tadalafil on ERECTILE DYSFUNCTION in men with DIABETES .

              Efficacy and safety of fixed-dose Udenafil (Zydena®) in men with DIABETES and ERECTILE DYSFUNCTION

              Efficacy and safety of oral mirodenafil in the treatment of ERECTILE DYSFUNCTION in DIABETIC men in Korea: a multicenter, randomized, double-blind, placebo-controlled …

              EFFICACY AND SAFETY OF ORAL MIRODENAFIL IN THE TREATMENT OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES : A MULTI-CENTER …

              Efficacy and safety of PDE5 inhibitors in the treatment of DIABETES mellitus ERECTILE DYSFUNCTION : Protocol for a systematic review

              Efficacy and safety of phosphodiesterase inhibitors for ERECTILE DYSFUNCTION in DIABETIC men: A meta analysis

              Efficacy and safety of sildenafil in men with type 2 DIABETES mellitus and ERECTILE DYSFUNCTION

              Efficacy and safety of tadalafil 2.5 mg and 5 mg administered once a day in men with DIABETES mellitus and ERECTILE DYSFUNCTION

              EFFICACY AND SAFETY OF TADALAFIL FOR THE TREATMENT OF ERECTILE DYSFUNCTION IN DIABETIC PATIENTS

              Efficacy and safety of two dosing regimens of tadalafil and patterns of sexual activity in men with DIABETES mellitus and ERECTILE DYSFUNCTION : Scheduled use vs. on …

              Efficacy and safety of vardenafil, a selective phosphodiesterase 5 inhibitor, in type 1 DIABETIC patients with ERECTILE DYSFUNCTION

              Efficacy of sildenafil citrate in treatment of ERECTILE DYSFUNCTION : effect of type 2 DIABETES

              Efficacy of tadalafil for the treatment of ERECTILE DYSFUNCTION in men with DIABETES : Results from MOMENTUS (Multiple observations in men with ED in …

              Efficacy of tadalafil once daily in men with DIABETES mellitus and ERECTILE DYSFUNCTION

              Efficacy of Tadalafil-SZ in the treatment of ERECTILE DYSFUNCTION in patients with type 2 DIABETES mellitus and with pre DIABETES

              Endothelial and ERECTILE DYSFUNCTION , DIABETES mellitus, and the metabolic syndrome: common pathways and treatments?

              Endothelial DYSFUNCTION in DIABETIC ERECTILE DYSFUNCTION

              DYSFUNCTION -patients/157/01222926″>ENDOTHELIAL FUNCTION OF ERECTILE DYSFUNCTION IN PATIENTS WITH OR WITHOUT DIABETES MELLITUS.

              Endothelial impairment and bone marrow‐derived CD34+/133+ cells in DIABETIC patients with ERECTILE DYSFUNCTION

              Endothelin antagonism and DIABETIC ERECTILE DYSFUNCTION : Changes in VEGF and NO in type I DIABETIC penis and effects of endothelin antagonism

              Engineered Mesenchymal Stem Cells Expressing Stromal Cell-derived Factor-1 Improve ERECTILE DYSFUNCTION in Streptozotocin-Induced DIABETIC Rats

              Enhanced relaxation of DIABETIC rabbit cavernosal smooth muscle in response to nitric oxide: potential relevance to ERECTILE DYSFUNCTION

              Epigenetic silencing of microRNA‐874‐3p implicates in ERECTILE DYSFUNCTION in DIABETIC rats by activating the Nupr1/Chop‐mediated pathway

              ERECTILE and sexual DYSFUNCTION in the aging DIABETIC male

              ERECTILE DYSFUNCTION (ED) and DIABETES mellitus

              ERECTILE DYSFUNCTION among DIABETIC men in two medical centers in Burkina Faso: Epidemiological, diagnosis and therapeutic aspects

              ERECTILE DYSFUNCTION among DIABETIC patients

              ERECTILE DYSFUNCTION among DIABETIC patients in Saudi Arabia: a hospital-based primary care study

              DYSFUNCTION %20among%20 DIABETIC .pdf”> ERECTILE DYSFUNCTION among DIABETIC Patients Registered in Al-Iskan Primary Health Care, Makkah, 2011

              ERECTILE DYSFUNCTION among male type 2 DIABETIC s in a South Western Teaching Hospital, Nigeria

              ERECTILE DYSFUNCTION among men with DIABETES is strongly associated with premature ejaculation and reduced libido

              ERECTILE DYSFUNCTION AMONG SOUTH ASIAN AND EUROPID MEN WITH AND WITHOUT DIABETES LIVING IN THE UK

              ERECTILE DYSFUNCTION amongst men with DIABETES in Malaysia: perception and reality, a cross-sectional study: ISMH World Congress 2010 Abstract 052

              ERECTILE DYSFUNCTION and Abnormality of Nitric Oxide Synthase in Mini-pigs with Type 2 DIABETES

              ERECTILE DYSFUNCTION and associated factors among men with DIABETES mellitus from a tertiary DIABETIC center in Northern Sri Lanka

              ERECTILE DYSFUNCTION and coronary atherothrombosis in DIABETIC patients: pathophysiology, clinical features and treatment

              ERECTILE DYSFUNCTION and DIABETES

              ERECTILE DYSFUNCTION and DIABETES

              ERECTILE DYSFUNCTION and DIABETES in Conakry (Guinea): frequency and clinical characteristics from 187 DIABETIC patients

              ERECTILE DYSFUNCTION and DIABETES mellitus

              ERECTILE DYSFUNCTION and DIABETES mellitus: mechanistic considerations from studies in experimental models

              ERECTILE DYSFUNCTION and DIABETES : a review of the current evidence-based medicine and a synthesis of the main available therapies

              ERECTILE DYSFUNCTION and DIABETES : a study in primary care

              ERECTILE DYSFUNCTION and DIABETES : Association with the impairment of lipid metabolism and oxidative stress

              ERECTILE DYSFUNCTION and DIABETES : epidemiological and Clinical Aspects in the Thies Region (Senegal)-

              ERECTILE DYSFUNCTION and fruit/vegetable consumption among DIABETIC Canadian men

              ERECTILE DYSFUNCTION and its association with metabolic syndrome and endothelial function among patients with type 2 DIABETES mellitus

              ERECTILE DYSFUNCTION and Its Associations among Men with DIABETES

              ERECTILE DYSFUNCTION and its management in patients with DIABETES mellitus

              ERECTILE DYSFUNCTION and low sex drive in men with type 2 DM: The potential role of DIABETIC pharmacotherapy

              ERECTILE DYSFUNCTION and other sexual activity DYSFUNCTION s among Saudi type 2 DIABETIC patients

              ERECTILE DYSFUNCTION and peripheral Neuropathy in Men with type 2 DIABETES Mellitus

              DIABETES journals.org/content/25/2/284″> ERECTILE DYSFUNCTION and quality of life in type 2 DIABETIC patients: a serious problem too often overlooked

              ERECTILE DYSFUNCTION and type 2 DIABETES mellitus in northern Pakistan

              ERECTILE DYSFUNCTION as a manifestation of urogenital autonomic neuropathy in patients with type 1 DIABETES : epidemiology, classification, pathophysiology …

              ERECTILE DYSFUNCTION as a marker of renal function deterioration in type 2 DIABETES male patients with late onset hypogonadism: Abstract ID:# 0049

              ERECTILE DYSFUNCTION as a Motivational Tool for Health Behavior Change in Men with DIABETES

              ERECTILE DYSFUNCTION as an Early Marker of Microangiopathic Complications in Type 2 DIABETES Mellitus

              ERECTILE DYSFUNCTION as an initial presentation of DIABETES discovered by taking sexual history

              ERECTILE DYSFUNCTION attenuation by naringenin in streptozotocin‐induced DIABETIC rats

              ERECTILE DYSFUNCTION cannot be used in primary screening of pre- DIABETES

              ERECTILE DYSFUNCTION in DIABETES

              ERECTILE DYSFUNCTION in DIABETES mellitus

              ERECTILE DYSFUNCTION in DIABETES mellitus contributes to poor quality of life

              ERECTILE DYSFUNCTION in DIABETES mellitus.

              ERECTILE DYSFUNCTION in DIABETES patients

              ERECTILE DYSFUNCTION in DIABETES : providing a nurse-led referral service

              ERECTILE DYSFUNCTION in DIABETES :’NO’role for the endothelium?

              DYSFUNCTION _in_ DIABETIC _males/links/5b8029664585151fd12f5925/Erectile- DYSFUNCTION -in- DIABETIC -males.pdf”> ERECTILE DYSFUNCTION in DIABETIC males

              ERECTILE DYSFUNCTION in DIABETIC males: Plausible mechanisms and management strategies

              ERECTILE DYSFUNCTION in DIABETIC men is linked more to microangiopathic complications and neuropathy than to macroangiopathic disturbances

              ERECTILE DYSFUNCTION IN DIABETIC MEN: THE NEUROLOGIC FACTOR REVISITED

              ERECTILE DYSFUNCTION in DIABETIC nephropathy

              ERECTILE DYSFUNCTION in DIABETIC patients

              ERECTILE DYSFUNCTION in DIABETIC Patients in the Holy Kerbala/Iraq in 2018

              ERECTILE DYSFUNCTION in DIABETIC patients.

              ERECTILE DYSFUNCTION IN DIABETIC S AND RESPONSE TO PAPAVERIN

              ERECTILE DYSFUNCTION in hemodialysis patients with DIABETES mellitus: association with age and hemoglobin A1c levels

              ERECTILE DYSFUNCTION in Men with Type 2 DIABETES : Is It Associated with Poor Glycemic Control?

              ERECTILE DYSFUNCTION IN NIGERIAN MALES WITH TYPE 2 DIABETES MELLITUS

              ERECTILE DYSFUNCTION in patients of DIABETES mellitus: a cross sectional study

              ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              ERECTILE DYSFUNCTION in patients with DIABETES mellitus—advances in treatment with phosphodiesterase type 5 inhibitors

              ERECTILE DYSFUNCTION in patients with DIABETES mellitus: Its magnitude, predictors and their bio-psycho-social interaction: A study from a developing country

              ERECTILE DYSFUNCTION in patients with DIABETES mellitus: results of epidemiological monitoring

              ERECTILE DYSFUNCTION in the patient with DIABETES mellitus

              ERECTILE DYSFUNCTION in the type II DIABETIC db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix

              ERECTILE DYSFUNCTION in type 1 DIABETIC males

              ERECTILE DYSFUNCTION in type 2 DIABETIC s: Does it need more attention?

              ERECTILE DYSFUNCTION in young men with type 1 DIABETES

              ERECTILE DYSFUNCTION in young non-obese type II DIABETIC Goto-Kakizaki rats is associated with decreased eNOS phosphorylation at Ser1177

              ERECTILE DYSFUNCTION is a strong predictor of poor quality of life in men with type 2 DIABETES mellitus

              ERECTILE DYSFUNCTION is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 DIABETES

              ERECTILE DYSFUNCTION is associated with severe retinopathy in DIABETIC men

              ERECTILE DYSFUNCTION is strongly linked with decreased libido in DIABETIC men

              ERECTILE DYSFUNCTION is strongly linked with decreased libido in DIABETIC men.

              ERECTILE DYSFUNCTION risk factors in noninsulin dependent DIABETIC Saudi patients

              ERECTILE DYSFUNCTION —an observable marker of DIABETES mellitus? A large national epidemiological study

              ERECTILE DYSFUNCTION , DIABETES mellitus, and sun-tan: the hypogonadism story with a difference

              ERECTILE DYSFUNCTION , its relation to DIABETES and its management in 2007

              ERECTILE DYSFUNCTION , microangiopathy and UKPDS risk in type 2 DIABETES

              ERECTILE DYSFUNCTION : a chronic complication of the DIABETES mellitus

              ERECTILE DYSFUNCTION : adherence to Mediterranean diet and ERECTILE DYSFUNCTION in men with type 2 DIABETES

              ERECTILE DYSFUNCTION : An underestimated presentation in patients with DIABETES mellitus

              ERECTILE DYSFUNCTION : assessment and treatment in DIABETES

              ERECTILE DYSFUNCTION : the new harbinger for major adverse cardiac events in the DIABETIC patient

              ERECTILE DYSFUNCTION . An important manifestation of autonomic DIABETIC neuropathy

              DYSFUNCTION _the_factors_of_erectile_ DYSFUNCTION _among_men_ DIABETIC _mellitus_type_2/links/5b7efc0892851c1e122e5421/Erectile- DYSFUNCTION -the-factors-of-erectile- DYSFUNCTION -among-men- DIABETIC -mellitus-type-2.pdf”> ERECTILE dysfunctıon: the factors of erectıle DYSFUNCTION among men DIABETIC mellitus type 2

              DYSFUNCTION -how-it-works-what-can-be-donewhen-i- DIABETES -stress-stenosis-sertraline-impotence-4801674.html”> ERECTILE function & DYSFUNCTION How it works & what can be donewhen i ( DIABETES stress stenosis sertraline impotence)

              ERECTILE sexual DYSFUNCTION in DIABETIC patients treated at therapy and sexual orientation multidiscipline consultation. Manzanillo

              Erythrocyte aldose reductase correlates with ERECTILE DYSFUNCTION in DIABETIC patients

              Essential role of brain‐derived neurotrophic factor (bdnf) in DIABETIC ERECTILE DYSFUNCTION

              Establishment of a cell culture model of corpus cavernosum smooth muscle cells derived from DIABETIC rats with ERECTILE DYSFUNCTION

              Establishment of a rat model of DIABETIC ERECTILE DYSFUNCTION

              Establishment of DIABETIC Rats Model with ERECTILE DYSFUNCTION and Change of nNOS in Corpus Cavernosum [J]

              Establishment of DIABETIC Rats Models with ERECTILE DYSFUNCTION [J]

              Establishment of DIABETIC Rats Models with ERECTILE DYSFUNCTION Caused by Streptozotocin [J]

              Ethnic differences of ERECTILE DYSFUNCTION in men with and without DIABETES

              ETIOLOGIC ASPECTS OF ERECTILE DYSFUNCTION IN MEN WITH DIABETES MELLITUS

              Etiologic factors of ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus

              Etiology and management of ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              Eucommia ulmoides Oliv. Leaf Extract Improves ERECTILE DYSFUNCTION in Streptozotocin-Induced DIABETIC Rats by Protecting Endothelial Function and Ameliorating …

              Evaluation and treatment of ERECTILE DYSFUNCTION in men with DIABETES mellitus

              Evaluation of a progressive treatment program for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              Evaluation of ERECTILE DYSFUNCTION and Associated Factors in Type-II DIABETIC Patients in Birjand, Iran in 2008-2009

              Evaluation of ERECTILE DYSFUNCTION in type 2 DIABETES : Prevalence, Clinical characteristics and Treatment effect of sildenafil citrate

              DIABETIC %20Patients%20with%20Erectile%20 DYSFUNCTION .pdf”>Evaluation of the Clinical Effect of Zallouh Extract (Ferula Hermonis) on DIABETIC Patients with ERECTILE DYSFUNCTION

              EVALUATION THE KNOWLEDGE & PERCEPTION OF DIABETIC S & NON DIABETIC S TOWARDS ERECTILE DYSFUNCTION IN USM MAIN CAMPUS.

              Exercise training improves central NMDA-induced ERECTILE DYSFUNCTION in DIABETES

              Exercising current treatments for ERECTILE DYSFUNCTION in DIABETES : effective, economic and ego‐boosting

              Expression change and significance of heme oxygenase in the corpus cavernosum of DIABETIC rats with ERECTILE DYSFUNCTION

              Expression of nerve growth factor in cavernous tissue and its effects on the treatment of rats with DIABETIC ERECTILE DYSFUNCTION

              Expression of neuronal nitric oxide synthase in corpus cavernosum with DIABETIC ERECTILE DYSFUNCTION : experiment with rabbits

              Expressions of eNOS and connexin 43 in the penile tissue of rats with DIABETIC ERECTILE DYSFUNCTION

              Extracellular vesicles from human urine-derived stem cells ameliorate ERECTILE DYSFUNCTION in a DIABETIC rat model by delivering proangiogenic microrna

              Farnesoid X receptor activation improves ERECTILE DYSFUNCTION in models of metabolic syndrome and DIABETES

              Free radical-scavenging activity of Korean red ginseng for ERECTILE DYSFUNCTION in non-insulin-dependent DIABETES mellitus rats

              Frequency and determinants of ERECTILE DYSFUNCTION in Turkish DIABETIC men

              FREQUENCY AND PREDICTORS OF ERECTILE DYSFUNCTION IN BANGLADESHI DIABETIC MALE

              Frequency and Predictors of ERECTILE DYSFUNCTION in Bangladeshi Men with Type 2 DIABETES Mellitus: Experience from a Tertiary Center.

              FREQUENCY AND RISK FACTORS OF ERECTILE DYSFUNCTION IN PATIENTS WITH DIABETES MELLITUS

              Frequency and Severity of ERECTILE DYSFUNCTION in Chinese Type 2 DIABETIC Men

              Frequency of autonomic neuropathy in patients with ERECTILE DYSFUNCTION in DIABETES mellitus

              DIABETES /diab/2002/06/002/frequency-erectile- DYSFUNCTION -ed-type- DIABETIC /2124/00003439″>Frequency of ERECTILE DYSFUNCTION (ED) in Type 1 and Type 2 DIABETIC Patients

              Frequency of hypogonadism and ERECTILE DYSFUNCTION in type-II DIABETIC patients

              Frequency of hypogonadism in males with type 2 DIABETES and its relation with ERECTILE DYSFUNCTION and obesity

              From the Cochrane Library: Phosphodiesterase inhibitors are effective in treating ERECTILE DYSFUNCTION in DIABETIC men

              Functional, metabolic, and morphologic characteristics of a novel rat model of type 2 DIABETES -associated ERECTILE DYSFUNCTION

              Gastrointestinal autonomic neuropathy, erectile-, bladder-and sudomotor DYSFUNCTION in patients with DIABETES mellitus: clinical impact, assessment …

              Gene expression profile comparison in the penile tissue of DIABETES and cavernous nerve injury-induced ERECTILE DYSFUNCTION rat model

              Glutathione levels in patients with ERECTILE DYSFUNCTION , with or without DIABETES mellitus

              Glyco-metabolic profile among type 2 DIABETIC patients with ERECTILE DYSFUNCTION

              Glycosylated Hemoglobin as a Predictor for Effectiveness of Sildenafil Citrate for DIABETIC Patients with ERECTILE DYSFUNCTION

              Gonadal and ERECTILE DYSFUNCTION in DIABETIC s

              Gross saponin of Tribulus terrestris improves ERECTILE DYSFUNCTION in type 2 DIABETIC rats by repairing the endothelial function of the penile corpus cavernosum

              Group B streptococcal septicemia following intracavernous injection therapy for ERECTILE DYSFUNCTION in DIABETES

              GWAS identifies novel risk locus for ERECTILE DYSFUNCTION and implicates hypothalamic neurobiology and DIABETES in etiology

              GWAS identifies risk locus for ERECTILE DYSFUNCTION and implicates hypothalamic neurobiology and DIABETES in etiology

              Herbs in the treatment of DIABETES induced ERECTILE DYSFUNCTION

              High prevalence of ERECTILE DYSFUNCTION in DIABETES : a systematic review and meta‐analysis of 145 studies

              High prevalence of ERECTILE DYSFUNCTION in DIABETIC men with depressive symptoms: a meta-analysis

              High prevalence of ERECTILE DYSFUNCTION in patients attending a DIABETES outpatient clinic.

              Hormonal determinants of ERECTILE DYSFUNCTION and lower urinary tract symptoms in middle-aged and elderly men with pre DIABETES

              How I treat and manage ERECTILE DYSFUNCTION in DIABETIC s

              How often do we ask about ERECTILE DYSFUNCTION in the DIABETES review clinic?

              How to treat ERECTILE DYSFUNCTION in men with DIABETES : from pathophysiology to treatment

              Human urine-derived stem cells alone or genetically-modified with FGF2 improve type 2 DIABETIC ERECTILE DYSFUNCTION in a rat model

              Hydrogen therapy may be a promising, safe and effective treatment for DIABETIC ERECTILE DYSFUNCTION : a hypothesis

              Hyperhomocysteinemia is a risk factor for ERECTILE DYSFUNCTION in men with adult-onset DIABETES mellitus

              Hypogonadism, ERECTILE DYSFUNCTION , and type 2 DIABETES mellitus: what the clinician needs to know

              Hypogonadotropic hypogonadism in ERECTILE DYSFUNCTION associated with type 2 DIABETES mellitus: a common defect?

              Hypovitaminosis D is associated with ERECTILE DYSFUNCTION in type 2 DIABETES

              Hypoxia precondition promotes adipose-derived mesenchymal stem cells based repair of DIABETIC ERECTILE DYSFUNCTION via augmenting angiogenesis and …

              IDENTIFICATION OF MICRORNA EXPRESSION PROFILE IN DIABETIC RATS’PENILE TISSUES AND POTENTIAL ROLE OF MIR-92A IN ERECTILE DYSFUNCTION

              Identifying patients with type 2 DIABETES with a higher likelihood of ERECTILE DYSFUNCTION : the role of the interaction between clinical and psychological factors

              Imbalanced low-grade inflammation and endothelial activation in patients with type 2 DIABETES mellitus and ERECTILE DYSFUNCTION

              Impact of DIABETES Mellitus on the Severity of ERECTILE DYSFUNCTION and Response to Treatment: Analysis of Data From Tadalafil Clinical Trials

              Impact of ERECTILE DYSFUNCTION on Quality of Life in Men with Type 1 and Type 2 DIABETES .

              Impact of ERECTILE DYSFUNCTION on the Conjugal Subsystem Functionality of the Patient with Type 2 DIABETES Mellitus

              Impact of undiagnosed pre DIABETES on phosphodiesterase type 5 inhibitors response in men with ERECTILE DYSFUNCTION

              Impaired veno-occlusion and associated decreases in cavernosal elastin and collagen in a type II DIABETIC mouse model of ERECTILE DYSFUNCTION

              Implanted muscle-derived stem cells ameliorate ERECTILE DYSFUNCTION in a rat model of type 2 DIABETES , but their repair capacity is impaired by their prior exposure to the …

              Improvement in ERECTILE DYSFUNCTION after insulin‐like growth factor‐1 gene therapy in DIABETIC rats

              Improvement in ERECTILE DYSFUNCTION after neurotrophic factor gene therapy in DIABETIC rats

              Improvement of sexual behavior, sperm quantity and quality by Quercetin in streptozotocin-induced DIABETIC ERECTILE DYSFUNCTION

              Improving the primary care management of ERECTILE DYSFUNCTION and testosterone deficiency in men with or without Type 2 DIABETES : findings from the REVITALISE …

              DIABETES _and_erectile.22.aspx”>In adult men with DIABETES and ERECTILE DYSFUNCTION , does a PDE-5 inhibitor improve sexual function?

              In vivo tracking on longer retention of transplanted myocardin gene-modified adipose-derived stem cells to improve ERECTILE DYSFUNCTION in DIABETIC rats

              Inactivation of phosphorylated endothelial nitric oxide synthase (Ser-1177) by O-GlcNAc in DIABETES -associated ERECTILE DYSFUNCTION

              Inactivation of the Ras/MAPK/PPARγ signaling axis alleviates DIABETIC mellitus-induced ERECTILE DYSFUNCTION through suppression of corpus cavernosal endothelial cell …

              Increased expression of arginase II in human DIABETIC corpus cavernosum: in DIABETIC -associated ERECTILE DYSFUNCTION

              Increased expression of TRPC 4 channels associated with ERECTILE DYSFUNCTION in DIABETES

              Increasing age, prostate weight, and DIABETES independently associated with ERECTILE DYSFUNCTION after robotic prostatectomy in Hispanic men

              Independent predictors of ERECTILE DYSFUNCTION in type 2 DIABETES mellitus: Is it true what they say about risk factors?

              Induced testosterone deficiency: from clinical presentation of fatigue, ERECTILE DYSFUNCTION and muscle atrophy to insulin resistance and DIABETES

              Infection induced inflammation is associated with ERECTILE DYSFUNCTION in men with DIABETES

              DIABETES -associated/8/00076734″>Insights and interventions in DIABETES associated ERECTILE DYSFUNCTION

              Intracavernosal injection therapy and surgical therapy in DIABETIC patients with ERECTILE DYSFUNCTION .

              Intracavernosal injection therapy and surgical therapy in DIABETIC patientswith ERECTILE DYSFUNCTION

              DYSFUNCTION _in_ DIABETIC _Patient_Preliminary_Report_of_6_Cases/links/57f4c12e08ae8da3ce54e480/Intracavernous-Administration-of-Adipose-Stem-Cells-A-New-Technique-of-Treating-Erectile- DYSFUNCTION -in- DIABETIC -Patient-Preliminary-Report-of-6-Cases.pdf”>Intracavernous administration of adipose stem cells: a new technique of treating ERECTILE DYSFUNCTION in DIABETIC patient, preliminary report of 6 cases

              Intracavernous delivery of synthetic angiopoietin-1 protein as a novel therapeutic strategy for ERECTILE DYSFUNCTION in the type II DIABETIC db/db mouse

              Investigation of DIABETIC men with ERECTILE DYSFUNCTION to determine coronary flow reserve (CFR) and cardiac risk under medication with sildenafil (Viagra)

              Is DIABETIC ERECTILE DYSFUNCTION More Difficult to Treat?

              Is type 2 DIABETES mellitus a cause of severe ERECTILE DYSFUNCTION in patients with metabolic syndrome?

              JTE‐013 Supplementation Improves ERECTILE DYSFUNCTION in Rats with Streptozotocin‐induced Type Ⅰ DIABETES through the Inhibition of the Rho‐kinase Pathway …

              La dysfonction érectile chez les personnes atteintes de diabète en Côte-d’Ivoire: ERECTILE DYSFUNCTION in patients with DIABETES in Ivory Coast

              Lack of central nitric oxide triggers ERECTILE DYSFUNCTION in DIABETES

              Lipoxin A4 improves ERECTILE DYSFUNCTION in rats with type I DIABETES by inhibiting oxidative stress and corporal fibrosis

              Localization of increased insulin-like growth factor binding protein-3 in DIABETIC rat penis: implications for ERECTILE DYSFUNCTION

              Long-term efficacy and safety of DIABETIC men with ERECTILE DYSFUNCTION

              Long‐term treatment with intracavernosal injections in DIABETIC men with ERECTILE DYSFUNCTION

              DIABETES journals.org/content/28/11/2637.short”>Longitudinal assessment of quality of life in patients with type 2 DIABETES and self-reported ERECTILE DYSFUNCTION

              Longitudinal patterns of occurrence and remission of ERECTILE DYSFUNCTION in men with type 1 DIABETES

              Low dose daily versus on-demand high dose tadalafil in DIABETIC patients with ERECTILE and ejaculatory DYSFUNCTION

              Low testosterone and severity of ERECTILE DYSFUNCTION (ED) are independently associated with poor health related quality of life (HRQoL) in men with type 2 DIABETES

              Low-Intensity Extracorporeal Shockwave Therapy for ERECTILE DYSFUNCTION in DIABETIC Patients

              Lower urinary tract symptoms and ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus

              Lycopene ameliorates ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

              Management and treatment of DIABETES , ERECTILE DYSFUNCTION and hypogonadism

              Management of ERECTILE DYSFUNCTION by general practitioners and endocrinologists in DIABETES : A survey of 130 patients

              Management of ERECTILE DYSFUNCTION in adult men with learning disabilities and DIABETES .

              Management of ERECTILE DYSFUNCTION in DIABETES : an update for 2008

              Management of ERECTILE DYSFUNCTION in DIABETIC patients.

              Management of ERECTILE DYSFUNCTION in men with DIABETES

              Management strategies for gastrointestinal, erectile, bladder, and sudomotor DYSFUNCTION in patients with DIABETES

              Managing ERECTILE DYSFUNCTION in DIABETES

              Mechanistic link between ERECTILE DYSFUNCTION and systemic endothelial DYSFUNCTION in type 2 DIABETIC rats

              Men with DIABETES may require more aggressive treatment for ERECTILE DYSFUNCTION

              Mesenchymal Stem Cells Treatment for ERECTILE DYSFUNCTION in DIABETIC Rats

              Meta-analysis on the risk factors for ERECTILE DYSFUNCTION in DIABETES mellitus patients [J]

              Metabolic risk factors, endothelial DYSFUNCTION , and ERECTILE DYSFUNCTION in men with DIABETES

              Metabolic syndrome and ERECTILE DYSFUNCTION among obese non- DIABETIC subjects

              Methods for treating ERECTILE DYSFUNCTION in patients with insulin-dependent DIABETES

              MICE WITH NULL LEPTIN RECEPTOR AS A TRANSLATIONAL MODEL OF TYPE II DIABETES -INDUCED ERECTILE DYSFUNCTION : IN VIVO ASSESSMENT AND …

              Microarray analysis reveals novel gene expression changes associated with ERECTILE DYSFUNCTION in DIABETIC rats

              Microarray data analysis of genes related with ERECTILE DYSFUNCTION in DIABETIC rats

              MicroRNA‐205 is associated with DIABETES mellitus‐induced ERECTILE DYSFUNCTION via down‐regulating the androgen receptor

              Mirabegron, A Selective β3-Adrenoceptor Agonist Causes an Improvement in ERECTILE DYSFUNCTION in DIABETIC Rats

              Molecular mechanisms associated with DIABETIC endothelial– ERECTILE DYSFUNCTION

              Molecular mechanisms involved in ERECTILE DYSFUNCTION associated to DIABETES

              Molecular targets for DIABETES mellitus-associated ERECTILE DYSFUNCTION

              Morphological assessment of corpora cavernosa tissue in DIABETIC and non DIABETIC patients with ERECTILE DYSFUNCTION

              Mouse model of ERECTILE DYSFUNCTION due to diet-induced DIABETES mellitus

              MP-07.06 Effect of Vardenafil Treatment in the Plasma Proteome of Patients With ERECTILE DYSFUNCTION and DIABETES Mellitus

              MP43-09 Effects of platelet rich plasma on improving ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

              MP43-20 JTE-013 SUPPLEMENTATION IMPROVES ERECTILE DYSFUNCTION IN RATS WITH STREPTOZOTOCIN-INDUCED TYPE? DIABETES THROUGH …

              MP74-17 TRAJECTORIES OF ERECTILE DYSFUNCTION SUBPHENOTYPES IN MEN WITH LONGSTANDING TYPE I DIABETES

              MP84-10 ORGASMIC AND ERECTILE DYSFUNCTION IN MEN WITH LONGSTANDING TYPE 1 DIABETES

              MP86-14 TREATMENT OF DIABETES MELLITUS-INDUCED ERECTILE DYSFUNCTION USING ENDOTHELIAL PROGENITOR CELLS GENETICALLY …

              MP89-01 VASOHIBIN-1 IS A NOVEL THERAPEUTIC TARGET FOR DIABETIC ERECTILE DYSFUNCTION IN MICE

              MP89-04 CF602 IMPROVES ERECTILE DYSFUNCTION IN DIABETIC RATS

              Multidisciplinary Workshop Improves ERECTILE Performance In DIABETIC Men With ERECTILE DYSFUNCTION .

              Myoinositol/folic acid combination for the treatment of ERECTILE DYSFUNCTION in type 2 DIABETES men: a double-blind, randomized, placebo-controlled study

              Nerve Growth Factor Improves the Outcome of Type 2 DIABETES –Induced Hypotestosteronemia and ERECTILE DYSFUNCTION

              Neuroprotective effects of melatonin on ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

              Neurotrophic effect of bone marrow mesenchymal stem cells for ERECTILE DYSFUNCTION in DIABETIC rats

              Neurotrophin and ERECTILE DYSFUNCTION in DIABETES

              New possibilities for treatment of ERECTILE DYSFUNCTION in men with type 2 DIABETES

              New treatment options for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              Nitric Oxide‐Releasing Polymeric Microspheres Improve DIABETES ‐Related ERECTILE DYSFUNCTION

              Nocturia and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: The Dogo Study

              Nocturnal electrobioimpedance volumetric assessment in DIABETIC men with ERECTILE DYSFUNCTION before and after tadalafil intake

              NON DIABETIC ENDOCRINE ETIOLOGY FOR ERECTILE DYSFUNCTION (ED)

              Novel phosphodiesterase-5 (PDE5) inhibitors in the alleviation of ERECTILE DYSFUNCTION due to DIABETES and ageing-induced oxidative stress

              DIABETES researchclinicalpractice.com/article/S0168-8227(14)70244-X/abstract”>OP38 THERAPEUTIC IMPACT OF DIABETIC ERECTILE DYSFUNCTION : CHANGES IN VEGF AND NO IN TYPE I DIABETIC PENIS AND EFFECTS OF …

              Optimizing treatment for DIABETES mellitus induced ERECTILE DYSFUNCTION

              Oral sildenafil in the treatment of ERECTILE DYSFUNCTION in DIABETIC men: a randomized double-blind and placebo-controlled study

              Oral testosterone undecanoate reverses ERECTILE DYSFUNCTION associated with DIABETES mellitus in patients failing on sildenafil citrate therapy alone

              Organic, relational and psychological factors in ERECTILE DYSFUNCTION in men with DIABETES mellitus

              Oxidative stress and antioxidant therapy: Their impact in DIABETES ‐associated ERECTILE DYSFUNCTION

              Oxidative stress and DIABETIC ERECTILE DYSFUNCTION

              Ozone Therapy in Type 2 DIABETIC ERECTILE DYSFUNCTION (A Preliminary report)

              Ozone Therapy in Type 2 DIABETIC ERECTILE DYSFUNCTION (A Preliminary report) ISMH World Congress 2010 Abstract 120

              P-01-016 Successful results of complex and gradual treatment of ERECTILE DYSFUNCTION in patients with DIABETES mellitus: Georgian experience

              P-03-017 Severity and associations of ERECTILE DYSFUNCTION in a sample of type 2 DIABETIC men

              P-03-044 Androgen deficiency-induced ERECTILE DYSFUNCTION of young male patient with newly diagnosed DIABETES mellitus type 2

              P2-73 Changes of nNOS in The Rats of DIABETES Mellitus Correlated with ERECTILE DYSFUNCTION

              Panax notoginseng saponins improve the ERECTILE DYSFUNCTION in DIABETIC rats by protecting the endothelial function of the penile corpus cavernosum

              Pancreatic kininogenase improves ERECTILE function in streptozotocin-induced type 2 DIABETIC rats with ERECTILE DYSFUNCTION

              Pathobiology of ischiocavernosus and bulbospongiosus muscles in long-term DIABETIC male rats and its implication on ERECTILE DYSFUNCTION

              Pathogenic mechanisms of ERECTILE DYSFUNCTION development in men with type 1 and type 2 DIABETES mellitus

              Pathophysiology and treatment of DIABETIC ERECTILE DYSFUNCTION

              Pathophysiology of DIABETIC ERECTILE DYSFUNCTION : potential contribution of vasa nervorum and advanced glycation endproducts

              DIABETES _Mellitus_and_Erectile_ DYSFUNCTION _Attending_a_Tertiary_Hospital_in_South_Eastern_Nigeria/links/57f87c2708ae886b89836904/Pattern-of-Serum-Testosterone-and-Glycated-Haemoglobin-among-Adult-Males-with-Type-2- DIABETES -Mellitus-and-Erectile- DYSFUNCTION -Attending-a-Tertiary-Hospital-in-South-Eastern-Nigeria.pdf”>Pattern of Serum Testosterone and Glycated Haemoglobin among Adult Males with Type 2 DIABETES Mellitus and ERECTILE DYSFUNCTION Attending a Tertiary …

              Patterns and their correlates of seeking treatment for ERECTILE DYSFUNCTION in type 2 DIABETIC patients

              PD-10.06: Localization of increased insulin-like growth factor binding protein-3 in the DIABETIC rat penis; implication for ERECTILE DYSFUNCTION

              PD49-04 ADIPOSE-DERIVED STEM CELL-DERIVED EXOSOMES AMELIORATE ERECTILE DYSFUNCTION IN A RAT MODEL OF TYPE 2 DIABETES

              PD50-11 A comparison of baseline ERECTILE function after on-demand 20 mg tadalafil vs. daily 5 mg tadalafil in men with ERECTILE DYSFUNCTION and DIABETES : a …

              DYSFUNCTION _IN_MEN.3.aspx”>PDE-5 INHIBITORS FOR ERECTILE DYSFUNCTION IN MEN WITH DIABETES

              PDE5 inhibitors offer new prospects for ERECTILE DYSFUNCTION in DIABETES

              PDE5 inhibitors: targeting ERECTILE DYSFUNCTION in DIABETIC s

              Penile axial rigidity and Doppler ultrasonography parameters in patients with ERECTILE DYSFUNCTION : association with type 2 DIABETES

              Penile Dimensions of DIABETIC and Non DIABETIC Men With ERECTILE DYSFUNCTION : A Case–Control Study

              Peyronie’s disease in DIABETIC patients being screened for ERECTILE DYSFUNCTION

              Pharmaceutical composition for preventing or treating DIABETIC ERECTILE DYSFUNCTION comprising C3G or extract of mulberry containing C3G

              Pharmacotherapy for ERECTILE DYSFUNCTION in DIABETIC males

              Phenotype modulation of smooth muscle in corpus cavernosum in penis tunica albuginea in DIABETES mellitus with ERECTILE DYSFUNCTION : experiment with rats

              Phosphodiesterase inhibitors for ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              Phosphodiesterase type 5 inhibitors for the treatment of ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              Phosphodiesterase-5 inhibitors for ERECTILE DYSFUNCTION in patients with DIABETES mellitus: A systematic review and meta-analysis of randomized controlled …

              Physical activity and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: The Dogo Study

              DYSFUNCTION %20among%20 DIABETES %20Mellitus%20Type%202%20Patients%20in%20Sanglah%20General%20Hospital%20Denpasar.pdf”>Physical Activity has no Relation with ERECTILE DYSFUNCTION among DIABETES Mellitus Type 2 Patients in Sanglah General Hospital Denpasar

              Physicians’ and patients’ perception of sexuality in DIABETIC men with ERECTILE DYSFUNCTION . The PREDICT study

              Pilot genome-wide association search identifies potential loci for risk of ERECTILE DYSFUNCTION in type 1 DIABETES using the DCCT/EDIC study cohort

              Platelet Indices as a marker for early prediction of ERECTILE DYSFUNCTION in DIABETIC patients

              PO-01-010 Synergistic effects of extracorporeal shockwave therapy and Korean herbal formulation on ERECTILE DYSFUNCTION in DIABETIC animal model

              PO-01-014 Impact of undiagnosed pre DIABETES on phosphodiesterase type 5 inhibitors response in men with ERECTILE DYSFUNCTION

              PO-01-068 Hormonal factors in patients with ERECTILE DYSFUNCTION and DIABETES

              DIABETES researchclinicalpractice.com/article/S0168-8227(14)70642-4/abstract”>PO348 ASSOCIATION OF ERECTILE DYSFUNCTION WITH TYPE 2 DIABETES AND INSULIN RESISTANCE

              POS-01.78: Study on correlation between metabolic syndrome and DIABETES -related ERECTILE DYSFUNCTION

              Potential of phloroglucinol to improve ERECTILE DYSFUNCTION associated with streptozotocin-induced DIABETES in rats

              Preconditioning of adipose‐derived stem cells by phosphodiesterase‐5 inhibition enhances therapeutic efficacy against DIABETES ‐induced ERECTILE DYSFUNCTION

              DIABETES -hypogonadism-amp-erectile- DYSFUNCTION /1429/00076734″>Pre DIABETES , hypogonadism & ERECTILE DYSFUNCTION : glycaemic control in 109 hypogonadal men treated with testosterone undecanoate injections (TU) for up to 8 years …

              Predictors for ERECTILE DYSFUNCTION among DIABETIC s

              Predictors of ERECTILE DYSFUNCTION in men with type 2 DIABETES mellitus referred to a tertiary healthcare centre

              Predictors of ERECTILE DYSFUNCTION in Type 2 DIABETES Mellitus

              Preliminary observations on the use of propionyl-L-carnitine in combination with sildenafil in patients with ERECTILE DYSFUNCTION and DIABETES

              Prevalence and associations of ERECTILE DYSFUNCTION in a sample of Italian males with type 2 DIABETES

              Prevalence and correlates of ERECTILE DYSFUNCTION in type 2 DIABETES mellitus: a cross-sectional single-center study among Turkish patients

              Prevalence and correlates of ERECTILE DYSFUNCTION in type 2 DIABETIC men: a population-based cross-sectional study in Chinese men

              Prevalence and determinants of ERECTILE DYSFUNCTION among DIABETIC patients attending in hospitals of central and northwestern zone of Tigray, northern …

              Prevalence and determinants of ERECTILE DYSFUNCTION among people with type 2 DIABETES in Ilorin, Nigeria.

              Prevalence and Factors Associated with Quality of Life among DIABETIC Men Living with ERECTILE DYSFUNCTION

              PREVALENCE AND PREDICTORS OF ERECTILE DYSFUNCTION IN AFRO-CARIBBEAN MALES WITH TYPE 2 DIABETES MELLITUS: IS THE …

              Prevalence and risk factors associated with ERECTILE DYSFUNCTION among Bahraini men with DIABETES mellitus.

              DYSFUNCTION _in_ DIABETIC _Men_Attending_Clinics_in_Kingston_Jamaica/links/5457745a0cf26d5090a9c9ed/Prevalence-of-Erectile- DYSFUNCTION -in- DIABETIC -Men-Attending-Clinics-in-Kingston-Jamaica.pdf”>Prevalence and risk factors associated with ERECTILE DYSFUNCTION in DIABETIC men attending clinics in Kingston, Jamaica

              Prevalence and risk factors for ERECTILE DYSFUNCTION in Japanese DIABETIC s

              Prevalence and risk factors of ERECTILE DYSFUNCTION in Iranian DIABETIC men

              Prevalence and risk factors of ERECTILE DYSFUNCTION in Japanese men with type 2 DIABETES

              Prevalence and severity of ERECTILE DYSFUNCTION as assessed by IIEF-5 in North Indian type 2 DIABETIC males and its correlation with variables

              Prevalence of Adult-Onset Hypogonadism and ERECTILE DYSFUNCTION in Males with Pre DIABETES

              Prevalence of and risk factors for ERECTILE DYSFUNCTION in young non DIABETIC obese men: results from a regional study.

              Prevalence of DIABETES Mellitus (DM) in a population of men affected by ERECTILE DYSFUNCTION (ED).

              Prevalence of ERECTILE DYSFUNCTION among Chinese men with type 2 DIABETES mellitus

              DYSFUNCTION _among_Saudi_type_2_ DIABETIC _patients/links/53fdd4bc0cf2364ccc0916a0/Prevalence-of-erectile- DYSFUNCTION -among-Saudi-type-2- DIABETIC -patients.pdf”>Prevalence of ERECTILE DYSFUNCTION among Saudi type 2 DIABETIC patients

              Prevalence of ERECTILE DYSFUNCTION and associated factors among DIABETIC men attending DIABETIC clinic at Muhimbili National Hospital in Dar-es-Salaam …

              Prevalence of ERECTILE DYSFUNCTION and associated factors among DIABETIC men attending the DIABETIC clinic at Felege Hiwot Referral Hospital, Bahir Dar, North …

              Prevalence of ERECTILE DYSFUNCTION and it’s related factors in type 2 DIABETIC patients

              Prevalence of ERECTILE DYSFUNCTION and its associated factors among Vietnamese men with type 2 DIABETES

              Prevalence of ERECTILE DYSFUNCTION in DIABETIC patients

              Prevalence of ERECTILE DYSFUNCTION in Korean men with Type 2 DIABETES mellitus

              Prevalence of ERECTILE DYSFUNCTION in men with pre- DIABETES : An investigation in Lanzhou

              Prevalence of ERECTILE DYSFUNCTION in non- DIABETIC uremia

              Prevalence of ERECTILE DYSFUNCTION in patients of DIABETES mellitus type-2 and its impact on quality of life.

              Prevalence of ERECTILE DYSFUNCTION in Tehranian DIABETIC men

              Prevalence of ERECTILE DYSFUNCTION in thyroid disorders: comparison with control subjects and with obese and DIABETIC patients

              Prevalence of ERECTILE DYSFUNCTION patients with DIABETES mellitus and its association with body mass index and glycated hemoglobin in Africa: a systematic review and …

              Prevalence of hypogonadism in type 2 DIABETIC patients with ERECTILE DYSFUNCTION attending a DIABETES clinic: 150

              Prevalence of risk factors of ERECTILE DYSFUNCTION among men with DIABETES

              Prevalence of, and risk factors for ERECTILE DYSFUNCTION in male type 2 DIABETIC outpatient attendees in Enugu, South East Nigeria

              Prevalence, correlates, attitude and treatment seeking of ERECTILE DYSFUNCTION among type 2 DIABETIC Chinese men attending primary care outpatient clinics

              PREVALENCE, INCIDENCE AND RISK FACTORS OF ERECTILE DYSFUNCTION IN MALES WITH TYPE 1 DIABETES ENROLLED IN THE PITTSBURGH …

              DIABETES /1233/00076734″>PROFILE OF MICRORNA EXPRESSION IN A MODEL OF DIABETES MELLITUS-INDUCED ERECTILE DYSFUNCTION

              Prolactinoma in a DIABETIC dialysis patient with ERECTILE DYSFUNCTION : A difficult differential diagnosis

              DIABETES _Obes_J_Prospective_Observational_Longitudinal_Study_Evaluating_Erectile_ DYSFUNCTION _in_50_Type_2_ DIABETIC _Patients_with_BMI_Below_35_Kgm_2_Submitted_to_Ileal_Interposition_Associate/links/5a12c23d458515cc5aa9f0e6/Curre-Res- DIABETES -Obes-J-Prospective-Observational-Longitudinal-Study-Evaluating-Erectile- DYSFUNCTION -in-50-Type-2- DIABETIC -Patients-with-BMI-Below-35-Kg-m-2-Submitted-to-Ileal-Interposition-Associ.pdf”>Prospective Observational Longitudinal Study Evaluating ERECTILE DYSFUNCTION in 50 Type 2 DIABETIC Patients with BMI Below 35 Kg/m2 Submitted to Ileal …

              Protective effects of hydrogen-rich saline against ERECTILE DYSFUNCTION in a streptozotocin induced DIABETIC rat model

              DIABETIC -cavernosal/25/01222926″>PROTEIN STRUCTURAL ALTERATIONS IN DIABETIC CAVERNOSAL TISSUE—THEIR ROLE IN ERECTILE DYSFUNCTION PROGRESSION

              PS 21. Mechanisms of DIABETES associated ERECTILE DYSFUNCTION

              PS-04-007 The beneficial effect of a selective ifunny channels blocker, ivabradine on ERECTILE DYSFUNCTION in DIABETIC rats

              PS-04-009 Vasohibin-1 is a novel therapeutic target for DIABETIC ERECTILE DYSFUNCTION

              DYSFUNCTION _among_ DIABETIC _and_non- DIABETIC _attributes_Penang_Malaysia/links/00b7d522fe7cbd5940000000.pdf”>Psychosocial survey on ERECTILE DYSFUNCTION among DIABETIC and non- DIABETIC attributes, Penang, Malaysia

              Purinergic Neurotransmission in ERECTILE DYSFUNCTION of DIABETIC Rats

              Radiological methods in the diagnosis of cavernous hemodynamic disorders in men with DIABETES mellitus and ERECTILE DYSFUNCTION

              Rare case of manifestation of ERECTILE DYSFUNCTION soon after thyroidectomy because of thyroid cancer in 56-year-old man with DIABETES mellitus type 2 and DIABETIC  …

              Re: addition of metformin to sildenafil treatment for ERECTILE DYSFUNCTION in eugonadal non- DIABETIC men with insulin resistance. A prospective, randomized …

              Re: Combination of Mesenchymal Stem Cell Injection with Icariin for the Treatment of DIABETES -Associated ERECTILE DYSFUNCTION .

              Re: Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 DIABETIC patients with ERECTILE DYSFUNCTION .

              Re: ERECTILE DYSFUNCTION -an observable marker of DIABETES mellitus? A large national epidemiological study: P. Sun, A. Cameron, A. Seftel, R. Shabsigh, C …

              Re: men with DIABETES may require more aggressive treatment for ERECTILE DYSFUNCTION .

              Re: Optimizing treatment for DIABETES mellitus induced ERECTILE DYSFUNCTION

              Re: Prevalence of ERECTILE DYSFUNCTION and Associated Factors among DIABETIC Men Attending DIABETIC Clinic at Muhimbili National Hospital in Dar-es-Salaam …

              Re: Self-Reported Sitting Time and Prevalence of ERECTILE DYSFUNCTION in Japanese Patients with Type 2 DIABETES Mellitus: The Dogo Study

              Re: Skin Autofluorescence (a Marker for Advanced Glycation End Products) and ERECTILE DYSFUNCTION in DIABETES

              Re: Treatment of DIABETES Mellitus-Induced ERECTILE DYSFUNCTION Using Endothelial Progenitor Cells Genetically Modified with Human Telomerase …

              Recent advances in the treatment of ERECTILE DYSFUNCTION in patients with DIABETES mellitus

              Redefining the role of long-acting phosphodiesterase inhibitor tadalafil in the treatment of DIABETIC ERECTILE DYSFUNCTION

              Relation Between ERECTILE DYSFUNCTION and Silent Myocardial Ischemia in DIABETIC Patients: A Multidetector Computed Tomographic Coronary Angiographic …

              Relationship between DIABETIC retinopathy, DIABETIC macular oedema and ERECTILE DYSFUNCTION in type 2 DIABETIC s

              DYSFUNCTION _and_HbA1C_Percentage_in_ DIABETIC _Patients_at_Sanglah_Hospital_Bali_Indonesia/links/59e2262a458515393d57eb4c/Relationship-between-Erectile- DYSFUNCTION -and-HbA1C-Percentage-in- DIABETIC -Patients-at-Sanglah-Hospital-Bali-Indonesia.pdf”>Relationship between ERECTILE DYSFUNCTION and HbA1C Percentage in DIABETIC Patients at Sanglah Hospital, Bali, Indonesia

              Relationship between ERECTILE DYSFUNCTION and silent myocardial ischemia in apparently uncomplicated type 2 DIABETIC patients

              Relationship between gut microbiota and type 2 DIABETIC ERECTILE DYSFUNCTION in sprague-dawley rats

              Relationship Between Sexual Desire, Premature Ejaculation and ERECTILE DYSFUNCTION Among Men with Type 2 DIABETES in Sri Lanka.

              Relationship of DIABETIC retinopathy and ERECTILE DYSFUNCTION .

              Reminder of important clinical lesson: ERECTILE DYSFUNCTION as an initial presentation of DIABETES discovered by taking sexual history

              Repositioning of molsidomine for its efficacy in DIABETES induced ERECTILE DYSFUNCTION in rats: In silico, in vitro and in vivo approach

              Research Progress of Traditional Chinese Medicine in Treatment of DIABETIC ERECTILE DYSFUNCTION

              Resveratrol and quercetin protect isolated mouse corpora cavernosa from in vitro-induced DIABETIC ERECTILE DYSFUNCTION

              Resveratrol and sildenafil synergistically improve DIABETES -associated ERECTILE DYSFUNCTION in streptozotocin-induced DIABETIC rats

              Review of ERECTILE DYSFUNCTION in DIABETIC animal models

              DYSFUNCTION .50.aspx?Ppt=Article%7Cajnonline:2008:02000:00050%7C%7C”>Revisions to the labeling of ERECTILE DYSFUNCTION and DIABETES drugs

              RhoA/Rho-kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for DIABETES -associated ERECTILE DYSFUNCTION

              Rigiscan evaluation of men with DIABETES mellitus and ERECTILE DYSFUNCTION and correlation with DIABETES duration, age, BMI, lipids and HbA1c

              Risk factors associated with ERECTILE and sexual DYSFUNCTION among non- DIABETIC hemodialysis patients/Hemodiyaliz tedavisi uygulanan non-diyabetik hastalarda …

              DYSFUNCTION _in20160212-932-1rqca58.pdf”>Risk factors for ERECTILE DYSFUNCTION in patients with newly diagnosed DIABETES mellitus

              Role of disturbed fatty acids metabolism in the pathophysiology of DIABETIC ERECTILE DYSFUNCTION

              Role of endogenous nitric oxide synthase inhibitor in ERECTILE DYSFUNCTION of DIABETIC rats

              Role of JAK2 in the Pathogenesis of DIABETIC ERECTILE DYSFUNCTION and an Intervention With Berberine

              Role of miR-145 in ERECTILE DYSFUNCTION in DIABETIC rats

              Role of Nitric Oxide and its Signal Transduction Pathway in DIABETIC ERECTILE DYSFUNCTION [J]

              Role of oxidative stress‐induced systemic and cavernosal molecular alterations in the progression of DIABETIC ERECTILE DYSFUNCTION 在糖尿病性勃起功能障碍的进展过程 …

              Role of Oxidative Stress, Adiponectin and Endoglin in the Pathophysiology of ERECTILE DYSFUNCTION in DIABETIC and Non- DIABETIC Men

              S116 PREVALENCE OF ERECTILE DYSFUNCTION AND ITS ASSOCIATED FACTORS IN MEN WITH TYPE-II DIABETES IN BIRJAND (2008)

              Sat-300: Risk factors of ERECTILE DYSFUNCTION in type 2 DIABETES

              Screening and managing ERECTILE DYSFUNCTION in DIABETIC patients

              Self-reported sitting time and prevalence of ERECTILE DYSFUNCTION in Japanese patients with type 2 DIABETES mellitus: The Dogo Study

              Serum biomarker measurements of endothelial function and oxidative stress after daily dosing of sildenafil in type 2 DIABETIC men with ERECTILE DYSFUNCTION

              Size

              25g, 100g, 300g

              16 reviews for THUNDER (Male Sexual Health)

              1. Rated 5 out of 5

                Tim – June 2, 2017

                This blend is a potent supercharger of sexual energy! Every aspect of my life benefits when I take it, and my lady partner couldn’t be more satisfied 😉
                I’ve had 10+ of the most reputable male libido supplements on the market, but this one is a league above the rest.
                Shortly after ingestion, I can feel its pure, potent nutrition being gladly greedily and magnetically pulled in and put to good work.
                Not only have my sexual escapades benefited from this blend, but my spiritual practices have been bumped into a higher gear too, as I have more energy to channel up the spine into the higher centers of consciousness.
                Supercharge your life!

              2. Rated 5 out of 5

                Rob Helfrick – June 6, 2017

                Gavin to me is an intuitive self trained master herbalist I’ve experienced his original interstellar blend which is an amazing overall health tonic I’ve also used trinity over time which is a wonderful universal helper for all that ails the mind body spirit harmonizing the mental emotional body in a way that is unsurpassed by anything I’ve ever tried and I’ve tried it all. It seems he has a relationship to the plant world with herbs that goes far beyond a mere education. Though I have nothing major that has debilitated me recently I’ve read testimonials from people that have and have had unusual if not miraculous results from taking his herbs regularly. I highly recommend his genius to my friends and I believe his products are very universal and can and do help the world at large. We all have a gift to bring to this world and herbalism Is obvious to me is one of his. Thanks Gavin for your contribution to my own journey

              3. Rated 5 out of 5

                Rob Helfrick – July 26, 2018

                I have taken different aphrodisiacs in the past thunder is by far the best its very balanced and i feel like beyond sexual benefits which it seems to promote overall desire and endurance I feel my vitality go up and feel over all that that is also a remarkable benefit of thunder. Just to say another kickass blend from Gavin, Rock on Brother.

              4. Rated 5 out of 5

                Gordon Fenty – January 3, 2019

                Thunder is a one of a kind blend. After taking it, I’ve felt recharged and ready for action in all aspects of my life. Thank you for your hard work and dedication with all your herbs blends, it has changed my life.

              5. Rated 5 out of 5

                Chad – August 15, 2019

                I’d been looking for a daily use sexual supplement for some time. I tried Stamina rx and Extenze but they gave me adverse side effects along with viagra.

                Then I found a sample pack of Thunder Penis at my doorstep courtesy of Gavin. The first day I started taking it I felt a difference and I haven’t missed a day since.

                Here’s why: It provides a boost in my energy level that helps with every day activities. My job calls for stamina and alertness. As for what it is especially designed for, I have tons of raves. With Thunder Penis I’m sustaining firmer and longer lasting erections then I have had in years (truth), prolonging the pleasure for me and my partner. It’s also increased sensitivity in my penis. Instead of struggling to achieve an orgasm, I actually have to hold it back. Sperm production has definitely increased. My ejaculations are more copious and forceful, and more pleasurable.

                Last but not least, my recovery time has been shortened. With only a few minutes in between rounds, I can regain arousal and engage in another period of sex and enjoy subsequent orgasms.

                On a recent get together with my special lady, I achieved climax three times in just over two hours.

                I’m nearly 40, but I feel like 25 again. Thanks to Interstellar!!!

              6. Rated 5 out of 5

                Paul – November 30, 2019

                I want to talk a moment about “Thunder.” I’m in my early thirties and have had heart problems for the past 17 years. Some days are fine, other days not so fine—and I’ve noticed over the years that when my heart is having problems, my prostate is having problems. In fact, sometimes it gets so bad that I don’t orgasm or ejaculate; it’s just done. Which, let’s be honest, sucks. And here’s the kicker—I’m in great shape, have a sixpack, and am strong.

                I decided to give Thunder a try and—wow! This stuff is potent and works! It took about a week of consistent use for me to really notice the benefits, but when they did, I am not joking, not giving any hyperbole, I had the best sex of my entire life and consistently had mind-blowing sex while using the herbs. I honestly didn’t know that it could feel so good (sorry if that’s too much info, but it’s true!).

                For me, I didn’t feel like a teenager again where the wind changes direction and now I have to adjust to avoid embarrassment. What I did feel was more alive and ready for the day. Because of the aforementioned prostate problems, peeing can sometimes be difficult. While using Thunder, I could pee like a champion racehorse. Which, if you’ve ever not been able to pee and it wakes you up in the night, you’ll know it’s one of the worst things ever. Thunder changed that for me. I love this stuff.

                Thanks, Gavin! This stuff is great!

              7. Rated 5 out of 5

                Cheri Webb (verified owner) – April 6, 2020

                I’m writing this review because it is a blessing. I’m almost 50 in good shape but I noticed I wasn’t able to “salute” for more than 15 minutes. This was troubling for me as well as my wife. She started juicing and I joined her. Then she started with fasting and I joined. When she found about the groups and herbs it really was a game changer. I’m always ready when she’s ready. Love the herbs.

              8. Rated 5 out of 5

                Scotty Schmadebeck – August 16, 2020

                Thunder is by FAR my favorite blend ive tried so far! It makes me feel so powerful and full of energy. I have felt so much more confident since i began to take it.

                I noticed the benefits right away after trying this blend for the first time. I had an amazing workout that day and went on a 3 mile run. Prior to taking Thunder i was hardly able to run one mile without feeling gassed…

                Okay nows the best part. I’ve have so much more confidence that i now can talk to any girl that i want to! I used to be so shy so this has been lifechanging. I really cant say enough about thunder. Its the TRUTH!

              9. Rated 5 out of 5

                reid rowlett – September 25, 2020

                This stuff is like rocket fuel, one of my favorite blends!
                Not only for the bedroom but also the gym!
                it makes me feel like a greek god, like I can accomplish anything and take anything on!
                lift heavier, move faster, train longer, last longer……… 😉
                this mixed in with the rest of the blends I take is a winning formula, I like to take a good dose of thunder on its own before I go out on the town, it makes me feel
                more confident and just more alpha really, like no one can fuck with me.
                also recently I’ve been very disciplined with taking the blends and following the 22/2 fasting Gavin recommends.
                not to lose weight but to actually put weight on, in the form of muscle, 3 weeks ago I was very low fat and 70kg, 3 weeks later with a strict training regime I’ve put 3.5kg of solid muscle on, I put this down to the blends and Gavin’s advice, cannot recommend enough!!!!!!!

              10. Rated 5 out of 5

                Abraham Hermosillo (verified owner) – October 30, 2021

                Thunder, in short, will make your dick hard af. There is no denying the potency of this product. My girlfriend has thanked me time and time again in her bursts of laughter and joy after making love. This will definitely make you juiced up.

                The blood flow is amazing. This aids in other aspects outside of your new and improved rod. I’ve noticed my circulation is through the roof. Even just laying in bed and feeling my blood flow through all parts of my body is such a relaxing, enjoyable, and even meditative practice.

                I feel amazing taking this in conjunction with pine pollen and other products such as shilajit. I feel as though my masculinity thrives while taking these supplements and my health has improved drastically since taking the blends consistently

              11. Rated 5 out of 5

                Anoop (verified owner) – June 12, 2022

                Wow what can I say, I feel like Zeus himself! This blend has honestly changed my life in all aspects, (mentally physically and emotionally)whenever I take it I feel energised and ready to take on the world !

                I went from only being able to achieve climax once and being done for the whole day to being ready to go straight away once again, its honestly amazing how this has boosted my confidence and makes me perform perfectly with the ladies 😉

                Thank you Gavin for recommending this miracle blend, I take this religiously 2 times a day and it works wonders !

              12. Rated 5 out of 5

                Cameron Thomas – July 9, 2022

                As a young man Thunder is just an awesome supplement to have, the benefits are obvious if you’ve read the name of the blend but I honestly didn’t expect it to work as well as it did…

                I only ordered the sample size when I bought other blends just to see what happened and I was actually amazed with my performance after taking it — it’s not an area of life I’ve ever struggled with anyway but the comparative difference is incredible…

                I’m not sure who was more impressed between me or the girls who experienced me taking it :’)

                This is a MUST HAVE for men of any age!!! Big shoutout to Gavin for making this absolute beauty of a blend!!!

              13. Rated 5 out of 5

                Anh Duc Nguyen – December 15, 2022

                I started with Interstellar back in 2020 and I can never look back, as the benefits it has provided me are an excellent value for money. At first I was skeptical because of the price, but please trust me there are no regrets!

                Below are the products that I have been taking and it’s health benefits to me.

                – Trinity- will give you a sense of calmness, stillness, and relaxed state of mind. If you’re short tempered like me then you start to become more cool, things stop bothering you.

                – Seven Sages – from all the food you eat, your environment, the people you surround yourself with, the media. It creates a negative thinking on you at times without you noticing, you wake up at times with a negative outlook on life. But Seven Sages clears all of this. You take it and you just feel absolutely blessed, no negativeness.

                – Nebula the confidence giver. This has particular helped me overcome myself, I do boxing and with Nebula lets just say I punch a lot more back! In the gym, the last rep that I struggle with: Nebula helps me get it.

                – Alderstone this specifically helps me within the gym, my muscle mass and testosterone level increase dramatically with this.

                – Thunder helps me with my sex life, I was suffering from premature ejaculation and low libido. This boosts me way back up. Its also the greatest aphrodisiac, you don’t have to wait so long for your next round!

                – Pine Pollen at first its a bit to drink this as its clumpy but if you’re about your health then mind over matter 🙂. This help improve my skin so much, smoother!

                All in all, each condition you are facing Intestellar will have a solution. Especially Gavin, I message him on facebook for any queries and he points me in the correct direction. Can’t thank him enough.

                Everyone tends to fast with these blends but to be honest, I don’t. But I still reap the benefits (of course if I fast it will be more) so don’t worry if you can’t fast. As long as you take them.

                Best

              14. Rated 5 out of 5

                Christian Lyons (verified owner) – February 15, 2023

                I first purchased Thunder as a sample and I liked it so much I bought the standard size of it. This blend combined with following the fasting protocol (VERY IMPORTANT!) will cure any symptoms of erectile dysfunction. You’ll feel “full”, you’ll have an abundance of stamina, but more importantly, you’ll leave a lasting impression. Even if you’re someone who does not suffer symptoms from ED, but rather just looking to enhance their game; it’s a must have blend to have in your arsenal !!

              15. Rated 5 out of 5

                Matthew W – August 11, 2023

                “I spent 9 years in pain searching for how to get back to going after what I really wanted. Finally after taking blends for a few months, I’m completely back to it. You don’t want to know the number of issues I was having from hiding from my dreams but all of them are solved. Depression, anxiety, muddled and cloudy thinking, emotional pain. I was really praying hard for something to help me. Finally found it.

                Luteolin helped me think normally again.

                Trinity allowed and eased my nervous system to work out the trauma.

                Spaceborn put my mind and body in a higher place.

                Seven Sages allowed me to see subtleties in what was going on with me.

                Autonomous let my mind be unencumbered when understanding.

                Rewire eased the process of changing habits.

                Supernova gave me that kick to keep working through it.

                Matcha let me focus in a relaxed state.

                Stomach reset really seemed to remove a lot of issues automatically, like a fresh slate with how emotions, brain, and gut are connected.

                Thunder is making me less controllable and under others’ influence. Big D energy.

                The others are just as powerful.

                Not to mention fasting making me push through it without physical distraction and coffee to keep me energized. Never would drink coffee before now it’s the best part of my day. I did combine it also with a healing technique called NET but I doubt it’s necessary unless you’re as fucked up as I was lol.

                Blends are it man. Buy them.”

              16. Rated 5 out of 5

                Ivonne Bohorquez – September 20, 2023

                Wow, I’m 35 years old and noticed my erections were not as prominent as they once were. I have always been hesitant to buy herbal formulas that claim to work for male libido and sexual drive. However, after an initial reviewing the ingredients in Thunder, I was confident to try out this formula. I haven’t tried other sexual potency formulas since I feared they would increase my existing heart palpitations and anxious tendencies.  I have also never tried viagra since I think that’s bad for your heart over the longterm and like I’ve mentioned in previous reviews, I always prioritize my heart health.

                My girlfriend (who also now takes these blends on a regular basis) was very pleased with the results.  Harder and bigger erections which gave me extra confidence in the bedroom and a light feeling of euphoria.  Thunder is a must have for any men looking to improve sexual performance and impress their partner. To reiterate, I did not have to worry about this blend giving me any increased heart palpitations or anxiety.

                Thunder is now one of my favorite blends for all the reasons listed and I also think it has increased my testosterone in a very natural way and added enduring energy to my gym workouts (a huge benefit for any man over the age of 30.)

                This blend will boost your performance as a man not only in the bedroom but in life overall.  Rest assured if you have any doubts or anxiety about trying a blend like this, you will not be disappointed. 100% exceeded my expectations!!!

              Add a review Cancel reply

              Your email address will not be published. Required fields are marked *

              Related products

              • On Sale
                SECRET BLENDS PROTOCOL - CHALLENGE COMBO ESSENTIALS - ROADMAP TO SUCCESS - MESSAGE GAVIN FOR PASSWORD

                Protected: SECRET BLENDS PROTOCOL – CHALLENGE COMBO ESSENTIALS – ROADMAP TO SUCCESS – MESSAGE GAVIN FOR PASSWORD

                Rated 5.00 out of 5
                $1,800.00 Original price was: $1,800.00.$777.00Current price is: $777.00.
                Select options This product has multiple variants. The options may be chosen on the product page
              • ACB (PI3K, AKT, mTOR, Sonic Hedgehog Pathway Inhibitor)

                ACB (PI3K, AKT, mTOR, Sonic Hedgehog Pathway Inhibitor)

                Rated 5.00 out of 5
                $275.00
                Select options This product has multiple variants. The options may be chosen on the product page
              • INTERSTELLAR PINE POLLEN

                INTERSTELLAR PINE POLLEN

                Rated 5.00 out of 5
                $75.00 – $250.00
                Select options This product has multiple variants. The options may be chosen on the product page
              • THERMO

                THERMO

                Rated 5.00 out of 5
                $275.00
                Select options This product has multiple variants. The options may be chosen on the product page
              • On Sale
                PEEL & SPICE (Combo Pack)

                PEEL & SPICE (Combo Pack)

                Rated 5.00 out of 5
                $500.00 Original price was: $500.00.$395.00Current price is: $395.00.
                Add to cart
              • On Sale
                ACB (10 Blend) 'VITAL FORCE' COMBO - Save 57%!

                ACB (10 Blend) ‘VITAL FORCE’ COMBO – Save 57%!

                Rated 5.00 out of 5
                $2,325.00 Original price was: $2,325.00.$995.00Current price is: $995.00.
                Add to cart
              © 2025 Interstellar Blends | All Rights Reserved
              Privacy Policy Terms and Conditions
               interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity
              interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity
                   interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity    interstellar herbs, interstellar blend, anti-aging herbs, longevity supplements, intermittent fasting benefits, herbal blends for health, nootropic formulas, herbal remedies for anxiety, skin rejuvenation supplements, anti-wrinkle natural products, detox supplements, herbal support for mental clarity    
                ✕

                Login

                Lost your password?

                Create an account?